Functional analysis of the notch signalling cascade in neural progenitors by Vilas-Boas, Filipe, 1983-
Universidade de Lisboa 
Faculdade de Medicina 
 
 
 
 
 
FUNCTIONAL ANALYSIS OF THE NOTCH 
SIGNALLING CASCADE IN NEURAL 
PROGENITORS 
 
 
 
Filipe Vilas-Boas 
 
 
 
Doutoramento em Ciências Biomédicas 
 
 
 
2010 
  
  
Universidade de Lisboa 
Faculdade de Medicina 
 
 
 
FUNCTIONAL ANALYSIS OF THE NOTCH 
SIGNALLING CASCADE IN NEURAL 
PROGENITORS 
 
Filipe Vilas-Boas 
 
 
Tese orientada pelo Professor Doutor Domingos Henrique 
Tese co-orientada pela Professora Doutora Kate Storey 
 
 
Doutoramento em Ciências Biomédicas 
Especialidade de Biologia do Desenvolvimento 
 
 
Todas as afirmações efectuadas no presente documento são da exclusiva 
responsabilidade do seu autor, não cabendo qualquer responsabilidade à 
Faculdade de Medicina de Lisboa pelos conteúdos nele apresentados. 
  
  
 
  
O trabalho descrito na presente tese foi desenvolvido no Instituto de Medicina 
Molecular, Faculdade de Medicina da Universidade de Lisboa, sob orientação do 
Professor Doutor Domingos Henrique, e no College of Life Sciences, University 
of Dundee, sob orientação da Professora Doutora Kate Storey. Este trabalho foi 
financiado por uma bolsa de doutoramento individual (SFRH/BD/24747/2005) e 
uma bolsa de projecto (PTDC/75106) da Fundação para a Ciência e a 
Tecnologia. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A impressão desta dissertação foi aprovada pela Comissão Coordenadora do 
Conselho Científico da Faculdade de Medicina de Lisboa em reunião de 28 de 
Setembro de 2010. 
  
   
 
 
 
 
 
 
 
 
 
 
 
 
Pai Notch que estais nas células, 
santificado seja o Vosso Nome, 
venha a nós o Vosso Ligando, 
seja feita a Vossa vontade 
assim na Drosophila como no ratinho. 
 
A proliferação de cada dia nos dai hoje, 
perdoai aos nossos proneurais, 
assim como nós perdoamos 
a quem nos tem induzido, 
e não nos deixeis cair em diferenciação 
mas livrai-nos do neuronal. 
 
Amém. 
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Abstract 
 
With the ageing of world population, the number of people suffering from neuronal 
degeneration is drastically increasing and new strategies to prevent or cure neurodegenerative 
diseases are urgently needed. One exciting avenue is the use of stem cells to replace damaged 
neural tissues, but this requires a more comprehensive understanding of the molecular events 
regulating nervous system development. 
In this thesis, I have investigated one molecular pathway that orchestrates vertebrate neural 
development: the Notch signalling pathway. Notch activity is known to restrain neuronal 
differentiation, maintaining a pool of neural progenitors throughout development to ensure 
the production of correct number and types of neurons. During differentiation, various 
mechanisms exist to modulate Notch activity and my work highlights how two particular HES 
proteins function to terminate Notch signalling in newborn neurons of the chick embryo: 
while HES6-2 represses transcription of genes encoding Notch effectors, HES6-1 acts to 
sequester and inactivate these effectors. 
I have also generated a novel reporter to monitor Notch signalling in neural progenitors at the 
single-cell level. A correlation was observed between the timing of Notch activation and the 
cell cycle of neural progenitors, supporting a model for how Notch signalling regulates neural 
fate decisions. When the pathway is active during mitosis, progenitor-generating divisions are 
favoured, whereas absence of Notch activity in mitotic progenitors might lead to different 
daughter cell fates. 
My work provides new insights into the role of Notch signalling in neural progenitors during 
vertebrate nervous system development, and how differentiating neurons terminate Notch 
activity. This knowledge is important to design novel strategies to control neural 
differentiation and might lead to future applications in regenerative medicine of the adult 
nervous system. 
 
Keywords: Notch signalling, chick, spinal cord, neurogenesis, transcriptional reporter, HES5, 
HES6, cell fate, expression dynamics, oscillations, left-right asymmetry, pancreas.
  
 
 
 
 
  
Resumo 
 
As constantes melhorias na qualidade de vida reflectem-se no aumento da esperança média de 
vida. No entanto, o consequente envelhecimento da população mundial tem causado um 
aumento da taxa de incidência de doenças neurodegenerativas. Por esse motivo, torna-se 
muito importante desenvolver novas estratégias de prevenção ou cura dessas doenças. Estas 
estratégias poderão envolver, no futuro, o recurso à medicina regenerativa, utilizando células 
estaminais para reparar tecidos nervosos danificados. As células estaminais podem 
diferenciar-se em diversos tipos celulares, desde que lhes sejam apresentados os devidos sinais 
moleculares. Logo, para que seja possível manipular estas células e diferenciá-las em tecido 
nervoso, é necessário um conhecimento aprofundado dos mecanismos moleculares que 
controlam a formação do sistema nervoso. Nesta tese, investigou-se um mecanismo utilizado 
em vários processos do desenvolvimento animal, incluindo o desenvolvimento do sistema 
nervoso central de vertebrados: a via de sinalização Notch. 
Para gerar o número correcto de neurónios durante o desenvolvimento, é necessária a 
manutenção de uma população residente de progenitores neurais com capacidade 
proliferativa, assegurando a produção contínua de novos neurónios durante o período de 
neurogénese. Cada progenitor neural pode dividir-se simetricamente e gerar duas células 
equivalentes que se dividem novamente (divisão P-P), ou duas células equivalentes que se 
diferenciam em neurónios (divisão N-N). Pode, ainda, dividir-se assimetricamente, para dar 
origem a duas células diferentes, em que uma se divide novamente e a outra se diferencia em 
neurónio (divisão P-N). Sendo assim, para assegurar a manutenção de progenitores durante 
todo o período de neurogénese, a regulação do número de cada tipo de divisão (P-P, P-N ou 
N-N) deverá ser importante. O balanço entre proliferação e neurogénese é assegurado pela 
actividade da via Notch, que restringe a diferenciação neuronal. No entanto, a actividade da 
via Notch na regulação do número de cada tipo de divisão ainda não foi investigada. 
A sinalização Notch é mediada por interacções entre células adjacentes: após o contacto entre 
um ligando transmembranar de uma célula (Delta ou Serrate), e o receptor transmembranar 
de outra célula (Notch), o receptor sofre uma clivagem proteolítica catalisada pela γ-secretase, 
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libertando o domínio intracelular de Notch (NICD) da membrana. O fragmento NICD é 
transportado para o núcleo, onde se liga às proteínas CSL e Mastermind (MAM), 
transformando a proteína CSL num activador transcricional, enquanto que na ausência de 
NICD a proteína CSL actua como repressor transcricional. O complexo NICD/CSL/MAM 
activa a transcrição de diversos genes, sendo que os melhor caracterizados são os genes Hes 
(Hairy and Enhancer of Split). Estes codificam proteínas que possuem o domínio basic helix-
loop-helix (bHLH) e são repressoras transcricionais que inibem a diferenciação neuronal. 
Alguns dos genes, cuja transcrição é reprimida pelas proteínas HES, são os genes proneurais, 
que estão envolvidos na promoção da diferenciação neuronal. Durante a neurogénese, os 
neurónios nascentes expressam altos níveis de proteínas proneurais, que promovem a 
expressão dos ligandos Delta ou Serrate. Estes ligandos sinalizam para os progenitores neurais 
vizinhos que expressem o receptor Notch. A activação deste receptor leva à expressão das 
proteínas HES e à inibição da actividade dos genes proneurais, prevenindo, assim, a 
diferenciação dos progenitores neurais num processo chamado de inibição lateral. 
Apesar da actividade Notch ser necessária para a manutenção da população de progenitores 
neurais, diversos factos sugerem que a actividade Notch não é constante: (a) os diversos 
passos da via Notch têm curta duração, inclusivé a actividade das proteínas HES, devido à 
repressão da transcrição dos seus próprios genes, e aos tempos de vida reduzidos dos ARNm’s 
e proteínas codificados pelos genes Hes; (b) a cada instante, os progenitores neurais com 
actividade Notch são apenas uma pequena porção do total de células que expressam o 
receptor Notch; (c) há diferentes níveis de expressão dos genes Hes entre células a cada dado 
momento; (d) os neurónios que se diferenciam acabam por migrar para longe da região onde 
se encontram os progenitores neurais, sugerindo que, após a diferenciação de uma célula, os 
progenitores neurais podem sofrer alterações nos níveis de actividade Notch. Esta possível 
actividade dinâmica de Notch já foi observada num outro processo do desenvolvimento de 
vertebrados, conhecido por somitogénese. No entanto, a observação de flutuações na 
actividade de Notch em progenitores neurais ainda não foi comprovada. 
Durante o trabalho descrito nesta tese, foram investigados dois genes Hes, tendo como 
objectivo a determinação das suas funções, utilizando o embrião de galinha como modelo 
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experimental. Estes genes Hes são peculiares, pois não são activados pela via Notch e não 
inibem a diferenciação, contribuindo, pelo contrário, para terminar a actividade de Notch em 
neurónios nascentes. Estes genes são expressos em tempos diferentes durante a diferenciação 
neuronal, sendo que a proteína HES6-2 é expressa antes da HES6-1. Para além disso, estas 
proteínas actuam por mecanismos diferentes, provavelmente devido a aspectos particulares 
das suas estruturas que permitem a ligação da proteína HES6-2, mas não da HES6-1, ao ADN, 
sugerindo que a proteína HES6-2 actua por repressão da transcrição, enquanto que a proteína 
HES6-1 funciona por interacção com outras proteínas. Estudos funcionais de diferentes 
variantes destas proteínas, geradas no decorrer do trabalho descrito nesta tese, sugerem um 
modelo para a terminação da via Notch em neurónios nascentes: a proteína HES6-2 é expressa 
primeiro e reprime a transcrição dos genes Hes – efectores da via Notch; em seguida, a 
proteína HES6-1 é expressa e sequestra as proteínas HES; juntas, as duas proteínas HES6 
contribuem para o término da actividade da via Notch, ao reprimirem a expressão e inibirem 
a função de componentes fundamentais desta via. No entanto, enquanto que homólogos dos 
dois genes Hes6 existem em peixes, rãs, galinhas e ornitorrincos, apenas um gene Hes6 existe 
em ratinhos e humanos, sendo este um homólogo do gene Hes6-1. Esta observação sugere o 
desaparecimento do gene Hes6-2 durante a evolução dos mamíferos. 
Para além do estudo dos mecanismos responsáveis pelo término da actividade da via Notch, 
construiu-se um repórter que permite a monitorização da sinalização Notch em progenitores 
neurais durante o seu ciclo celular. Nesta parte do trabalho, foram vários os objectivos 
principais: (a) a determinação da existência, ou não, de uma actividade dinâmica da via Notch 
em progenitores neurais; (b) a observação do início da actividade Notch, determinando se esta 
actividade pode ser iniciada durante todo o ciclo celular, ou apenas em algumas fases; (c) a 
determinação de uma possível participação da via Notch nos mecanismos responsáveis pela 
distinção entre as divisões P-P, P-N e N-N. 
A monitorização da actividade Notch permitiu-me concluir que esta pode ocorrer durante 
diversas fases do ciclo celular dos progenitores neurais, sugerindo a existência de 
estocasticidade nas activações. Por outro lado, a observação do momento inicial das activações 
Notch em progenitores neurais sugere que nestas células possam ocorrer activações sucessivas 
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de Notch. Para além disso, a determinação dos tempos exactos das activações Notch durante o 
ciclo celular sugerem o seguinte modelo para a função desta via na definição do futuro destas 
células: a actividade da via Notch antes da mitose poderá dar origem a uma divisão celular 
simétrica, na qual serão geradas duas células progenitoras que entrarão novamente em 
divisão; pelo contrário, a activação de Notch apenas depois da mitose poderá dar origem a 
duas células diferentes – a célula que activa Notch poderá dividir-se novamente, enquanto que 
a célula desprovida de qualquer actividade Notch poderá entrar em diferenciação neuronal. 
Estes resultados sugerem a existência de uma actividade dinâmica da sinalização Notch e um 
modelo em que a estocasticidade das activações Notch pode contribuir para a definição dos 
diferentes tipos de divisão celular. 
No seu todo, o trabalho descrito nesta tese revela aspectos fundamentais da função da via de 
sinalização Notch na manutenção de progenitores neurais durante o desenvolvimento do 
sistema nervoso de vertebrados e revela alguns mecanismos pelos quais as células em 
diferenciação promovem o fim da actividade desta via. Por fim, espera-se que, no futuro, este 
trabalho contribua para as aplicações da medicina regenerativa no tratamento das doenças do 
sistema nervoso. 
 
Palavras-chave: Sinalização Notch, galinha, espinal medula, neurogénese, repórter de 
transcrição, HES5, HES6, destino celular, dinâmica de expressão, oscilações, assimetria 
esquerda-direita, pâncreas. 
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Chapter I – General Introduction 
CHAPTER I – GENERAL INTRODUCTION 
 
The nervous system is an intriguing system, not only because of the large number and 
diversity of cell types, but also because of the tremendous complexity in cellular connectivity, 
which in the end control the behaviour of living multicellular organisms. With the ageing of 
world population, the number of people suffering from neuronal degeneration is drastically 
increasing, with several diseases affecting the human nervous system, such as Parkinson’s, 
Alzheimer’s, Huntington’s and multiple sclerosis, which are triggered by molecular 
mechanisms that are still largely unexplained. It is therefore of ultimate importance that new 
strategies to prevent or cure these diseases are developed. These strategies may involve, for 
instance, pharmacological applications or regenerative medicine. Regenerative medicine 
consists in creating living, functional tissues to repair or replace damaged tissues. It can be 
based on the activation of regeneration of existing damaged tissues in the organism, or on the 
creation of new tissues using stem cells, which will replace the damaged tissues. For the 
application of regenerative medicine to cure neuronal degeneration it is required to activate 
the molecular events that drive the formation of the nervous system. Therefore, before new 
regenerative medicine strategies are developed we must first expand our knowledge on the 
molecular mechanisms required for the development of the vertebrate embryonic nervous 
system tissues. 
In this thesis I have focused on one of the mechanisms that orchestrate the development of the 
vertebrate central nervous system: the Notch signalling pathway. 
For logical ethical reasons, vertebrate neurogenesis is mostly studied in model organisms, the 
most common being zebrafish, Xenopus, chick and mouse. For the studies described in this 
thesis, I have taken advantage of the ease of chick embryo manipulation. 
In Chapter I, I will describe the early development of the chick embryo and explain the origin 
of neural tissues in this animal. I will then explore the complexity of the Notch signalling 
pathway and give examples on how it controls vertebrate neurogenesis. In the end, I will state 
the questions I wish to address in this thesis. 
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I.1. DEVELOPMENT OF THE CHICK EMBRYO 
 
I.1.1. Early development of the chick embryo 
(reviewed in Gilbert, 2000; Bellairs and Osmond, 2005) 
 
After fertilization, the zygote rapidly undergoes several cell divisions. Initially, the chick 
embryo is comprised of a flat disc, the blastoderm. Between the blastoderm and the yolk there 
is a space called the subgerminal cavity that is created when the blastoderm cells absorb fluid 
from the albumin and secrete it between themselves and the yolk (Fig. I.1A). 
The ventral side of the embryo will form closer to the yolk, while the dorsal side will form 
immediately beneath the vitelline membrane (the membrane that surrounds the embryo and 
the yolk). The antero-posterior axis is established according to gravity, with the anterior end 
forming in the lowest region whereas the future posterior end forms at the highest region. 
With the interaction of these two axes the embryo acquires a left and a right side. 
When the egg is laid the chick embryo already comprises several thousand cells. During the 
first 24 hours after incubation, the embryo is divided into the area pellucida, the almost 
transparent central region, and the area opaca, the more opaque peripheral ring (Fig. I.1B). 
Between the area pellucida and the area opaca there is a thin layer of cells called the marginal 
zone. The area pellucida consists of two layers, the epiblast, which is the upper layer, and the 
hypoblast. The hypoblast is formed by delaminated cells from the epiblast into the 
subgerminal cavity and from the growth of a sheet of cells at a thickening called the Koller’s 
sickle located at the posterior margin of the blastoderm (Fig. I.1B,C). The space between the 
two layers is called the blastocoel. All cells from the avian embryonic tissues are derived from 
the epiblast, while the extra-embryonic tissues are derived from the epiblast, hypoblast and 
area opaca. 
Gastrulation in chick depends on a structure called primitive streak. Primitive streak cells 
arise from a population of epiblast cells in the posterior midline of the area pellucida, just 
anterior to Koller’s sickle, at about 6-7h of incubation (stage HH2 (Hamburger and Hamilton, 
1951)), its apex lying in the area pellucida and its base close to the area opaca (Fig. I.2A). 
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Epiblast cells converge at the posterior end of the area pellucida towards the midline and, as 
these cells enter the primitive streak, the streak elongates towards the future head region 
(stage HH3) reaching its full length of about two thirds of the way across the area pellucida by 
about 15h of incubation (stage HH4) (Fig. I.2B,C). At the anterior end of the primitive streak 
of stage HH4 embryos there is a thickening of cells called the Hensen's node (Fig. I.2C). The 
primitive streak elongates by extending not only anteriorly, but also posteriorly, with the 
posterior end moving into the area opaca and causing the area pellucida to become pear-
shaped (Fig. I.2C). 
 
 
 
 
Figure I.1: The early chick embryo is comprised of the area pellucida and area opaca. 
(A-C) The early chick embryo is comprised of a flat disc, the blastoderm (A), which is subdivided into the area 
pellucida and the area opaca (B). Between the blastoderm and the yolk there is a space called the subgerminal 
cavity (A). The area pellucida consists in two layers, the upper layer which is the epiblast, and the lower layer 
called the hypoblast, which derives from delaminating cells from the epiblast and from the migration of a sheet of 
cells from the Koller’s sickle into the subgerminal space (B,C). Adapted from Gilbert (2000). 
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Figure I.2: Formation of the primitive streak and beginning of gastrulation. 
(A-C) Gastrulation in the chick depends on the formation of the primitive streak, which arises at the posterior 
region of the epiblast, just anterior to the Koller’s sickle (A). Convergence of cells towards the posterior midline 
elongates the primitive streak towards the anterior region of the embryo (B). The primitive streak elongates until 
two thirds of the way across the area pellucida (C). At the anterior-most region of the primitive streak a 
thickening of cells arise, named Hensen’s node. Once the formation of the primitive streak is complete, the area 
pellucida becomes pear-shaped (C). (D) After the generation of the primitive streak, gastrulation starts with the 
formation a structure just anterior to the Hensen’s node named head process and with the regression of the 
Hensen’s node towards the posterior end of the embryo along the primitive streak. Adapted from Gilbert (2000). 
 
 
The primitive streak defines the axes of the embryo: it extends from posterior to anterior, 
migrating cells ingress from the dorsal side into the ventral side, it separates the left and right 
halves of the embryo, and cells close to the streak will be part of medial structures, while those 
farther from it will incorporate distal structures. 
Once the primitive streak has formed, epiblast cells migrate through it into the blastocoel. 
Cells of the epiblast undergo epithelial to mesenchymal transition (EMT), ingressing in the 
primitive streak and Hensen’s node on their way to become organized again in epithelia as 
they become transformed into two different layers below the epiblast: endoderm and 
mesoderm (Fig. I.3). One of the immediate consequences of gastrulation is to convert the two-
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layered embryo (consisting of the epiblast and hypoblast) into a three-layered one, composed 
of ectoderm, mesoderm and endoderm. 
Cells migrating inwardly through the lateral portion of the primitive streak enter the 
blastocoel and separate into endoderm and mesoderm. The endodermal layer joins the 
hypoblast along its midline and displaces the hypoblast cells to the sides. These deep-moving 
cells give rise to all endodermal tissues of the embryo and to most of the extraembryonic 
membranes. The mesodermal layer spreads between the endoderm and the epiblast, forming a 
loose layer of cells. These middle layer cells generate the mesodermal tissues of the embryo 
and extraembryonic membranes (Fig. I.3). 
Cells migrating through the Hensen's node into the blastocoel migrate anteriorly, forming the 
foregut, head mesoderm and the anterior notochord (see below) and pushing up the anterior 
midline region of the epiblast to form the head process (Fig. I.2D). 
At stage HH5 the disappearance of the primitive streak is initiated from the anterior to the 
posterior end of the embryo, with the Hensen’s node moving along the disappearing primitive 
streak, being always present in its anterior-most end (Fig. I.2D). As regression of the Hensen's 
node starts, the presumptive notochord cells in Hensen's node and the anterior primitive 
streak give rise to the trunk notochord, a mesodermal rod of cells running along the entire 
midline of the embryo. The most anterior part of this rod is the already referred head process, 
formed by the anteriorward migration of cells from the Hensen's node, whereas the trunk 
notochord is formed by condensation of mesodermal tissue that has ingressed through the 
lateral portion of the primitive streak. 
Once the Hensen's node regresses to its most posterior position, all presumptive endodermal 
and mesodermal cells have ingressed and the epiblast is composed entirely of presumptive 
ectodermal cells. By about stage HH11, the remnants of Hensen's node and the primitive 
streak are aggregated at the posterior end of the area pellucida into a mass of cells called the 
tail bud, which continues generating the most posterior tissues of the embryo. 
Because of the gradual process of gastrulation along the anterior-posterior axis, differentiation 
of the tissues occurs also gradually from anterior to posterior following regression, with 
anterior tissues developing before the posterior ones. 
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Figure I.3: Gastrulation of the chick 
embryo. 
During gastrulation, cells of the 
epiblast ingress through the 
primitive streak and Hensen's node 
into the blastocoel and arrange 
themselves into endoderm and 
mesoderm layers: endodermal cells 
migrate deeply and displace the 
hypoblast to the sides and the 
mesoderm forms between the 
epiblast and the endoderm. Adapted 
from Gilbert (2000). 
 
 
I.1.2. Left-right asymmetry 
 
Despite the external bilateral symmetry of vertebrates, the internal organs display striking 
asymmetries, with the heart, pancreas, stomach and spleen located on the left side, and the 
liver and gallbladder on the right side. Even though vertebrates show an asymmetric 
morphology, the molecular processes that break the initial body symmetry to establish left-
right asymmetry can vary. Nonetheless, they all contribute to the asymmetric expression of 
genes in the embryo (reviewed in Raya and Belmonte, 2006). 
Since the first discovery of genes that are expressed differentially in the left and right sides of 
the embryo, such as Nodal, Activin Receptor IIa, Sonic Hedgehog (SHH) and HNF3β (Levin et 
al., 1995), many new findings have led to an increasing knowledge on the molecular 
mechanisms responsible for the determination of the left-right axis. These findings revealed 
the existence of many other asymmetrically expressed genes, which are specifically expressed 
only on the left or on the right sides of the embryo (reviewed in Raya and Belmonte, 2004; 
Raya and Belmonte, 2006) (Fig. I.4). While the genes on the left side of the embryo contribute 
to the body asymmetry, the genes on the right side repress the transcription of left-sided 
genes, revealing cross-inhibition between the gene regulatory networks on the two sides 
(reviewed in Raya and Belmonte, 2004). 
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Figure I.4: The asymmetric expression of genes between the left and right sides of the embryo contributes to 
the creation of a left-right body axis. 
Several genes are asymmetrically expressed in the chick and contribute to the creation of body asymmetry. Some 
of these genes are depicted in this figure. (A,B) Asymmetric gene expression starts in the Hensen's node (A) and 
is then transduced to the lateral plate mesoderm (B). Asymmetric expression of Nodal on the left side of the 
embryo is reflected in the asymmetric expression of downstream genes, such as Pitx2, which is transduced in the 
specification of left-sided structures (B). Adapted from Gilbert (2000). 
 
 
In chick, although the process that breaks the initial symmetry is still unknown, the first 
known event that is related to this process is an asymmetric H+/K+-ATPase activity at stage 
HH3-4. This activity has been reported to induce a leftward movement of cells around the 
Hensen’s node (Gros et al., 2009), an asymmetric expression of SHH and Fibroblast Growth 
Factor 8 (FGF8) around the node (Levin et al., 2002) (Fig. I.4A), and also an asymmetric 
extracellular accumulation of calcium, that is transduced into the activation of Notch 
signalling and Nodal expression on the left side on the node (Raya et al., 2004). 
After the initial break of symmetry, the information on the left side of the Hensen’s node is 
transduced to the lateral plate mesoderm (see below) around stage HH6-7, as revealed by the 
expression of Nodal only on this side (reviewed in Raya and Belmonte, 2004). NODAL and 
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other signals further increase Nodal expression, with these positive feedback loops expanding 
its expression throughout most of the left lateral plate mesoderm. Other proteins are 
expressed downstream of NODAL, including LEFTY1 and LEFTY2, which are inhibitors of 
the function and expression of NODAL. These negative feedback loops restrain the duration 
and extent of its expression in the lateral plate mesoderm (reviewed in Raya and Belmonte, 
2006). These positive and negative feedback loops allow a vast field of cells to be informed as 
to their left identity. During the short duration of NODAL signalling, the expression of PITX2 
and NKX3.2 is activated. The asymmetric expression of these two proteins is maintained 
during the following developmental stages and it is believed that these transcription factors 
confer left-sided instructions to the developing organ primordia, transducing the initial 
molecular asymmetry into the asymmetric morphology of adult organs (reviewed in Raya and 
Belmonte, 2004; Raya and Belmonte, 2006) (Fig. I.4B). 
 
I.1.3. Embryo endodermal derivatives 
(reviewed in Gilbert, 2000; Bellairs and Osmond, 2005) 
 
The function of the embryonic endoderm is to construct the linings of the digestive tube and 
the respiratory tube. The digestive tube extends throughout the length of the body and buds 
from this tube form the liver, gallbladder and pancreas. The respiratory tube forms as an 
outgrowth of the digestive tube and eventually bifurcates into two lungs. The digestive and 
respiratory tubes share a structure called the pharynx, which gives rise to the tonsils, thyroid, 
thymus and parathyroid glands. 
The endoderm of the gut is divided in the anterior-posterior axis in three main regions called 
the foregut, midgut and hindgut. The endoderm contributes to the epithelial lining of the gut 
and the ducts of the mucous glands, while the mesoderm gives rise to the muscular wall and 
associated structures. Interactions between endoderm and mesoderm play a crucial role in the 
development of the gut. 
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I.1.4. Embryo mesodermal derivatives 
(reviewed in Gilbert, 2000; Bellairs and Osmond, 2005) 
 
To form the mesoderm, cells pass into and through the primitive streak and then migrate 
laterally between the epiblast and the endoderm to generate all organs between the ectodermal 
wall and the endodermal tissues. The mesoderm of a neurula stage embryo (see below) can be 
divided into five regions (Fig. I.5): 
- The chordamesoderm (or axial mesoderm) forms the notochord, a transient organ 
that induces the formation of the neural tube and establishes the anterior-posterior 
body axis. 
- The paraxial mesoderm (or somitic mesoderm) undergoes a process called 
somitogenesis to form somites, blocks of mesodermal cells in a row on either side of 
the notochord that generate many of the connective tissues of the back (bone, muscle, 
cartilage, and dermis). During somitogenesis, mesenchymal cells in the pre-somitic 
mesoderm (PSM), the still unsegmented paraxial mesoderm, become epithelial as they 
are organized into somites. Groups of cells at the anterior end of the two segmental 
plates (pre-somitic mesoderm on either side of the notochord) become separated 
simultaneously to form the left and the right of a pair of somites. The first pair of 
somites appears at stage HH7 and succeeding pairs are formed sequentially further 
and further posteriorly (Fig. I.6). The layout of these segmented structures influences 
that of all the other segmental structures that form subsequently. 
- The lateral plate mesoderm ingresses through the primitive streak before the somitic 
mesoderm, thus spreading more distally, reaching the edge of the area opaca and also 
continuing into this region as extra-embryonic mesoderm. It gives rise to the heart, 
blood vessels and blood cells of the circulatory system, and also to the lining of the 
body cavities and to all the mesodermal components of the limbs except the muscles. It 
also forms extraembryonic membranes that are important for transporting nutrients 
to the embryo. 
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- The intermediate mesoderm is localized between the somites and the lateral plate 
mesoderm, to both of which it is initially attached. It gives rise to most of the 
urinogenital system, including the kidneys, the gonads and their respective duct 
systems. 
- The head mesenchyme contributes to the connective tissues and musculature of the 
face. 
 
 
 
 
 
Figure I.5: Different regions of the mesoderm of a neurula stage embryo. 
The mesoderm of a neurula stage embryo can be sub-divided into intermediate mesoderm, chordamesoderm, 
paraxial mesoderm, lateral plate mesoderm and head mesenchyme. The chordamesoderm forms the notochord, 
while the other regions form all mesodermal tissues of the adult animal. Adapted from Gilbert (2000). 
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Figure I.6: Segmentation of the paraxial 
mesoderm generates epithelial structures 
named somites. 
Scanning electron microscope image showing 
groups of cells at the anterior end of the two 
segmental plates becoming simultaneously 
separated from the remaining pre-somitic 
mesoderm, forming a new pair of somites in a 
process called somitogenesis. Adapted from 
Gilbert (2000). 
 
 
 
 
 
 
I.1.5. Embryo ectodermal derivatives 
 
At the end of gastrulation, the epiblast is composed entirely of presumptive ectodermal cells 
(Gilbert, 2000). The ectoderm gives rise to several tissues including the nervous system and 
the epidermis (Fig. I.7). 
 
I.1.5.1. Neural Induction 
(reviewed in Bellairs and Osmond, 2005; Linker and Stern, 2009) 
 
The ectoderm forms the neural tissue in a process named neural induction. In the Xenopus 
embryo, the ectoderm is inhibited to form neural tissue (neural plate) by Bone Morphogenetic 
Protein (BMP) signalling, but the Spemann’s organizer (equivalent to the chick Hensen’s 
node) secretes BMP antagonists (like Noggin or Chordin), so that the ectoderm is able to 
develop into neural plate. However, it appears that in chick the process is more complex, since 
BMP inhibition is necessary, but not sufficient, to induce neural markers, and inhibition of 
Wingless Integrated (Wnt) signalling may also be important. 
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Figure I.7: The ectoderm divides into three 
regions to give rise to numerous adult 
tissues. 
The ectoderm divides into the outer 
ectoderm (epidermis), neural crest and 
neural tube, giving rise to several tissues 
including, for example, the ones from the 
central and peripheral nervous systems, the 
epidermis, melanocytes and facial cartilage. 
Adapted from Gilbert (2000). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chick neural induction is initiated before the start of gastrulation and before the organizer 
(Hensen’s node) forms. The hypoblast expresses FGF, which induces a sequential expression 
of genes required for neural induction. However, although the hypoblast initiates this process, 
it is not sufficient to induce a neural plate. This can only be accomplished after the initial 
induction has been later reinforced and completed by signals from other tissues, most likely 
by the early organizer. When the Hensen’s node is formed, it contains both the early and late 
signals required for neural induction, explaining why grafts of the organizer can induce the 
formation of a neural plate. 
Epiblast cells that receive signals from the hypoblast and Hensen’s node become sensitized to 
BMP antagonists, necessary to counteract the action of BMPs, which prevent the ectoderm 
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from acquiring a neural fate. This allows the formation of a mature neural plate, which is the 
origin of the central nervous system and part of the peripheral nervous system, containing the 
neural stem cells, which later become competent to differentiate into neurons. 
The epiblast region that gives rise to the neural plate is an extensive area lying over Hensen's 
node and extending anteriorly, laterally and posteriorly. Ectodermal cells around the Hensen’s 
node, and later at the tail bud, are kept under the influence of FGFs that maintain a neural 
stem zone and allow the continuous production of new neural tissue, while the embryo 
continues to grow further and further posteriorly (reviewed in Diez del Corral and Storey, 
2004) (this subject will be discussed later in Section I.2.1). 
 
I.1.5.2. Neurulation 
(reviewed in Gilbert, 2000; Bellairs and Osmond, 2005) 
 
After the neural plate has been specified, several morphological changes occur in the ectoderm 
to form the neural tube (the structure that gives rise to the brain and spinal cord), the neural 
crest (gives rise to dermal melanocytes, cranial cartilage and bones, and peripheral nervous 
system) and the epidermis. The process by which the neural tube forms is called neurulation 
(Fig. I.8) and an embryo undergoing this process is called a neurula. There are two sequential 
ways of forming a neural tube, these being the primary and the secondary neurulations. 
Initially, the cells of the neural plate and the adjacent ectoderm are morphologically 
indistinguishable. However, after the neural plate is formed, the morphogenetic movements of 
regression lead to a narrowing and posterior extension of the trunk region and a widening of 
the brain region, leading to the pear-shaped area pellucida. These regression movements are 
accompanied by changes in the shapes and arrangements of the cells, induced by the 
underlying mesoderm, with the edges of the neural plate thickening and moving upward to 
form the neural folds. In this “primary neurulation”, the notochord is attached to the neural 
plate at the medial hinge point (MHP) cells and acts as a hinge that allows the neural plate to 
fold and bend to form a tube (Fig. I.8A-C). 
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Figure I.8: Separation of the neural plate from the non-neural 
ectoderm occurs by primary neurulation. 
(A-F) After the induction of the neural tissue, the borders between the 
non-neural ectoderm and the neural plate thicken and move upward, 
using the notochord as a hinge at the medial hinge point (MHP) of the 
neural plate and forming the neural folds (A-C). The neural folds fuse, 
separating the neural tissue from the epidermis. The dorsal-most cells 
of the neural plate, which correspond to the borders between the neural 
plate and the non-neural ectoderm, form the neural crest (which are 
mesenchymal cells), while the remaining neural tissue forms the neural 
tube (epithelial cells) (D-F). Adapted from Gilbert (2000). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fusion of the neural folds begins at about stage HH8 at the level of the midbrain and is rapidly 
followed by fusion throughout the entire brain and the anterior regions of the trunk (Fig. 
I.8D,F). The final point of fusion in the brain is the anterior neuropore, which is extinguished 
by stage HH12. At stage HH13, neural tube closure is almost complete, with an opening 
remaining only at the posterior end of the embryo (the posterior neuropore). As the neural 
folds fuse, the cells at the dorsal-most portion of the neural tube become the neural crest cells 
and the ectoderm that is not enclosed within the neural tube subsequently becomes the 
epidermis (Fig. I.8F). The neural crest is derived from the ectoderm at the junction between 
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the non-neural ectoderm and the presumptive neural ectoderm and, like the notochord and 
somites, it is found only in the early embryo. 
The neural tube continues forming in the tail bud in a process called secondary neurulation, 
to distinguish it from the process described above, called primary neurulation. In secondary 
neurulation, mesenchyme cells in a region of the tail bud called chordo-neural hinge originate 
the posterior neural tube and the posterior notochord (Fig. I.9). These cells become 
condensed into an epithelial-like rod, which then separates off from the remaining tissues and 
cavitates to form the lumen of the neural tube. 
 
 
 
 
Figure I.9: Formation of the posterior neural tissue occurs by secondary neurulation. 
At the posterior-most end of the embryo a region of the tail bud named chordo-neural hinge proliferates and 
generates cells that organize into an epithelial-like rod that separates from the remaining tissues. This structure 
cavitates and forms the lumen of the posterior neural tube. D: dorsal; V: ventral; P: posterior. Adapted from Le 
Douarin (2001). 
 
 
I.2. PATTERNING OF THE NERVOUS SYSTEM 
 
The neural tube organizes into the various regions of the central nervous system (CNS) in 
different ways: the neural tube outgrows and constricts to form the compartments of the brain 
and spinal cord, and the neuroepithelial cells within the walls of the neural tube rearrange 
themselves and differentiate into the numerous types of neurons (nerve cells) and glia 
(supportive cells) present in the body (reviewed in Gilbert, 2000). The wide range of cell types 
in the CNS relies on neural progenitors acquiring particular identities at specific positions 
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within the neural tube along both the dorsal-ventral and the anterior-posterior axes (reviewed 
in Diez del Corral and Storey, 2004). 
 
I.2.1. Anterior-posterior patterning of the neural tube 
 
As described above, the gradual process of avian gastrulation along the anterior-posterior axis 
causes an advance in development of the anterior tissues in comparison the posterior ones. 
This is also true for the nervous system (reviewed in Diez del Corral and Storey, 2004). 
The early neural plate forms the forebrain and more caudal regions of the CNS form the 
midbrain, hindbrain and spinal cord in response to signals provided by the newly formed 
mesodermal tissues: FGF, Wnts and Retinoic Acid (RA). The cells of the posterior neural 
plate, which regress alongside the primitive streak, constitute the caudal stem zone and will 
then become integrated into the tail bud (as the chordo-neural hinge) to give rise to the 
caudal-most spinal cord (reviewed in Diez del Corral and Storey, 2004). 
Once cells leave the stem zone they enter a transition region in which a few cells become ready 
to differentiate. However, neuronal differentiation only initiates in the developing neural tube 
as it becomes flanked by somites (Diez del Corral et al., 2002; Diez del Corral et al., 2003). 
This suggests that signals in the region of the stem zone maintain cells in the undifferentiated 
state, while signals from the somites promote the beginning of neuronal differentiation. 
Indeed, the pre-somitic mesoderm secretes FGF, which has been found to induce the 
expression of stem zone markers and repress the induction of neuronal genes (Diez del Corral 
et al., 2002; Diez del Corral et al., 2003). By contrast, RA secreted from the somites has been 
found to activate the expression of neuronal genes in the neural tube (Diez del Corral et al., 
2003). Furthermore, these pathways mutually inhibit each other: FGF represses RALDH2 
expression, responsible for the synthesis of RA in the paraxial mesoderm, and RA attenuates 
FGF levels, both in the stem zone and pre-somitic mesoderm (Diez del Corral et al., 2003). As 
the primitive streak continues regressing, this mutual inhibition creates a caudalward 
travelling wave of RA expression and a complementary decline in FGF levels (reviewed in 
Diez del Corral and Storey, 2004) (Fig. I.10). FGF signalling also induces the expression of 
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Wnt, which acts, following the decline of FGF activity, to allow the activity of RA in the 
neuroepithelium (Olivera-Martinez and Storey, 2007). 
Continued FGF signalling in the stem zone not only keeps cells undifferentiated but allows 
them to respond to further caudalising signals: during the formation of the spinal cord there is 
a progressive onset of expression of Hox genes (reviewed in Diez del Corral and Storey, 2004) 
downstream of FGF signalling (Delfino-Machin et al., 2005). Hox genes are expressed in the 
paraxial mesoderm and the caudal hindbrain and spinal cord and act to confer positional 
identity in the rostro-caudal axis (reviewed in Diez del Corral and Storey, 2004). 
 
 
Figure I.10: Mutual inhibition between RA and 
FGF maintains a stem zone and activates 
neurogenesis in the neural tube. 
FGF secreted at the posterior-most region of the 
embryo maintains the caudal neural plate cells 
proliferating. By contrast, RA secreted by the 
somites activates neurogenesis in cells in the neural 
tube. Inhibition of FGF at the anterior region and 
inhibition of RA at the posterior region of the 
embryo creates a gradient of the two signals. Cells 
leaving the stem zone due to continuous posterior 
growth of the embryo pass through a transition 
zone where they are ready to differentiate, but 
differentiation only initiates when these cells 
become under the influence of RA, which activates 
the expression of genes involved in neuronal 
differentiation. Furthermore, RA also activates the 
expression of genes that set the ventral patterning of 
the neural tube. Adapted from Diez del Corral and 
Storey (2004). 
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I.2.2. Dorso-ventral patterning of the spinal cord 
 
Cells leaving the stem zone and giving rise to the spinal cord not only acquire anterior-
posterior, but also a dorsal-ventral identity. Furthermore, acquisition of a dorsal-ventral 
identity coincides with the onset of neurogenesis, suggesting that these two processes are 
regulated by the same mechanisms. Indeed, FGF represses and RA activates the expression of 
spinal cord ventral genes (reviewed in Diez del Corral and Storey, 2004) (Fig. I.10). 
The lateral walls of the neural tube contain neural progenitors that differentiate into both 
neurons and glia, whereas the dorsal and ventral regions of the tube, the roof and floor plates, 
respectively, are narrower with wedge-shaped cells and only give rise to glial cells. 
Cells in the notochord and floor plate express SHH, while cells in the roof plate and epidermal 
ectoderm express members of the Transforming Growth Factor-β (TGF-β) family (reviewed 
in Lee and Jessell, 1999). While SHH is required for the specification of ventral domains, 
TGF-β specifies dorsal domains. Their expression creates a gradient of the two signalling 
molecules, which is reflected in different dorso-ventral patterns of expression of proteins in 
the spinal cord, such as homeodomain (HD) and basic helix-loop-helix (bHLH) factors 
(reviewed in Jessell, 2000; Helms and Johnson, 2003) (Fig. I.11A). Wnt signalling appears to 
be also involved in the specification of dorsal domains (reviewed in Helms and Johnson, 
2003). There are cross-repressive interactions between these domains, creating sharp 
boundaries and consolidating domain identity (reviewed in Jessell, 2000). The proteins 
expressed in each domain specify the identity of each of the classes of neurons that derive 
from individual progenitor domains (reviewed in Jessell, 2000; Helms and Johnson, 2003) 
(Fig. I.11A). 
The dorso-ventral patterning of the spinal cord allows this structure to be divided in different 
domains. The neurons and circuits that process cutaneous sensory input and relay it to the 
brain are concentrated in the dorsal spinal cord, whereas circuits involved in relaying 
information about trunk and limb position and circuits involved in motor control are 
confined to the ventral spinal cord (reviewed in Jessell, 2000) (Fig. I.11B). 
 
  20
Chapter I – General Introduction 
 
 
Figure I.11: Dorso-ventral patterning of the spinal cord. 
(A) Sonic hedgehog (SHH) signals secreted from the notochord and floor plate specify the ventral domains of the 
spinal cord, whereas Transforming Growth Factor-β (TGF-β) generated from the epidermal ectoderm and roof 
plate specify the dorsal domains of the spinal cord. Their expression creates a gradient of the two signalling 
molecules, which is reflected in the specification of different dorso-ventral domains and from which arise 
different types of neurons. (B) Neurons and circuits that process sensory input are located in the dorsal spinal 
cord, whereas circuits involved in motor control are confined to the ventral spinal cord. Adapted from Gilbert 
(2000). 
 
 
I.3. HISTOLOGY OF THE NEUROEPITHELIUM, INTERKINETIC NUCLEAR MIGRATION AND CELL 
CYCLE 
 
Once the neural tube forms, its walls are composed of bipolar-shaped epithelial cells, taller 
than cells from the floor and roof plates. Only the cells from the walls of the neural tube have 
descendants that differentiate into neurons, whereas cells from the floor and roof plates 
provide patterning cues for neural tube development, as described above (reviewed in 
Hollyday, 2001). Neuroepithelial cells are polarized, with the basal region terminating in an 
endfoot that contacts basal lamina at the periphery of the tube, whereas the apical end is next 
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to the lumen of the tube. Cells are in close contact to one another in the apical regions by a 
variety of specialized junctions, while contacts at the lateral cell surfaces are less extensive and 
no connections are observed in the basal endfeet (reviewed in Hollyday, 2001). 
The nucleus of a neuroepithelial cell moves within the cytoplasm back and forth across the 
wall of the tube, in a process called interkinetic nuclear migration (INM), which was first 
identified 75 years ago (Sauer, 1935; reviewed in Fujita, 2003). Because the nuclei of 
neuroepithelial cells show unsynchronized displacements in the neuroepithelium due to INM, 
this tissue looks layered ("pseudo-stratified") (Fig. I.12A). 
A key feature of interkinetic nuclear migration is that nuclear position varies in relation to the 
phases of the cell cycle, with mitotic figures being always adjacent to the lumen of the tube and 
the nuclei of cells in S-phase being always close to the basal lamina (reviewed in Fujita, 2003), 
as identified by the incorporation of thymidine analogues during DNA replication (Fujita, 
1962) (Fig. I.12B). 
 
 
 
 
Figure I.12: Interkinetic nuclear migration of neuroepithelial cells. 
(A) Scanning electron microscope image showing nuclei of neuroepithelial cells at different positions across the 
apical-basal axis, constituting a “pseudo-stratified neuroepithelium”. (B) Nuclei of neuroepithelial cells migrate 
back and forth within the cytoplasm across the wall of the neural tube in a process called interkinetic nuclear 
migration (INM). Nuclear position varies in relation to the phases of the cell cycle, with mitotic figures being 
always present at the apical surface and the nuclei of cells in S-phase being always close to the basal lamina. 
Although not represented in the figure, the basal process is retained during mitosis. Adapted from Gilbert 
(2000). 
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As cells leave S-phase and enter G2, their nuclei move rapidly towards the ventricular surface. 
By contrast, the G1 phase has the longest duration (Takahashi et al., 1993). 
Cells become nearly spherical by late prophase and remain at the lumen until late telophase 
(reviewed in Hollyday, 2001). During mitosis, although cells round up close to the lumen, they 
still retain the thin basal process, which is inherited by only one daughter cell (reviewed in 
Wodarz and Huttner, 2003). 
After division, each of the daughter cells either repeats or exits the cell cycle. The daughters 
that exit cell cycle withdraw the apical endfoot attachments and move basally through the 
neuroepithelium to a region called the mantle layer (ML), which is peripheric to the region 
where neuroepithelial cells are replicating, called the ventricular zone (VZ) (reviewed in 
Hollyday, 2001). Cells that have withdrawn from the cell cycle are considered to be in G0 and 
the time when this occurs is considered to be their birthdate. Cell cycle withdrawal has been 
proposed to be a mechanism to prevent already specified progenitor cells from the influence 
of extrinsic signals (reviewed in Edlund and Jessell, 1999). 
During development, there is a progressive change in competence and restriction in the range 
of fates available to individual cells (reviewed in Edlund and Jessell, 1999). During nervous 
system development, cells that exit the cell cycle early take on early fates (neuronal fates), 
while cells that exit the cell cycle later take on later fates (glial fates) (reviewed in Ohnuma and 
Harris, 2003). The fate of certain classes of neural cells appears to be restricted several 
divisions before cell cycle exit, but for other cell types, similar restrictions appear to occur 
much closer to the time of cell cycle exit or only after they have exited the cell cycle (reviewed 
in Edlund and Jessell, 1999). 
Cell cycle transitions are regulated by Cyclin-dependent kinases (CDKs) and blocked by the 
action of CDK inhibitors. Some of these components play an active role in both determining 
neuronal cell fate choice and regulating cellular differentiation. In turn, some fate 
determinants can influence cell cycle (reviewed in Ohnuma et al., 2001; Salomoni and 
Calegari, 2010). 
Although many years have passed since the initial description of INM in the vertebrate 
neuroepithelium, many questions remain about this process, including its functional role and 
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why this movement correlates with the cell cycle. Interestingly, although this correlation 
exists, it appears that these two processes can be uncoupled, as chemical inhibition of the INM 
does not block cell cycle progression (Murciano et al., 2002; Schenk et al., 2009) and 
interference with the cell cycle does not block INM (Murciano et al., 2002). However, this is 
still controversial, since another report indicates that the INM is blocked after arresting the 
cell cycle (Ueno et al., 2006), and other reports show a correlation between extension of the 
cell cycle and proportional slowing down of the INM (reviewed in Baye and Link, 2008). 
The INM depends on the actin and microtubules cytoskeleton and their associated motor 
forces (reviewed in Taverna and Huttner, 2010). As such, the INM is dependent on the 
coupling of the nucleus to the apically localized centrosome by microtubules (Xie et al., 2007). 
The centrosome is located in the apical endfoot of neural progenitors due to the presence of a 
primary cilium, and the nucleus may be required to move to the apical endfoot in order for 
the centrosome to be available for mitosis. However, the total apical surface area is limited and 
it would be impossible for all cells to be dividing at the same time, indicating that a functional 
role for INM could be the separation of mitotic events to provide space for cell division 
(reviewed in Miyata, 2008; Taverna and Huttner, 2010). 
 
I.4. VERTEBRATE NEUROGENESIS 
 
I.4.1. Lengthening of the cell cycle 
 
The cell cycle seems to be regulated differently in different regions of the nervous system and 
at various times during development (reviewed in Hollyday, 2001). Cell cycle lengthens as 
development proceeds and this is mostly due to a lengthening of G1 (reviewed in Salomoni 
and Calegari, 2010). Interestingly, cell cycles of neural progenitors that undergo neurogenic 
divisions (give rise to neurons after mitosis) are characterized by an increased G1 phase 
(Calegari et al., 2005), which is the phase of the cell cycle where it is believed that cells decide 
whether to continue proliferating or exit cell cycle to start differentiation (reviewed in 
Salomoni and Calegari, 2010). This is in agreement with the fact that experimental 
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lengthening of the cell cycle by chemical inhibition or knockdown of Cyclins/CDKs increases 
neurogenesis (Calegari and Huttner, 2003; Lange et al., 2009) and its shortening by 
Cyclins/CDKs overexpression decreases the rate of neuron production (Lange et al., 2009; 
Pilaz et al., 2009), supporting the view that G1 lengthening is both necessary and sufficient to 
cause the switch from proliferation to neurogenesis. It was suggested that the increase in G1 
length gives the cell more time to respond to the action of cell fate determinants (reviewed in 
Gotz and Huttner, 2005; Salomoni and Calegari, 2010). It should also be noted that forced 
expression of Cyclins in neural progenitors has also been reported to maintain these cells on 
cycle while progressing through neuronal differentiation (Lobjois et al., 2008), indicating that 
neuronal commitment can be uncoupled from cell cycle exit. 
 
I.4.2. Modes of division (P-P, P-N, N-N) 
 
Neural progenitors can undergo symmetric cell divisions that originate two progenitors (P-P 
divisions) or two neurons (N-N divisions), or asymmetric cell divisions giving rise to one 
progenitor and one neuron (P-N divisions) (reviewed in Gotz and Huttner, 2005) (Fig. I.13). 
Although many studies have attempted to determine the mechanisms responsible for the 
three cell division modes, many different and controversial reports have been published 
(reviewed in Shioi et al., 2009). The most accepted model about the mechanism that 
distinguishes symmetric from asymmetric cell divisions involves the angle of division plane 
and the way it bisects or bypasses the apical elements of the dividing cell, which are suggested 
to be the responsible for the final fates of the daughter cells (reviewed in Gotz and Huttner, 
2005). It has been suggested that perpendicular cleavage planes that bisect the apical 
constituents generate daughter cells with similar amounts of these apical elements, which then 
acquire the same cell fate (symmetric P-P or N-N divisions) (Kosodo et al., 2004). In contrast, 
parallel or perpendicular cleavage planes that bypass the apical constituents generate one 
daughter cell with all these apical elements, while the other daughter cell would be devoid of 
these constituents, originating asymmetric P-N divisions (reviewed in Gotz and Huttner, 
2005). However, although this model explains one possible mechanism for the generation of 
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symmetric or asymmetric divisions, it does not explain how both symmetric P-P or N-N 
divisions can be generated by the equal partitioning of the apical constituents. 
A recent study indicates that P-P divisions can occur in either parallel or perpendicular 
cleavage planes (0-90º), while P-N divisions are mostly generated in parallel (0-75º) and N-N 
divisions are only generated in perpendicular cleavage planes (75-90º). This suggests that the 
angle of cleavage plane only affects the type of division when cells have the potential to 
generate neurons and that the neurogenic ability is separable from division orientation 
(Wilcock et al., 2007). Neurogenic potential will be discussed in the next Section. 
 
 
Figure I.13: Types of divisions in the 
neuroepithelium. 
(A-C) Dividing neural progenitors can 
generate two neural progenitors that divide 
again (symmetric P-P division) (A), or one 
progenitor that divides while the other 
differentiates as a neuron (asymmetric P-N 
division) (B), or two cells that differentiate as 
neurons (symmetric N-N division) (C). In 
each panel, the series of images corresponds to 
different time points progressing from left to 
right. Apical is down and basal is up. Nuclei of 
dividing cells are depicted in white and nuclei 
of neurons are depicted in black. 
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I.4.3. Proneural genes and neuronal differentiation genes 
 
The anterior-posterior and the dorsal-ventral patternings of the vertebrate nervous system are 
not only required for the specification on cell types but they also contribute to initiate 
neurogenesis by activating the expression of transcription factors required for this process. 
Once cells of the neural tube become under the influence of RA secreted by the somites, they 
become competent to differentiate as neurons (reviewed in Diez del Corral and Storey, 2004), 
starting to express proneural genes, which are implicated in neuronal differentiation 
(reviewed in Bertrand et al., 2002). Proneural proteins share several features that define them 
as proneural: they are responsible for the initiation of programmes of neurogenesis in neural 
progenitors by leading to neuronal commitment, cell cycle exit and differentiation, and all 
have a basic helix-loop-helix (bHLH) domain (reviewed in Guillemot, 2007). Proneural 
proteins can activate the expression of other proteins containing a bHLH domain, such as the 
neuronal differentiation proteins, which are expressed in post-mitotic cells and contribute to 
the neuronal differentiation programme (reviewed in Guillemot, 2007). In this thesis, these 
two types of bHLH proteins will be collectively called as neural bHLH proteins. 
 
I.4.3.1. Neural bHLH proteins structure 
 
The bHLH domain allows the neural bHLH proteins to dimerize with other partners through 
interactions between the two helices of each partner and subsequently bind DNA via the basic 
domain (reviewed in Bertrand et al., 2002) (Fig. I.14). 
 
 
Figure I.14: bHLH proteins dimerize and bind DNA. 
bHLH proteins dimerize with other bHLH proteins by the two 
helices in the HLH domain. After dimerizing, these complexes bind 
DNA through their basic regions. Adapted from Bertrand et al. 
(2002). 
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I.4.3.2. Neural bHLH proteins families 
 
Genes encoding neural bHLH proteins were first identified in Drosophila. Initially, a cluster of 
four genes including achaete (ac), scute (sc), lethal of scute (lsc) and asense (ase) was identified 
in a 100Kb DNA region, constituting the achaete-scute complex (asc). Then three more genes 
were identified, these being atonal (ato), absent MD neurons and olfactory sensilla (amos) and 
cousin of atonal (cato), defining the atonal (ato) family (reviewed in Bertrand et al., 2002; 
Gibert and Simpson, 2003). 
Many genes related to the asc and ato families have been identified in vertebrates. The 
vertebrate asc family includes ash1 (achaete-scute homologue, also known as ASCL1), which is 
present in all species analysed (for example Mash1 in mouse and Cash1 in chick), and three 
other genes that have each been found in only one class of vertebrates (Mash2 in mammals, 
Xash3 in Xenopus and Cash4 in chick). There is a higher number of vertebrate genes related 
to the ato family, but only two of them (Math1 and Math5 in the mouse – atonal homologue) 
encode proteins containing a bHLH domain with sufficient homology to that of ato to be 
considered as orthologues (reviewed in Bertrand et al., 2002). Other vertebrate ato-related 
genes can be grouped into distinct families, such as the Neurogenin (Ngn, also known as 
Neurog), the NeuroD and the Olig families, which are distinguished by the presence of specific 
residues in the bHLH domains of their protein products. This indicates that members of each 
family share biochemical properties that distinguish them from other neural bHLH proteins 
(reviewed in Hassan and Bellen, 2000; Bertrand et al., 2002). 
 
I.4.3.3. Neural bHLH proteins function 
 
Neural bHLH proteins bind the ubiquitously expressed E proteins, other bHLH proteins 
encoded by the Drosophila daughterless (da) or one of the three mammalian genes E2A (with 
its two alternative products E12 and E47), HEB and E2-2, and bind specific DNA sequences 
called E-boxes (consensus sequence CANNTG). Neural bHLH proteins normally activate 
transcription of target genes, although in some cases they can act as transcriptional repressors. 
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Even though neural bHLH-E protein heterodimers bind E-boxes, the binding specificity 
requires other than the four consensus nucleotides in the E-box and it is likely that specificity 
is also obtained through binding of other co-factors (reviewed in Bertrand et al., 2002). 
In vertebrates, genetic analysis has shown that neural bHLH proteins have different functions, 
as some act like proneural proteins, whereas others act like neuronal differentiation proteins, 
being involved in neuronal differentiation or also in the specification of neuronal fates 
(reviewed in Bertrand et al., 2002). Neural bHLH proteins promote commitment to 
neurogenesis (Ma et al., 1996; Kim et al., 1997; Fode et al., 1998; Perron et al., 1999; Farah et 
al., 2000; Tomita et al., 2000; Gowan et al., 2001; Nieto et al., 2001; Sun et al., 2001; Nakada et 
al., 2004) directly activating cell cycle exit (Farah et al., 2000). In addition, they contribute to 
the inhibition of gliogenesis (Tomita et al., 2000; Nieto et al., 2001; Sun et al., 2001; He et al., 
2005; reviewed in Vetter, 2001), and to the specification of progenitor-cell identity (Fode et al., 
2000; Gowan et al., 2001; Parras et al., 2002; Nakada et al., 2004), which can be achieved by 
cross-inhibition between different bHLH proteins in distinct domains (Fode et al., 2000; 
Gowan et al., 2001) or by cooperation (Mizuguchi et al., 2001; Novitch et al., 2001). This could 
be one of the strategies for the ability of a limited number of transcription factors to regulate 
specification of such a diversity of cell types in the nervous system. 
 
I.4.3.4. Neural bHLH gene cascade during neuronal differentiation 
 
Once neural progenitors become competent to differentiate by the expression of proneural 
genes, neuronal commitment is initially reversible, as long as these genes are expressed at low 
levels. However, once proneural genes have reached a high level of expression, commitment to 
differentiation is irreversible (reviewed in Kintner, 2002). 
Several mechanisms have been described that reinforce the expression of proneural proteins 
(reviewed in Gibert and Simpson, 2003). For example, proneural proteins can activate 
transcription of their own genes, as it has been observed for the ato family MATH1 protein 
(Helms et al., 2000). Proneural proteins can also increase their levels by activating the 
expression of proteins that release proneural gene expression from Notch signalling inhibition 
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(Koyano-Nakagawa et al., 2000; Fior and Henrique, 2005) (Notch signalling will be described 
in detail in Section I.5).  
After neural progenitors commit irreversibly to neuronal differentiation and exit cell cycle, 
proneural proteins activate the expression of the neuronal differentiation genes that 
implement the neuronal differentiation programme in a genetic cascade. After that, proneural 
gene expression is down-regulated (reviewed in Bertrand et al., 2002; Guillemot, 2007). 
Proneural gene down-regulation is essential for the progression and completion of 
neurogenesis, as ectopic expression of proneural proteins in neurons causes cell death (Cai et 
al., 2000). 
Neural progenitors express a number of transcription factors that act in combinatorial ways to 
specify other transcription factors after withdrawal from the cell cycle (reviewed in Hollyday, 
2001). For example, in Xenopus, Ngnr1, Xath3 and NeuroD are expressed sequentially: 
NGNR1 activates the expression of both Xath3 and NeuroD (Ma et al., 1996), whereas XATH3 
and NEUROD can induce each other’s expression, but not that of Ngnr1 (Perron et al., 1999). 
More recently, Neurog2 expression was shown to overlap with that of Ascl1 and Neurog1, 
although it has later temporal characteristics, with Neurog2 expression being downstream of 
Ascl1 (Helms et al., 2005). Overall, in Xenopus and mouse, Ascl1 and the Neurog’s are 
expressed earlier than the ato homologues, which in their turn are expressed earlier than 
NeuroD (reviewed in Gibert and Simpson, 2003). 
The existence of a temporal cascade of bHLH gene expression during neuronal differentiation 
implies that there must be mechanisms to ensure the switch-off of genes expressed earlier in 
the cascade. For instance, HES6, which is downstream of the NEUROG’s, inhibits the Notch 
signalling pathway (see below) to ensure the switch off of the progenitor program (Koyano-
Nakagawa et al., 2000; Fior and Henrique, 2005). Furthermore, the paired box PAX6 protein 
is required for NEUROG2 expression but its sustained expression prevents the progression of 
neurogenesis. NEUROG2, in turn, down-regulates PAX6 expression through an unknown 
factor, releasing the blocking of neurogenesis caused by this protein (Bel-Vialar et al., 2007). 
In another example, NEUROG2 activates the expression of the transcriptional repressor 
MTGR1, which in turn down-regulates the expression of NEUROG2 (Aaker et al., 2009). This 
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shows that the neurogenic programme relies on the consecutive activation of expression of 
different factors, which not only activate the next step in the cascade, but also switch off the 
previous one. 
 
I.5. NOTCH SIGNALLING 
 
One of the features of the proneural proteins is their ability to trigger Notch signalling and a 
process called lateral inhibition (reviewed in Bertrand et al., 2002). This process is essential for 
the maintenance of a pool of progenitors throughout development to ensure the production 
of the correct number and types of neurons and will be described in Section I.5.3.1. 
Notch is a transmembrane receptor that coordinates a signalling system known as the Notch 
pathway. The Notch gene was identified in 1917 by Thomas Hunt Morgan, after the 
observation of a mutant fly with "notches" in its wings, which indicated its requirement in 
wing outgrowth. Other components of Notch signalling were then identified through mutant 
animals whose phenotypes resembled those of Notch mutants. For the last 90 years, Notch has 
been intensively investigated and numerous roles for this pathway in development have been 
found in several species throughout the animal kingdom (reviewed in Lai, 2004). Notch 
signalling is likely involved in the development of almost all metazoan tissues, if not all 
(reviewed in Louvi and Artavanis-Tsakonas, 2006). It is therefore not surprising that 
abnormal Notch signalling underlies some human diseases (reviewed in Talora et al., 2008). 
Due to the importance of Notch signalling in development and diseases this will still be the 
focus of investigation for many years. 
 
I.5.1. Notch signalling core components 
 
I.5.1.1. Notch signalling pathway 
 
The Notch receptors and ligands are single-pass transmembrane proteins. Upon interaction 
between the extracellular domains of the ligand and receptor of adjacent cells, the binding 
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triggers a series of proteolytic events that result in cleavage of the Notch intracellular domain 
(NICD). NICD carries nuclear localization signals and can therefore translocate to the 
nucleus. Once in the nucleus, the intracellular domain acts as an activation and recruitment 
element of a complex that contains the DNA-binding protein CSL (Mammalian CBF1/RBPjκ, 
Drosophila Suppressor of Hairless, C. elegans Lag-1) and the nuclear protein Mastermind 
(MAM). Without Notch activation, the CSL protein is part of a transcriptional repressor 
complex including N-CoR, SHARP and CtBP. However, upon interactions with NICD, the 
repressor complex is dissociated and CSL becomes part of an activator complex that includes 
NICD, MAM and p300/CBP, which drives transcription of previously repressed Notch target 
genes (reviewed in Lai, 2004; Le Borgne et al., 2005; Louvi and Artavanis-Tsakonas, 2006; 
Fischer and Gessler, 2007) (Fig. I.15). 
 
 
Figure I.15: Notch signalling pathway. 
Upon Notch receptor activation by contact with a ligand 
from a neighbouring cell, the receptor suffers proteolytic 
cleavages and the Notch intracellular domain (NICD) is 
released from the membrane. NICD then translocates to 
the nucleus where it binds CSL, displacing the co-
repressor (Co-R) complex and recruiting Mastermind 
(MAM) and other co-activators (Co-A). Together, this 
activator complex induces the expression of Notch target 
genes. Adapted from Kageyama et al. (2007b). 
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I.5.1.2. Notch ligands 
 
Although the Notch signalling pathway is highly conserved across species, the number of 
Notch components is highly variable, with these genes being expressed in different tissues and 
having different functions (reviewed in Louvi and Artavanis-Tsakonas, 2006; Kopan and 
Ilagan, 2009) (Table I.1). 
 
 
Table I.1: Notch components in different species. 
List of homologues of the Notch receptors, Notch ligands, CSL and Mastermind in Drosophila, C. elegans, chick 
and mammals, showing the variability of the number of Notch components across species. Adapted from Fior 
and Henrique (2009). 
 
 Drosophila C. elegans Chick Mammals 
Notch receptor Notch lin-12 Notch1 Notch1 
  glp-1 Notch2 Notch2 
  Notch3 
  Notch4 
Notch ligands Delta lag-2 Dll-1 Dll-1 
 Serrate apx-1 Dll-4 Dll-3 
  arg-2 Jagged1 Dll-4 
  f16b12.2 Jagged2 Jagged1 
  Jagged2 
CSL Su(H) lag-1 CBF1/RBPJK CBF1/RBPJK 
Mastermind Mam lag-3 Mam1 Mam1 
  Mam2 Mam2 
  Mam3 Mam3 
 
 
While only two ligands exist in Drosophila, Delta and Serrate, there are two ligands of each 
type in chick, these being DLL1 and DLL4 (Delta-like), JAG1 and JAG2 (Jagged, the 
homologue of Serrate) (reviewed in Fior and Henrique, 2009) (Table I.1). In mammals, 
besides these four, there is also another Notch ligand called DLL3, although its functions are 
still largely unknown and seems to be expressed in differentiating cells to inhibit Notch 
signalling in cis (in the same cell), instead of activating it in trans (in neighbouring cells) 
(Dunwoodie et al., 1997; Ladi et al., 2005; Geffers et al., 2007). 
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The Notch ligands are type I transmembrane proteins and are characterized by three related 
structural motifs: an N-terminal DSL (Delta/Serrate/LAG-2) motif, specialized tandem 
epidermal growth factor (EGF) repeats called DOS domains (Delta and OSM-11-like 
proteins), and EGF-like repeats. Both the DSL and DOS domains are involved in receptor 
binding. While all Serrate/Jagged ligands contain the DOS domain, its presence in Delta 
ligands is variable, since it exists in DLL1 but not in DLL3 or DLL4. Serrate/Jagged ligands are 
also characterized by the presence of a cystein-rich domain, which is absent from Delta 
ligands. Additional proteins lacking DSL and DOS domains have been reported to act as non-
canonical ligands for Notch receptors and the activity of ligands can also be influenced by 
proteins containing only the DOS domain (reviewed in Kopan and Ilagan, 2009). 
 
I.5.1.3. Notch receptors 
 
As observed for the ligands, the number of Notch receptors is also variable between species, 
with only one existing in Drosophila and four Notch receptors existing in mammals that 
display both redundant and unique functions (reviewed in Louvi and Artavanis-Tsakonas, 
2006; Kopan and Ilagan, 2009) (Table I.1). 
Notch receptors are large single-pass type I transmembrane proteins. Their extracelullar 
region contains 29-36 tandem EGF-like repeats, some of which mediate interactions with the 
Notch ligands. EGF repeats bind to calcium ions, which modulate ligand-receptor binding 
affinities and consequent signalling efficiency. Also present in the extracellular region are a 
negative regulatory region (NRR), which plays a critical role in preventing receptor activation 
in the absence of ligands, and a heterodimerization domain, which can be cleaved by furin-
like convertases at site 1 (S1). The S1 cleavage converts the Notch polypeptide into an NECD-
NTMIC (Notch extracelullar domain-Notch transmembrane and intracelullar domain) 
heterodimer, held together by non-covalent interactions between the N- and C-terminal 
halves of the heterodimerization domain. Intracellularly, the Notch receptor contains a RAM 
(RBPjκ association module) domain that forms a high-affinity binding module for the CSL 
protein, seven ankyrin repeats (ANK domain), two nuclear localization sequences (NLS), a 
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glutamine-rich OPA domain, a transactivating domain (TAD), and PEST motifs that harbour 
degradation signals and regulate the stability of NICD (reviewed in Kopan and Ilagan, 2009). 
Notch receptor activation is mediated by a sequence of proteolytic events. Ligand binding 
leads to cleavage of Notch by ADAM (a disintegrin and metaloprotease) proteases at site 2 
(S2), located 12 amino acids before the transmembrane domain. The release of the Notch 
ectodomain creates a membrane-tethered intermediate called Notch extracellular truncation 
(NEXT). NEXT is then progressively cleaved by γ-secretase between sites 3 and 4 (S3 and S4), 
releasing the Notch intracellular domain from the membrane, which translocates to the 
nucleus due to its NLS sequences. In the nucleus, NICD interacts with CSL, first through 
NICD’s RAM domain and then through its ANK domain. The binding between NICD and 
CSL induces dissociation of repressor complexes and the recruitment of Mastermind, which 
in turn recruits histone acetyltransferase p300, chromatin remodelling factors and the MED8 
mediator transcription activation complex, thereby inducing up-regulation of downstream 
target genes (reviewed in Kopan and Ilagan, 2009). Recently, other regions of NICD have been 
identified, such as PPD (potential phosphorylated domain), DTS (down-regulation targeting 
sequence) and S4 (for WSSSSP). PPD enhances the binding of NICD to CSL, DTS is required 
for endocytic trafficking of Notch and crosstalk with the Ras signalling pathway, and S4 is the 
C-terminal phosphorylation site, important for Notch turnover (reviewed in Borggrefe and 
Oswald, 2009). 
 
I.5.1.4. Notch effectors 
 
Although there are numerous CSL binding sites throughout the genome, the best 
characterized Notch transcriptional targets are genes encoding bHLH transcriptional 
repressors, which include the Enhancer of Split (E(spl)) complex in Drosophila and the Hairy 
and Enhancer of Split homologues (Hes) or Hes-related (Hesr/Hey) families of genes in 
vertebrates (reviewed in Louvi and Artavanis-Tsakonas, 2006). 
Drosophila has 13 known proteins related to the proteins encoded by the E(spl) complex, 
including eight E(spl) (seven m-type and Her), three Hairy (Hairy, Deadpan and Side), and 
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two Hey-like (Hesr-1 and Sticky/Ch1) proteins. Vertebrate proteins related to the E(spl) 
complex-encoded proteins in Drosophila can be grouped into distinct subfamilies based on 
their primary structures and by homology to the Drosophila proteins: Hairy, E(spl), Hey and 
Stra13 (reviewed in Davis and Turner, 2001) (Fig. I.16). 
 
 
 
 
Figure I.16: Distinct sub-families of E(spl) proteins. 
E(spl)-related proteins can be grouped into distinct subfamilies with unique structural features. Hairy, E(spl), 
Hey and Stra13 all contain bHLH and Orange domains, but are distinct in other domains, which are also 
represented. Hairy, E(spl) and Hey are downstream targets of Notch activity, while Stra13 proteins are not. 
Adapted from Davis and Turner (2001). 
 
 
All proteins in these subfamilies contain a conserved amino acid sequence known as the 
Orange domain (helix3/4) located C-terminal to the bHLH domain. These proteins can thus 
be called bHLH-Orange (bHLH-O) (reviewed in Davis and Turner, 2001). The members of 
each subfamily are identified by the length of the sequence between the bHLH and the Orange 
domain and by the C-terminal tetrapeptide motif, which can be WRPW in Hairy and E(spl) 
subfamilies, or YXXW in Hey subfamily. No conserved C-terminal tetrapeptide is found in 
members of the Stra13 subfamily. Hairy proteins also have a short sequence with unknown 
function called HC domain, between the Orange domain and the C-terminus of the protein 
(reviewed in Davis and Turner, 2001). The YXXW motif of Hey proteins is followed by a 
conserved TE(I/V)GAF peptide with unknown function (reviewed in Fischer and Gessler, 
2007). 
Vertebrate genomes contain several bHLH-O encoding genes belonging to the different 
subfamilies. The nomenclature for the bHLH-O family is complicated by the problem of 
independent isolation in multiple laboratories, as well as by the subfamily structure. Hairy-
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like and E(spl)-like proteins have been collectively named HES (Hairy and Enhancer of Split), 
HER (Hairy and Enhancer of Split-Related) or ESR (Enhancer of Split-Related) in mammals, 
zebrafish and Xenopus, respectively. HEY proteins have also been named HRT or HESR 
(reviewed in Davis and Turner, 2001). 
bHLH-O proteins exert their function by DNA-binding and transcriptional repression (Fig. 
I.17). HES proteins can bind DNA in sequences called E-boxes (consensus sequence 
CANNTG) or N-boxes (CACNAG) (Fig. I.17B), with different proteins having different 
binding affinities for the two boxes. HEY proteins bind to E-, but not to N-boxes, while Stra13 
proteins do not bind to either E- or N-boxes (reviewed in Davis and Turner, 2001). Like the 
binding of neural bHLH proteins to E boxes described above, the flanking nucleotides of these 
sequences may also influence the binding of bHLH-O proteins (reviewed in Fischer and 
Gessler, 2007). Furthermore, DNA-binding of bHLH-O proteins is also mediated by a region 
of basic amino acids immediately N-terminal to the HLH dimerization domain (Fig. I.17A). 
The basic region of HES proteins differs from that of other bHLH proteins by the presence of 
a proline residue at a conserved position. The HEY proteins have a conserved glycine at the 
same position, while the basic region of the Stra13 proteins has a proline at a different position 
(reviewed in Davis and Turner, 2001). This proline is proposed to confer unique DNA-
binding activity to HES proteins (reviewed in Kageyama et al., 2007b). 
After binding to DNA, HES proteins recruit the Groucho/TLE co-repressor, an action 
mediated by the WRPW domain (Fig. I.17A,B). Groucho/TLE functions by recruiting histone 
deacetylases (HDACs) and members of the Sin3 complex to repress target genes, while it can 
also mediate interactions between bHLH-O proteins and other types of repressors (reviewed 
in Davis and Turner, 2001; Fischer and Gessler, 2007; Kageyama et al., 2007b). Although 
Drosophila Hairy and E(Spl) proteins end precisely with the WRPW tetrapeptide, some 
vertebrate HES proteins have a short extension sequence. For example, mammalian HES1 
ends with WRPWRN, but it is still able to interact with the TLE1 protein. Since vertebrates 
have multiple TLE proteins, it is possible that variations on the WRPW motif might restrict 
which TLE proteins bind to a specific bHLH-O protein (reviewed in Davis and Turner, 2001). 
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The WRPW domain can also act as a polyubiquitination signal (Kang et al., 2005) (Fig. I.17A), 
conferring short half-lives to HES proteins (Hirata et al., 2002). 
Transcriptional repression by HEY proteins does not require HDAC function or the YXXW 
domain, whereas the Stra13 proteins can repress transcription by HDAC-dependent and 
HDAC-independent mechanisms. It is not known whether Stra13 proteins exert their 
function by recruitment of Groucho/TLE (reviewed in Davis and Turner, 2001). HEY proteins 
do not bind to TLE proteins. Instead, they use the bHLH domain to recruit the N-CoR and 
mSin3A repressors, which then indirectly recruit HDACs. The bHLH domain of HEY 
proteins can also recruit directly SIRT1, another histone deacetylase. It seems that HES and 
HEY proteins require recruitment of both HDAC1 and SIRT1 for full repression activity. 
While HDAC1 can be recruited using the bHLH and the C-terminus domains, SIRT1 is only 
bound by the bHLH domain (reviewed in Fischer and Gessler, 2007). 
 
 
Figure I.17: Structure and function of HES 
proteins. 
(A) HES proteins dimerize through the HLH 
domain, with the binding specificity provided 
by the Orange domain. The dimers can then 
bind DNA through the basic domain (b) and 
use the WRPW domain to recruit the co-
repressor Groucho/TLE to repress transcription 
of target genes. (B) HES proteins can form 
homodimers or heterodimers (with different 
transcriptional repressors, such as with HEY 
proteins) to repress transcription of target 
genes. (C,D) However, HES proteins may also 
form heterodimers with transcriptional 
activators, such as E47 proteins (C), impairing 
the formation of proneural-E47 heterodimers 
that normally activate transcription of target 
genes (D). Adapted from Kageyama et al. 
(2007b). 
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Like other bHLH proteins, the bHLH-O proteins form homodimers or heterodimers via their 
HLH domain. Dimerization has been reported to occur with neural bHLH proteins, inhibiting 
their function, or with bHLH-O proteins (Fig. I.17). Although heterodimerization may lead to 
non-functional heterodimers, if it happens between different bHLH-O proteins it might lead 
to heterodimers with novel functions, including stronger transcriptional repressor abilities. 
Protein-protein interactions specificity is mediated by the Orange domain (reviewed in Davis 
and Turner, 2001; Fischer and Gessler, 2007; Kageyama et al., 2007b) (Fig. I.17A). 
Even though most Hes and all Hey genes are up-regulated by ectopic Notch activation, some 
are not affected by mutations in either the Notch receptor, CSL or presenilins, indicating that 
Hes genes can integrate signals from other signalling pathways independently of Notch 
(reviewed in Davis and Turner, 2001; Fischer and Gessler, 2007). There is a crosstalk between 
Notch and the BMP/TGF-beta, JAK-STAT, Ras and HIF signalling pathways to enhance 
activation of bHLH-O proteins (reviewed in Fischer and Gessler, 2007). 
All these possible combinations of binding partners, modes of transcriptional repression and 
also post-translational modifications of the Notch effectors (see below), add to the complexity 
of Notch signalling and allow repression of a multitude of genes from different signalling 
pathways in different tissues, indicating that bHLH-O proteins might function as signal 
integrators and regulate many different developmental programs (reviewed in Fischer and 
Gessler, 2007). 
 
I.5.2. Modulation of Notch signalling 
 
In a 1998 review by Sarah Bray, the following statement about Notch signalling can be found: 
“The essential components are NICD and CSL. This means that the opportunities for 
regulation of this pathway are limited” (Bray, 1998). Eight years later the same author 
published another review entitled "Notch signalling: a simple pathway becomes complex" 
where she wrote that "we are still just beginning to understand the full complexities of Notch 
regulation" (Bray, 2006). This can give an idea of the rapid evolution of our knowledge on the 
high complexity of Notch signalling pathway, which currently is still not well understood. 
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Developmental processes are extraordinarily sensitive to the dosage of Notch signalling. Since 
each Notch molecule undergoes proteolysis to generate a signal and thus can only signal once, 
modulating the quantity of the ligand or receptor availability at the cell surface is fundamental 
to controlling Notch activation and might alter the developmental consequences of Notch 
signalling (reviewed in Louvi and Artavanis-Tsakonas, 2006; Fior and Henrique, 2009; Kopan 
and Ilagan, 2009). 
Several mechanisms have been identified that control ligand or receptor availability, including 
regulation of expression patterns, trafficking and post-translational modifications. Besides 
modulating the availability and activity of Notch receptors and ligands at the cell surface, 
other modulators have been found that affect Notch signalling in the nucleus or affect its 
downstream targets. In the following Sections I will give some insights into the current 
knowledge of Notch signalling regulation. 
 
I.5.2.1. Ubiquitination and endocytosis 
 
Activation of the Notch receptor by Delta requires the addition of ubiquitin to the ligand. This 
ubiquitination is performed by either one of the E3 ubiquitin ligases named Neuralized and 
Mindbomb, and promotes the internalization of Delta. The way though which endocytosis of 
Delta promotes activation of the Notch receptor is still controversial, with different models 
proposed. For example, the generation of a pulling force on a bound receptor could cause a 
conformational change, facilitating the S2 cleavage of Notch in the Notch-expressing cell. 
Another possibility is that ubiquitination promotes ligand clustering, which is known to 
promote a more effective Notch activation. A third possibility is that ubiquitination induces 
trafficking of the ligand into an endocytic compartment, which enables its modification or 
results in recycling of the ligand into specific membrane domains (reviewed in Lai, 2004; Le 
Borgne et al., 2005; Bray, 2006; Kopan and Ilagan, 2009). Paradoxically, some functional 
ligands in C. elegans are secreted, but even in this case the ubiquitin-binding protein Epsin is 
required for Notch activation, indicating that ubiquitination is essential for Notch signalling 
(reviewed in Bray, 2006). 
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Localization of ligands is important for effective signalling and might be influenced by other 
proteins, such as Echinoid, which co-localizes with Notch and Delta at adherens junctions in 
Drosophila and functions as a positive regulator to promote Notch signalling. Echinoid co-
localizes with Delta in endocytic vesicles and its overexpression depletes Delta from the 
membrane, suggesting that it might promote endocytosis of Delta. Alternatively, Echinoid 
could favour Notch-Delta interactions by mediating adhesion (reviewed in Bray, 2006). 
Like the ligands, the Notch receptor can also be ubiquitinated by the E3 ubiquitin ligases 
Deltex, Nedd4, Su(Dx)/Itch and Cbl. The consequent endocytosis can either take the receptor 
towards lysosomal degradation or towards recycling, thereby influencing receptor half-life, 
the length of time the receptor is located on the surface, or its capability to interact with y-
secretase (reviewed in Le Borgne et al., 2005; Bray, 2006; Fior and Henrique, 2009; Kopan and 
Ilagan, 2009). There are also other mechanisms, not mediated by ubiquitination, involving the 
ESCRT complex and the Lethal Giant Discs (LGD) protein, that also control endosomal 
sorting of the receptor and promote its targeting to lysosomal degradation (reviewed in Fior 
and Henrique, 2009). 
The prevention of improper ligand-independent Notch receptor activation is not only 
regulated by the negative regulatory region of the Notch receptor, but also by endosomal 
sorting, which restricts receptor activation at or near the surface, as mistrafficking of Notch 
leads to ectopic activation of the pathway. Endosomal sorting has also been suggested to be 
required for receptor cleavage by γ-secretase in endosomes. However, this is still controversial 
and it is likely that cleavage occurs instead at the plasma membrane (reviewed in Le Borgne et 
al., 2005; Kopan and Ilagan, 2009). 
Another protein that binds Notch, and is likely one of its regulators, is Numb. Numb binds 
both Notch and the ear domain of α-adaptin, which is one of the subunits of the adaptor 
protein 2 (AP2) complex that links cargoes recruited for endocytosis to the clathrin coat of the 
transport vesicles. Numb mediated inhibition of Notch appears to require α-adaptin function, 
suggesting that Numb may directly recruit Notch into endocytic vesicles (reviewed in Le 
Borgne et al., 2005; Bray, 2006). Endocytosis of other components of the Notch pathway can 
also affect its effectiveness. In Drosophila, it is likely that the activity of Numb promotes 
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endocytosis of Sanpodo, which is essential for Notch signalling, since its absence from the 
membrane inhibits the activity of this pathway (reviewed in Le Borgne et al., 2005; Bray, 
2006). However, the role of Numb in regulating Notch signalling in vertebrates is still 
controversial (reviewed in Yoon and Gaiano, 2005; Fior and Henrique, 2009). 
 
I.5.2.2. Glycosylation 
 
Notch receptors are glycoproteins, as they can be modified by two forms of O-glycosylation 
(O-fucose and O-glucose) in their EGF repeats by the GDP fucose protein O-
fucosyltransferase (O-Fut1 in Drosophila; Pofut1 in mammals) and by the N-
acetylglucosaminyltransferase Fringe (Drosophila: Fringe; Mammals: Lunatic fringe (Lfng), 
Manic fringe (Mfng), Radical fringe (Rfng)), respectively (reviewed in Kopan and Ilagan, 
2009). However, fucosylation is not required for Notch receptor function and it appears that 
the requirement is for O-fut's fucosylation-independent ER chaperone activity, which is 
responsible for the folding and transport of Notch from the endoplasmic reticulum to the cell 
membrane (reviewed in Bray, 2006; Kopan and Ilagan, 2009). In addition, O-Fut may also 
control the removal of Notch molecules from the plasma membrane and their entry into the 
degradation pathway (reviewed in Fior and Henrique, 2009). The Fringe proteins extend O-
fucose by adding more sugar moieties. This leads to an inability of the Notch receptor to be 
activated by Serrate/Jagged ligands, while it can still be activated by Delta. Differences in 
glycosylation of the various vertebrate Notch receptors can account for some of the observed 
receptor-specific responses to ligands (reviewed in Kopan and Ilagan, 2009). Fringe is often 
expressed in a specific restricted pattern to create directional Notch signalling during cell fate 
inductive events. One example of this is the development of the fly wing margin (see below). 
O-Fut might also contribute to the spatial regulation of Notch activity, as its expression 
pattern is not uniform (reviewed in Bray, 2006). 
Another recently found modifier of Notch is RUMI, which also adds O-glucose, but to serine 
residues. The Notch receptor can also be modified by galactosyltransferases, sialyltransferases 
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and xylosyltransferases, showing that a series of modifications of the Notch receptors can 
modulate their activity (reviewed in Kopan and Ilagan, 2009). 
 
I.5.2.3. Phosphorylation and proteolysis 
 
The γ-secretase complex is an essential component of Notch signalling, since it is required for 
the cleavage of the Notch receptor that releases it from the cell membrane. This complex 
consists in the catalytic component presenilin and three limiting cofactors, NCT (Nicastrin), 
PEN2 and APH1. Because mammals have two presenilin isoforms and at least two APH1 
isoforms, mammalian cells can have at least four different γ-secretase enzyme complexes with 
differing biochemical properties and protein interactions. It is possible that the different 
complexes might contribute differentially to Notch signalling (reviewed in Kopan and Ilagan, 
2009). Furthermore, γ-secretase activity can also be modulated by Crumbs, a regulator of 
epithelial polarity that mediates a negative feedback on γ-secretase activity (reviewed in Bray, 
2006). 
Activation of Notch receptors releases signal in the form of NICD, which is reflected in the 
activation of target genes. However, there are mechanisms that modulate the duration of 
NICD activity in the nucleus: 
- The assembly of the NICD/CSL/MAM co-activator complex not only promotes 
transcription, but also results in turnover of NICD. During the transcriptional 
activation process, Mastermind recruits the CyclinC/CDK8 complex, which 
phosphorylates the PEST domain of NICD. After the action of E3 ubiquitin ligases that 
include Sel10/Fbw7, NICD is targeted for proteasomal degradation. This causes the 
disassembly of the transcription activation complex and resets the cell for the next 
round of signalling (Fryer et al., 2002; Fryer et al., 2004). 
- Another region of the PEST domain, the WSSSSP motif, is also involved in NICD 
phosphorylation and degradation, although it is not phosphorylated by 
CyclinC/CDK8 (Chiang et al., 2006). 
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- NICD can be also phosphorylated by the GSK-3β kinase when it is not bound to DNA. 
The outcome of this phosphorylation is not clear, as it can lead to increased or 
decreased Notch activity depending on the cellular context (Foltz et al., 2002; Espinosa 
et al., 2003; Fryer et al., 2004). 
Delta can also be cleaved by ADAM proteases, although the role of this process is still 
unknown. This might contribute to ligand down-regulation or to inhibition of the Notch 
receptor by soluble ligand fragments. Another possibility is that cleavage of transmembrane 
ligands could also release intracellular fragments that are able to transmit intracellular signals 
(reviewed in Bray, 2006; Kopan and Ilagan, 2009). 
 
I.5.2.4. Repression and activation at Notch target sites 
 
CSL binds to DNA recognizing either low (RTGRGAR) or high affinity (YGTGRGAA) CSL-
binding sites (CBS) (where R is a purine and Y is a pyrimidine), with the surrounding 
sequence environment being also important for NICD transcriptional activation (Ong et al., 
2006). CSL sites alone are often not very efficient at mediating activation in vivo, indicating 
that NICD functions in combination with tissue-specific factors. In some cases, the precise 
arrangement of binding sites influences the cooperation between Notch and other DNA-
bound activators. However, only a few activators that work in cooperation with Notch have 
been identified, so the extent and diversity of such factors is still unclear (reviewed in Bray, 
2006). 
Besides associating with NICD, CSL can also bind other proteins to activate transcription. For 
example, CSL can associate with PTF1a (Beres et al., 2006) to activate transcription of target 
genes, such as Neurog2 (Henke et al., 2009). The binding of CSL to factors other than NICD 
might influence the availability of CSL for binding to NICD. Mastermind, which is also 
required for the transcriptional activity of the NICD/CSL complex, can also bind proteins 
other than this complex (reviewed in Kopan and Ilagan, 2009), which might affect its 
availability to Notch signalling. 
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In Drosophila, in the absence of NICD, CSL actively represses its target promoters by 
recruiting the transcriptional co-repressor proteins SKIP, hairless/CtBP and Gro/TLE. In 
addition, CSL was also suggested to transiently bind to target sites and recruit the histone 
chaperone Asf1, to maintain repression at these sites after CSL departure (Goodfellow et al., 
2007). Since CSL occupancy on the target promoters can be a dynamic process, it is possible 
that the differential CSL occupancies can cause different activation kinetics in different Notch 
targets (reviewed in Kopan and Ilagan, 2009). In the mammalian nucleus, although CSL can 
form complexes with many ubiquitous co-repressor proteins that modify chromatin 
(reviewed in Borggrefe and Oswald, 2009), it is SHARP/MINT/SPEN that has emerged as the 
critical repressor of Notch target genes in vivo. However, in other species, CSL may not act as 
a repressor (reviewed in Kopan and Ilagan, 2009). 
After binding of activated Notch to CSL, this latter protein stops acting like a transcriptional 
repressor and becomes an activator. This activity of Notch signalling requires recruitment of 
histone acetylase complexes and exchange of histone variants to activate transcription, the 
activity of which might be regulated by ubiquitination and sumoylation. Notch activity is thus 
highly sensitive to chromatin modifications and histone re-arrangements and this might also 
contribute to target-gene specificity (reviewed in Bray, 2006). 
 
I.5.2.5. cis-inhibition 
 
It has been suggested that ligands of Notch signalling can bind to and inhibit the Notch 
receptors in a cell autonomous manner (in cis), preventing their interaction with ligands from 
neighbouring cells (in trans). This process has been best described in invertebrates, and might 
require direct interactions between the ligands and receptors. cis-inhibition does not seem to 
require ubiquitination and endocytosis of the ligand (reviewed in del Alamo and Schweisguth, 
2009). 
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I.5.2.6. Notch effectors auto-regulation and short half-life 
 
In some cases, proteins encoded by Notch target genes repress transcription of their own 
genes, ensuring that only a transient burst of transcription occurs in response to Notch 
activation (Fig. I.18). This can be observed, for instance, in the activities of mouse HES1 and 
HES7 (Hirata et al., 2002; Bessho et al., 2003). Besides repressing the transcription of their 
own genes, some HES proteins can also repress the transcription of other Hes genes, as 
exemplified by the several cross-regulations in the chick between the three Hes5 genes and 
Hes6-2 (Fior and Henrique, 2005). 
Furthermore, proteins and mRNAs from Notch target genes are, in many cases, rapidly 
degraded, helping to decrease the duration of the Notch signal (Fig. I.18). For instance, HES1 
and HES7 have been described to have very short half-lives (Hirata et al., 2002; Bessho et al., 
2003). The short half-life of HES7 has been reported to be crucial for somitogenesis, as a 
mutation that increases the stability of this protein impairs somitogenesis (Hirata et al., 2004). 
The short-lived character of the HES proteins is due in part to their WRPW, which has been 
reported to be a degradation signal (Kang et al., 2005). HES proteins can also be targeted for 
degradation by binding of other HES proteins. Mouse HES6, for instance, has been reported 
to associate with HES1 and, upon being phosphorylated, decreases HES1 stability (Gratton et 
al., 2003). Other HES proteins have been reported to be phosphorylated, leading to a decrease 
in their DNA-binding and transcriptional repression abilities (reviewed in Fior and Henrique, 
2009). 
 
 
Figure I.18: Notch effectors auto-regulation 
and short half-life. 
The Notch signal is intrinsically short-lived, 
since the Notch effectors, such as the HES 
proteins, can repress the transcription of their 
own genes and their proteins and mRNAs are 
highly unstable. Adapted from Kageyama et al. 
(2008a). 
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The short half-life of HES proteins wouldn’t have a strong effect on their expression if they 
were continuously being translated from their mRNA molecules. This implies that their 
mRNAs must be short-lived, as it has been described for mouse Hes1 (Hirata et al., 2002) and 
Xenopus Hairy2 (Davis et al., 2001) mRNAs. But how are these mRNAs degraded? This can 
occur by several mechanisms (reviewed in Garneau et al., 2007), one being the presence of 
AU-rich elements (AREs) in their 3’ untranslated regions (3’UTR). AREs are classified into 
several classes on the basis of the number and context of the AUUUA pentamer. Class I AREs 
contain several dispersed copies of the AUUUA motif within U-rich regions, Class II AREs 
possess at least 2 overlapping UUAUUUA(U/A)(U/A) nonamers and Class III AREs are U-
rich regions, but that do not contain AUUUA motifs. There are no identical AREs, since the 
flanking sequence is also involved in influencing mRNA stability. AREs enhance mRNA decay 
by recruiting the mRNA-decay machinery or in some cases they can perform this action 
alone. In other cases, the presence of AREs does not promote mRNA degradation, but inhibits 
translation. Several ARE-binding proteins that modulate mRNA degradation have been 
identified, with some of these proteins promoting mRNA degradation, while others prevent 
this effect (reviewed in Barreau et al., 2005; Garneau et al., 2007). Although Class I AREs have 
been found in the 3’UTRs of Notch1, Notch2, Notch3, Notch4, Dll1, Dll2, Dll3 and Dll4 of 
several species (Gonsalves and Weisblat, 2007; Cisneros et al., 2008), it remains to be 
determined whether these AU-rich elements are present in the 3’UTRs of Notch target genes 
and if they influence their mRNA stability. 
Another possible mechanism of mRNA degradation in the developing nervous system is the 
action of microRNAs (miRNAs). miRNAs have several roles in the nervous system (reviewed 
in Kosik, 2006) and have been reported to mediate degradation of Drosophila E(spl) genes by 
binding to Brd-, GY- or K-boxes in the 3’UTR of their mRNAs (Lai et al., 2005). 
miRNAs are small regulatory RNAs derived from longer primary transcripts containing one 
or more local hairpins, which are cleaved in the nucleus by RNase III enzyme Drosha, and a 
protein called Pasha in Drosophila or DGCR8 in mammals. After exportin-5-mediated 
transport to the cytoplasm, the transcripts are further processed by the RNA III endonuclease 
Dicer complex to yield ~21-24 nucleotide duplexes. Final processing by Dicer associates single 
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stranded miRNAs into the Argonaute-containing RNA-induced silencing complex (RISC), 
which guides them to complementary target mRNAs for their miRNA-mediated post-
transcriptional regulation (reviewed in Valencia-Sanchez et al., 2006; Flynt and Lai, 2008). 
miRNAs do not need to be 100% complementary to target mRNAs. Instead, most miRNA 
target sites contain seven nucleotides that are complementary to the positions 2-8 of the 5' end 
of the miRNA, also known as the "seed". miRNAs can induce degradation or translational 
repression of target mRNAs. Individual animal miRNAs are predicted to have >100 targets 
and at least 20-30% of animal transcripts bear at least one conserved miRNA binding site in 
their 3'UTR (reviewed in Flynt and Lai, 2008). 
In vertebrates, there are several miRNAs expressed in the developing nervous system (Darnell 
et al., 2006; Kapsimali et al., 2007; Hoesel et al., 2010), suggesting that they are implicated in 
the regulation of neurogenesis. Indeed, miR-124 has been implicated in the post-
transcriptional inhibition of progenitor genes in neurons (Cao et al., 2007; Visvanathan et al., 
2007; Yoo et al., 2009). In zebrafish, Her5 and Her9 are expressed in the midbrain/hindbrain 
boundary (MHB) and their mRNAs are targets of miR-9, which is not expressed in MHB cells, 
helping to delimit the boundary (Leucht et al., 2008). 
In vertebrates, although no other Hes mRNA has been shown to be a target of miRNA, it has 
been suggested that the Notch1 and Delta1 mRNAs can also be regulated by miRNAs 
(reviewed in Latasa et al., 2009) and in vitro analysis shows that human Notch1 mRNA can be 
targeted by multiple miRNAs (Fukuda et al., 2005). In Drosophila, a muscle specific miRNA 
was also shown to affect Delta ligand expression (Kwon et al., 2005). 
Given that Drosophila E(spl) and zebrafish Her5 and Her9 mRNAs are regulated by miRNAs, 
and several other vertebrate Hes mRNAs are short-lived, it is possible that miRNA-mediated 
post-transcriptional regulation of Hes gene is a common mechanism to modulate Notch 
activity. 
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I.5.3. Notch signalling working mechanisms 
 
Even though Notch signalling is extremely complex, as discussed above, its functions can be 
summarized into three main different modes of action. As defined by Angeliki Louvi and 
Spyros Artavanis-Tsakonas, “Notch signalling generally links the fate of one cell to that of its 
neighbours (...) segregating specific cell lineages from fields of developmentally equivalent 
cells and defining borders between distinct cellular fields” (Louvi and Artavanis-Tsakonas, 
2006) (Fig. I.19). 
 
 
 
 
Figure I.19: Notch signalling modes of action. 
(A) In lateral inhibition, all cells are initially equivalent (grey) and signal to their neighbours. Eventually, one cell 
signals more than the others and also receives less signalling, becoming distinguished from the group. This cell 
acquires one fate (black) and their neighbours acquire another fate (white). In a gain-of-function experiment, 
where Notch signalling is activated in all cells, they all acquire the white fate. In a loss-of-function experiment, 
where Notch signalling is absent from all cells, they all acquire the black fate. (B) In lateral induction, specific 
cells (grey) signal to their neighbours (white) to change their fate (to black). In a gain-of-function experiment, all 
cells acquire the black fate. In a loss-of-function experiment, all cells maintain their initial fates. Adapted from 
Lai (2004). 
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I.5.3.1. Restriction of cell fates – lateral inhibition 
 
The classical model for lateral inhibition postulates how one cell may be selected from a group 
of equivalent precursors and prevent their neighbours from acquiring the same specialized 
fate (Fig. I.19A). For example, in Drosophila neural-epidermal choice, groups of cells known 
as proneural clusters have neural potential because of their expression of proneural proteins. 
In each proneural cluster, the cell with the highest levels of proneural proteins will become a 
neuroblast (reviewed in Skeath and Thor, 2003). Experimentally, when Notch signalling is 
abolished, all cluster cells increase the levels of proneural proteins and become neural. By 
contrast, constitutive Notch signalling inhibits neural differentiation (reviewed in Lai, 2004). 
What is the role of Notch signalling in this process? According to the lateral inhibition model, 
all cells in the proneural cluster initially express proneural proteins, Notch ligands and 
receptors. These cells compete with each other for the neural fate by signalling through the 
Notch pathway. Stochastic variations in gene expression cause one cell to acquire higher levels 
of proneural gene expression, which will become the presumptive neuroblast, while cells 
expressing lower levels of proneural genes are directed towards the epidermal fate. The high 
levels of proneural proteins in the presumptive neuroblast strongly activate the expression of 
the Delta ligand in this cell. The neuroblast signals to its neighbours in the proneural cluster, 
activating Notch and the expression of the E(spl) genes in these cells. The E(spl) proteins 
down-regulate the expression of the proneural genes in the neuroblast’s neighbours, resulting 
in a decrease in Delta expression in these cells. This reduces the ability of signal receiving cells 
to activate Notch in the surrounding cells, diminishing signalling into the presumptive 
neuroblast. Therefore, initial subtle differences in proneural levels between the cells in the 
proneural cluster at any one point are amplified in a positive feedback loop and lead to the 
stable selection of a single cell as the neuroblast. The presumptive neuroblast triggers the 
Notch pathway to extinguish proneural expression from the remaining cells of the cluster and 
diverts them towards the epidermal fate (reviewed in Bray, 1998; Skeath and Thor, 2003). 
In another example, in the vulva of C. elegans, Notch signalling acts as a “binary switch” in 
two cells to distinguish between the fate choices “anchor cell” (AC), a terminally differentiated 
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cell that organizes vulval development, or “ventral uterine cell” (VU), which divides to 
produce descendants that contribute to the uterus. In these cells, lin-12 activity is necessary 
and sufficient to specify the VU fate. Two initially equivalent cells, Z1.ppp and Z4.aaa, express 
equal levels of LIN-12 (receptor) and LAG-2 (ligand), and engage in bi-directional Notch 
signalling. However, feedback loops amplify an apparently stochastic small difference in lin-12 
expression, limiting lin-12 transcription to the presumptive VU and lag-2 transcription to the 
presumptive AC. In the presumptive VU, continued transcription of lin-12 appears to be 
maintained by a positive, auto-regulatory, feedback loop, involving activated LIN-12. 
Moreover, lag-2 expression is repressed by the activity of LIN-12. In the end, one cell 
expresses only the ligand and differentiates as AC, while the other cell expresses only the 
receptor and turns into VU (reviewed in Lai, 2004). 
These two examples show the remarkable ability of Notch to amplify small differences in the 
signalling capacities of different cells: the more signal a cell receives, the less signal it is able to 
produce, so that any small differences in Notch activity between interacting cells are 
amplified, leading to distinct fates. 
 
I.5.3.2. Specification of cell fates and creation of boundaries – lateral induction 
 
Notch signalling also has the ability to induce the development of a particular cell type or 
body region, often by inducing the expression of transcriptional activators. The creation of a 
new cell type can be the result of cell-cell interactions at the boundary between distinct cell 
populations. This process is referred to as lateral induction (reviewed in Lai, 2004) (Fig. 
I.19B). 
For instance, in Drosophila wing development, Notch signalling between the dorsal and 
ventral compartments of the future wing specifies the wing margin, a line of cells that 
organizes the outgrowth of the wing. Loss of Notch signalling eliminates the wing margin and 
wing tissue (causing wing “notching”), while ectopic Notch activation results in extra wing 
tissue (reviewed in Lai, 2004). Notch signalling is activated in cells at the interface between the 
dorsal and ventral fields of cells and keeps the two populations distinct by directional 
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signalling from one side to the other, but not inside each field. This is accomplished by the 
activities of the Serrate ligand and Fringe in the dorsal cells, and the Delta ligand in ventral 
cells. As discussed above, Fringe inhibits the ability of Notch to be activated by Serrate and 
hence the dorsal cells can only signal to the ventral cells. In contrast, Fringe facilitates the 
interaction between Delta and Notch, which makes the ventral cells signal better to the dorsal 
cells. This creates a boundary between the dorsal and ventral sides of the wing (reviewed in 
Bray, 1998). 
 
I.5.3.3. Notch activity in asymmetrically dividing cells – lineage decisions 
 
Directional Notch signalling can also occur through the asymmetric segregation of factors 
that influence Notch signalling, after asymmetric cell divisions. 
One classical example occurs during the development of the external sensory organs of 
Drosophila, which comprises four distinct cells: neuron, sheath, shaft and socket. Each sensory 
organ arises from sequential asymmetric divisions of the sensory organ precursor (SOP) (Fig. 
I.20). SOP cells delaminate from a polarized epithelium and then divide asymmetrically into 
an anterior pIIb and a posterior pIIa cell (reviewed in Le Borgne, 2006; Knoblich, 2008). 
 
 
 
 
Figure I.20: Asymmetric cell divisions in Drosophila sensory organ development. 
In Drosophila peripheral nervous system development, the sensory organ precursor (SOP) undergoes sequential 
asymmetric divisions to generate the four different cells of the sensory organ: neuron, sheath, shaft and socket 
(the glial cell is eliminated by apoptosis). The divisions are asymmetric due to the unequal segregation of cell fate 
determinants that lead to differential activity of Notch signalling between the two daughter cells. White cells: 
signal sending cells. Black cells: signal receiving cells. Adapted from Le Borgne (2006). 
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During SOP division, the cell fate determinants Numb and Neuralized localize asymmetrically 
to the pIIb cell, but not to pIIa. As described above, Numb negatively regulates Notch and 
Neuralized is required for activation of the Delta ligand. Furthermore, shortly after SOP 
division, Rab11 endosomes accumulate around the centrosome in pIIb, but not pIIa, and 
Delta is targeted for the endosome in pIIb, but not pIIa. Trafficking through Rab11-positive 
recycling endosomes is essential for the signalling activity of Delta. Thus, Notch activity is 
inhibited in the pIIb by Numb, whereas Delta activity is increased by the activities of 
Neuralized and Rab11. The pIIb can therefore signal to the pIIa cell, which leads to Notch 
activation in pIIa, but not in pIIb (reviewed in Le Borgne, 2006; Knoblich, 2008). 
After SOP division, pIIa and pIIb divide once more asymmetrically. The pIIa cell generates 
the two outer cells of the sensory organ: the socket and the shaft. The pIIb cell generates a glial 
cell and pIIIb. The glial cell is eliminated by apoptosis and the pIIIb cell divides 
asymmetrically once more to generate the two inner cells of the sensory organ: the neuron and 
the sheath. Asymmetry in all of these divisions is also generated by different levels of Notch 
activity in the two daughter cells (reviewed in Le Borgne, 2006; Knoblich, 2008). 
 
I.5.4. Roles of Notch in vertebrate neural development 
 
The three main working mechanisms of Notch signalling were first described in Drosophila. 
However, during the last 15 years, Notch has been intensively studied also in vertebrates. In 
this Section, I will focus on the function of Notch signalling in the developing vertebrate 
nervous system. 
 
I.5.4.1. Maintenance of the stem zone 
 
As described in Section I.2.1, cells that give rise to the chick posterior neural tube are present 
in the caudal neural plate and are maintained in this stem zone by the action of FGFs. These 
signalling molecules activate the expression of genes in the neural plate, such as Cash4 
(reviewed in Diez del Corral and Storey, 2004), which is one of the chick proneural genes 
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(Henrique et al., 1997b). Interestingly, Delta1, Notch1 and several Hes genes were also found 
to be uniformly expressed in the stem zone (Henrique et al., 1995; Caprioli et al., 2002; Fior 
and Henrique, 2005), suggesting a role for Notch signalling downstream of FGF in these early 
stages of neural development. Indeed, Cash4 directly activates Delta1 expression in the stem 
zone, which in turn is required for the expression of Hes5 in neighbouring cells (Akai et al., 
2005). The uniform Notch signalling activity in stem zone cells leads to cell proliferation in 
this region. However, loss of Notch signalling and cell cycle exit are not sufficient to promote 
neuronal differentiation in the stem zone (Akai et al., 2005), which is in agreement with the 
requirement of retinoic acid for the onset of neurogenesis (Diez del Corral et al., 2003). 
 
I.5.4.2. Maintenance of neural progenitors – lateral inhibition 
 
Once cells in the neural tube become under the influence of retinoic acid, they acquire 
competence to differentiate as neurons by expressing other proneural genes. The activity of 
these proneural transcription factors in neural progenitors induces these cells to differentiate. 
However, to ensure a continuous production of new neurons throughout development and 
generate the correct number and types of these cells, a pool of progenitors must be maintained 
during the whole process of neurogenesis. Therefore, there must be a balance between 
differentiation and proliferation in neuroepithelia. 
In vertebrates, similar to what is described for Drosophila, proneural proteins can induce the 
activity of Notch signalling by activating the expression of ligands (Castro et al., 2006). In 
Drosophila proneural clusters, where every cell expresses proneural proteins, the activation of 
Notch up-regulates the expression of genes from the E(spl) family. The increase in expression 
of these genes is due to the cooperativity between proneural proteins and NICD on the E(spl) 
promoters, which contain regulatory sequences for both CSL and proneural proteins 
(reviewed in Bray, 2006). The same cooperation can be observed in vertebrates (Lamar and 
Kintner, 2005). Due to similarities with the lateral inhibition in Drosophila, it is likely that 
neurogenesis in vertebrates is also regulated by a similar process, allowing differentiation of 
some neural progenitors while maintaining others proliferating. Indeed, several lines of 
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evidence point to a role of Notch signalling in the maintenance of vertebrate neural 
progenitors in the undifferentiated state through the action of HES proteins, as I will describe 
next. 
Disruption of Notch signalling in mouse embryos by mutations in the Notch1 or CSL genes 
causes a down-regulation of Hes5 and Nestin expression (progenitor markers) and premature 
neurogenesis, which is accompanied by up-regulation of Dll1, Dll3, Mash1 and Math1 (de la 
Pompa et al., 1997; Lutolf et al., 2002). Furthermore, ectopic Notch activation by Delta1 
misexpression in chick embryos leads to a decrease in neurogenesis, while blocking Notch 
signalling with a dominant-negative Delta1 protein variant promotes neuronal production 
(Henrique et al., 1997a) (Fig. I.21). 
 
 
Figure I.21: Lateral inhibition in vertebrates. 
(A) In a wild-type neuroepithelium, differentiating 
neurons signal through Delta-Notch signalling to 
inhibit their neighbours from entering neuronal 
differentiation, maintaining them in the 
undifferentiated state. (B) In a gain-of-function 
experiment, all cells signal to their neighbours, 
preventing all cells from differentiating and leading 
to the maintenance of all cells as neural progenitors. 
(C) In a loss-of-function experiment, no cells signal 
to their neighbours. Since no cells are inhibited from 
differentiating, they all acquire the neuronal fate. 
Adapted from Henrique et al. (1997a). 
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In mouse, expression of Hes1 and Hes5 is regulated by Notch signalling. In the absence of the 
two genes, inhibition of neuronal differentiation by Notch signalling is severely impaired, 
indicating that Hes1 and Hes5 are essential effectors of Notch signalling (Ohtsuka et al., 1999). 
By contrast, Hes3 expression appears not to be controlled by Notch signalling (Nishimura et 
al., 1998). However, only simultaneous disruption of all three genes leads to premature 
neurogenesis of virtually all neural progenitors in the embryo (except in the telencephalon), 
suggesting the existence of redundancy between the three Hes genes in nervous system 
development (Hatakeyama et al., 2004; Imayoshi et al., 2008). In Hes1;Hes3;Hes5 triple 
knockout mice, neural progenitors prematurely differentiate into early-born types of neurons 
and no later-born cell types are born due to depletion of the neural progenitor pool 
(Hatakeyama et al., 2004). Thus, Hes genes maintain neural progenitors until later stages of 
development, ensuring that correct numbers and types of cells are generated. 
Mimicking Notch activation through the expression of Hes1, Hes3 or Hes5 in the developing 
brain of mouse embryos was also shown to inhibit neuronal differentiation (Ishibashi et al., 
1994; Hirata et al., 2000; Ohtsuka et al., 2001). In chick, the three existing Hes5 genes are 
downstream of Notch signalling and their misexpression also leads to a decrease in neuronal 
differentiation (Fior and Henrique, 2005). 
HEY proteins have also been described to be downstream of Notch signalling and to perform 
similar functions to those of HES proteins. It is possible that HES and HEY proteins 
cooperatively regulate the maintenance of neural progenitors (reviewed in Kageyama et al., 
2005). 
The premature neuronal differentiation in Hes-mutant mice is associated with up-regulation 
of proneural genes (Hatakeyama et al., 2004), suggesting that Notch maintains proliferating 
neural progenitors via Hes genes, which regulate the normal timing of differentiation by 
repressing premature onset of expression of proneural genes. 
How are the proneural expression and function regulated by HES proteins? It is known, for 
example, that HES1 represses the proneural ASCL1 expression by directly binding to its 
promoter (Chen et al., 1997). HES1 was also reported to form non-functional heterodimers 
with E47 and inhibit formation of transcriptional activator ASCL1-E47 heterodimers (Sasai et 
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al., 1992). Thus, HES1 may antagonize ASCL1 by two mechanisms: transcriptional repression 
and protein sequestration. 
HLH proteins lacking the basic domain required for DNA-binding (such as Drosophila Extra 
Macrochaetae (Emc) and vertebrate Inhibitor of Differentiation (ID)) can also counteract the 
function of proneural proteins by forming inactive heterodimers with E proteins (reviewed in 
Norton, 2000; Bertrand et al., 2002; Tzeng, 2003). Interestingly, it was recently found that the 
expression of ID proteins is also directly regulated by Notch signalling (Meier-Stiegen et al., 
2010). 
In conclusion, high levels of proneural proteins in neural progenitors induce neuronal 
differentiation and at the same time activate the transcription of Notch ligands, which signal 
to neighbouring neural progenitors. This leads to expression of Notch target genes, which 
encode proteins that inhibit the expression and activity of proneural proteins. Therefore, 
neighbours of newborn neurons will have low levels of proneural proteins and will be unable 
to differentiate. Notch signalling thus maintains a pool of undifferentiated neural progenitors 
until the following round of differentiation, when another neural progenitor is selected for 
differentiation and the lateral inhibition process restarts. 
 
I.5.4.3. Induction of gliogenesis 
 
In the vertebrate central nervous system, neurons are born before glial cells. Neural 
progenitors in the early neurogenic stages do not produce glia even if they are prematurely 
exposed to extrinsic gliogenic stimuli. The switch from neurogenesis to gliogenesis not only 
involves the activation of genes required for glial development but also the attenuation of 
genes required for neurogenesis (reviewed in Okano and Temple, 2009). Several studies point 
to a role for Notch signalling in this process (reviewed in Gaiano and Fishell, 2002): 
- Misexpression of the NICD fragment in the retina of frog, zebrafish or rat leads to an 
increase in the number of Müller glia (Furukawa et al., 2000; Hojo et al., 2000; Scheer 
et al., 2001; Ohnuma et al., 2002). In the case of zebrafish, there is premature 
differentiation of this type of cell (Scheer et al., 2001). 
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- Misexpression of HES1 and HES5, which are transiently expressed by Müller glia in 
the retina and by differentiating astrocytes in the telencephalon, increases the 
generation of these cells (Furukawa et al., 2000; Hojo et al., 2000; Ohtsuka et al., 2001). 
- CSL seems to be required for normal gliogenesis (Ge et al., 2002; Taylor et al., 2007), 
possibly by directly activating GFAP expression, an astrocytic marker (Ge et al., 2002), 
and maintaining Sox9 expression during gliogenesis (Taylor et al., 2007), which has 
recently been reported to be a direct target of Notch (Meier-Stiegen et al., 2010). 
- Notch signalling has been reported to activate the expression of Nuclear Factor 1A 
(NFIA) at the onset of gliogenesis in a CSL-dependent manner. NFIA binds to 
promoters of genes required for gliogenesis, such as that of GFAP, and inhibits the 
maintenance of chromatin methylation, thereby promoting transcription of these 
genes (Namihira et al., 2009). 
However, although Notch signalling might induce formation of Müller glia or astrocytes, it 
may also contribute to inhibition of the oligodendroglial fate (Fig. I.22): 
- In adult hippocampal progenitors, ectopic NICD promotes astroglial identity at the 
expense of neuronal and oligodendroglial identity (Tanigaki et al., 2001). 
- Ectopic Notch activation in the rat optic nerve inhibits differentiation of 
oligodendrocyte precursor cells (OPCs) (Wang et al., 1998). Furthermore, inhibition 
of Notch activity in OPCs in the central nervous system of mice leads to precocious 
differentiation of oligodendrocytes (Genoud et al., 2002). 
Several studies suggest a role for Notch signalling in the promotion of gliogenesis. In some 
cases, this action seems to be instructive, with ectopic NICD expression causing precocious 
gliogenesis (Scheer et al., 2001) or direct activation of genes required for gliogenesis, such as 
NFIA (Namihira et al., 2009). However, other studies argue against an instructive role of 
Notch in gliogenesis, suggesting instead that the main function of Notch signalling in this 
process is the inhibition of neuronal differentiation and maintenance of neural progenitors, 
increasing the neural progenitor pool until the gliogenic stage. For instance, a transient 
activation of Notch signalling in the mouse cortex does not induce premature gliogenesis, 
causing only a delay in neurogenesis and generating later born neurons at the expense of early 
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born neurons, in accordance with the embryonic stage of the removal of ectopic Notch 
activity (Mizutani and Saito, 2005). This means that transient Notch activation does not 
induce gliogenesis and that after the removal of ectopic Notch activity the neural progenitors 
retain their ability to generate neurons. Therefore, the role of Notch signalling in the 
induction of gliogenesis remains unclear. 
 
 
 
Figure I.22: Notch signalling 
promotes astrogliogenesis. 
Besides inhibiting neurogenesis in 
neural progenitors, Notch 
signalling can also inhibit the 
oligodendrocytic fate. In contrast, 
Notch activity can promote the 
astroglial fate. Adapted from Louvi 
and Artavanis-Tsakonas (2006). 
 
 
 
 
 
 
 
 
I.5.4.5. Neuronal cell fate diversity 
 
Notch signalling has been implicated not only in progenitor maintenance, but also in the 
specification of neuronal cell fates. For instance, the p2 progenitor domain in the ventral 
spinal cord gives rise to two interneuron subtypes, V2a and V2b, which integrate into local 
neuronal networks that control motor activity and locomotion. The Notch ligand DLL4, 
which is specifically expressed in the p2 domain, signals through NOTCH1 to subdivide the 
p2 progenitor pool. Cells expressing DLL4 become V2a cells, whereas cells receiving signals 
through NOTCH1 trigger the genetic cascade leading to V2b interneurons (Del Barrio et al., 
2007; Peng et al., 2007; Rocha et al., 2009). 
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I.5.4.6. Neuronal migration and extension of neurites 
 
Notch has been reported to function also in terminally differentiated post-mitotic neurons of 
the neocortex, as indicated by the expression of Notch1 in these cells. 
The role of Notch signalling in the process of neuronal migration has not been explored to a 
great extent. Presenilin mutants show neuronal migration defects. However, presenilin is also 
involved in other pathways that affect neuronal migration, hindering the conclusion that the 
phenotypes observed are consequences of the impairment of Notch signalling in these 
mutants (reviewed in Louvi and Artavanis-Tsakonas, 2006). 
As neurons are generated in the developing mammalian brain cortex, they migrate out of the 
ventricular zone and integrate into the developing neocortical circuitry. Reelin regulates 
neuronal migration through poorly understood mechanisms. However, it has recently been 
found that Reelin signalling leads to phosphorylation of several proteins, including Dab1. 
Activated Dab1 inhibits Fbxw7-mediated degradation of NICD1, therefore increasing NICD1 
levels in the nucleus and increasing Notch activity. This activity of Reelin through Notch 
signalling is necessary for the correct neuronal migration in the developing cortex. However, 
since both Reelin and Notch are expressed in radial glial cells, which are neural progenitors 
that serve as scaffold for migration of newborn neurons, it is also possible that Reelin and 
Notch are only required for the maintenance of these progenitors, while it is their absence that 
impairs migration of differentiating newborn neurons (reviewed in Gaiano, 2008). 
Notch was also found to regulate neurite extension in neocortical neurons. Ex vivo studies 
have shown that Notch activity can influence neuronal morphology by affecting the extension 
of existing neurites: inhibition of Notch activity affects neurite elaboration and activation of 
Notch (by ligands or constitutively active forms of the receptor) cause shorter dendrites with 
more branches (reviewed in Louvi and Artavanis-Tsakonas, 2006). 
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I.5.4.7. Formation of boundaries 
 
As previously described, one of the functions of Notch is to establish borders between distinct 
cellular fields. In the example described in Section I.5.2.2, Notch signalling establishes the 
Drosophila dorsal-ventral wing boundary by the action of the Serrate and Delta ligands, which 
differentially activate Notch along the boundary due to the modulation of ligand-receptor 
interactions by Fringe  
Boundaries in the vertebrate nervous system are formed by specialized cells that have unique 
features, including slow proliferation, delayed or no neurogenesis, and organizer activities that 
specify neighbouring compartments by secreting molecules required for their development. 
Cells migrate within each compartment but do not usually cross boundaries, forming units 
that consist of distinct sets of cell types (reviewed in Kiecker and Lumsden, 2005). 
Interestingly, expression of Radical Fringe (Rfng), a vertebrate Fringe homologue, can be 
observed in boundary cells, and CSL-dependent Notch activation can regulate cell affinity 
properties and segregate cells to the boundaries (Cheng et al., 2004). 
The isthmic organizer, which is located at the midbrain-hindbrain boundary, expresses Hes1 
and Hes3. Mice lacking both genes show premature differentiation of isthmic cells into 
neurons and termination of the organizer function (secretion of molecules essential for the 
development of the midbrain and the hindbrain) (Hirata et al., 2001). Similarly, in double 
Hes1;Hes3 or Hes1;Hes5-knockout mice, and more evidently in triple Hes1;Hes3;Hes5-null 
mice, the zona limitans intrathalamica (ZLI), the isthmus, the inter-rhombomeric boundaries, 
and the floor and roof plates of the spinal cord, boundaries in the nervous system, are not 
properly maintained and show premature differentiation (Baek et al., 2006). This indicates 
that HES1, HES3 and HES5 maintain boundary cells in the undifferentiated state and with 
organizer function. Boundary cells show sustained expression of Hes1, due to the action of ID 
proteins (Bai et al., 2007), preventing both cell proliferation and differentiation (Baek et al., 
2006). This shows that persistent and high levels of Hes1 expression regulate boundary 
formation and further suggests that Notch signalling contributes to boundary formation in 
the vertebrate nervous system. However, Hes1 is also regulated by other pathways (reviewed 
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in Sanalkumar et al., 2010), indicating that Hes1 function in boundary formation may be 
regulated by pathways other than Notch signalling. Similarly, zebrafish HER3 and HER5, 
whose expression does not rely on Notch signalling, have activities similar to those of mouse 
HES1, inhibiting neurogenesis and contributing to the formation of the midbrain-hindbrain 
boundary (reviewed in Kageyama et al., 2007b). 
 
I.5.5. Notch, cell cycle and cell fate in vertebrate neurogenesis 
 
I.5.5.1. Regulation of the cell cycle by Notch signalling 
 
As discussed in Section I.5.4.2, Notch signalling is involved in neural progenitor maintenance 
by inhibiting differentiation of these cells. As a consequence, neural progenitors are 
maintained in cell cycle. Since Notch signalling prevents cell cycle exit, it is plausible that it is 
also involved in the promotion of cell cycle progression. However, the link between Notch and 
the cell cycle is not well understood. 
During the G1 phase, cyclin-dependent kinases (CDK) promote cell cycle progression by 
forming complexes with cyclins, whereas the CDK inhibitors p21 and p27 antagonize this 
process. Low levels of HES1 promote cell proliferation in several cell types by down-regulating 
p21 and p27 (Castella et al., 2000; Murata et al., 2005). However, persistent and high levels of 
HES1 expression have been shown to inhibit the cell cycle by blocking cells in G1, due to 
repression of CyclinD1 expression (Shimojo et al., 2008), and probably because HES1 can 
repress the expression of some cell cycle regulators such as E2F-1, which promotes the G1-S 
transition (in breast cancer cells (Hartman et al., 2004)). Thus, high versus low levels of HES1 
expression may confer different proliferation characteristics to cells. However, HES1 
expression is also under the influence of signalling pathways other than Notch and its role in 
cell cycle regulation might not reflect the role of Notch signalling in this process. 
In other examples, ectopic activation of Notch has been shown to allow progenitor 
proliferation during mouse pituitary or cortical development (Mizutani and Saito, 2005; Zhu 
et al., 2006), contrasting with experiments where HES1 was misexpressed. In the zebrafish 
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retina, activated Notch prevents cell division and increases cell death (Scheer et al., 2001). 
Surprisingly, despite the role of Notch in neural progenitor maintenance, in other cases, such 
as in the Xenopus retina, it has been reported that Notch cooperates with proneural proteins 
to promote cell-cycle withdrawal during neuronal differentiation (Ohnuma et al., 2002). 
These different reports suggest different roles for the regulation of the cell cycle by Notch 
activity, depending on cell context. 
 
I.5.5.2. Notch activity during the cell cycle 
 
Despite the different roles of Notch in cell cycle progression or cell cycle withdrawal, Notch 
expression does not seem to require cell cycle progression (Dorsky et al., 1995). 
Although high levels of Notch activity promote progenitor maintenance and down-regulation 
of Notch activity is required for cell cycle exit and differentiation (reviewed in Bertrand et al., 
2002), it is possible that Notch signalling is not equally active throughout all the cell cycle of 
neural progenitors. Indeed, several studies provide insights into the time window when Notch 
is active during the cell cycle. 
It has been reported that chick neuroepithelial cells expressing the highest levels of Notch1 
and Hes5-1 do not to incorporate 5-bromo-2-deoxyuridine (BrdU, a thymidine analogue), 
suggesting that neural progenitors are not competent to receive Notch instructive signals 
when in S-phase (Murciano et al., 2002; Cisneros et al., 2008). Analysis of Notch1 expression 
with intronic probes reveals that Notch1 mRNA is expressed throughout the entire cell cycle, 
while mature mRNA is not expressed in S-phase. This was reported to be caused by mRNA 
instability during S-phase (Cisneros et al., 2008), suggesting why cells in this phase of the cell 
cycle are not competent to activate Notch. In contrast, neuroepithelial cells seem to be able to 
receive Notch signals in G2/M/G1, since Notch1 and Hes5-1 mRNAs can be detected in cells 
whose nuclei are closer to the lumen, where mitosis occurs (Murciano et al., 2002; Cisneros et 
al., 2008). In agreement with these observations, synchronization of cells in S-phase by the use 
of hydroxyurea in vivo and in primary cultures reduces the levels of Notch1 expression in the 
whole cell population (Murciano et al., 2002; Cisneros et al., 2008). 
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In the zebrafish retina, Notch activity has been also detected in the apical region of the 
neuroepithelium, using an antibody specific for activated NICD1 (Del Bene et al., 2008). In 
agreement, in live-imaging experiments where Notch activity can be monitored in vivo by the 
use of a reporter and cell cycle phases can be identified by following interkinetic nuclear 
migration of neural progenitors, the same can be observed: a reporter driven by the zebrafish 
Her4 promoter shows that the majority of Notch activity occurs in cells which have their 
nuclei migrating from basal to apical, in contrast to the decreasing activity in Notch signalling 
observed in cells that have their nuclei moving from apical to basal. This leads to an overall 
increased Notch activity in the apical region of the neuroepithelium, in comparison to the 
basal region where Notch signalling is not detected (Del Bene et al., 2008). Thus, it is likely 
that cells with highest Notch activity are in the G2/M/G1 phases of the cell cycle, when the 
nucleus of the cell is apically localized. 
In contrast, using an antibody specific for activated NICD1 in the mouse cortex, high levels of 
Notch activity can be detected in cells that incorporate BrdU, but not in mitotic cells near the 
lumenal surface (Tokunaga et al., 2004). However, mouse cortex presents a different 
architecture of the neuroepithelium, with the existence of a ventricular zone (VZ) closer to the 
lumenal surface, and a subventricular zone (SVZ) at a more basal position, where a different 
kind of neural progenitors (intermediate progenitors) reside (reviewed in Noctor et al., 2007). 
Although this was not investigated, it is possible that Notch activity occurs in mitotic basal 
progenitors in the SVZ. Therefore, although Notch activity can not be detected in the apical 
region of the neuroepithelium, it is possible that it occurs in the G2/M/G1 phases of the cell 
cycle in intermediate progenitors of the SVZ. 
The preferential activation of Notch in the G2/M/G1 phases of the cell cycle of neural 
progenitors suggests that cell fate decisions, concerning whether these cells differentiate or 
not, occur during this window of the cell cycle, when the nucleus is located apically. However, 
the specific phase where Notch is activated can only be ascertained by time-lapse monitoring 
Notch activity at the single-cell level. 
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I.5.5.3. Influence of the interkinetic nuclear migration in Notch-mediated cell fate decisions 
 
The studies referred above do not present coherent results, possibly due to the differences in 
species and tissues analysed. However, they all indicate a correlation between Notch activity 
and specific cell cycle phases, which in turn are correlated with the position of the nucleus in 
the neuroepithelium due to INM. 
Several studies have addressed the influence of cell cycle and INM in cell fate decisions within 
the neuroepithelium. For instance, in the chick retina, chemical inhibition of actin 
polymerization by cytochalasin B disrupts INM while allowing cell cycle progression, and 
causes an increase in the rate of neurogenesis. Conversely, in the chick presumptive 
diencephalon, blocking cells in S-phase by chemical inhibition with hydroxyurea allows 
progression of the INM, but also causes an increase in neurogenesis. The increase in the rate 
of neurogenesis in cells synchronized in S-phase correlates with the lower level of Notch 
activity in cells undergoing S-phase, which can be permissive for cell differentiation 
(Murciano et al., 2002). 
In the zebrafish retina, disruption of Dynactin-1, a gene encoding a microtubule-motor-
associated protein, causes the migration of nuclei from retinal progenitors to be more rapid 
and deep into the basal surface, while the movement towards the apical surface, when the cell 
is preparing for mitosis, is slower (Del Bene et al., 2008; Norden et al., 2009). In this mutant 
cell population, the rate of retinal neurogenesis is increased. Since Notch activity occurs to a 
higher extent when nuclei are located closer to the apical surface, it was suggested that the 
deeper movement of nuclei towards the basal surface would leave these cells out of the 
influence of Notch signalling for longer time, therefore facilitating their premature 
neurogenesis (Del Bene et al., 2008). In agreement with the study described above, 
investigation of cell behaviour in wild-type retinas shows a correlation between the 
acquisition of potential to differentiate and a deeper nuclear migration and shorter cell cycle 
periods than siblings that remain proliferative (Baye and Link, 2007). Therefore, this can be 
another indication that the presence of nuclei away from the apical region of the 
neuroepithelium, in regions of low Notch activity, favours commitment to neuronal 
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differentiation. Altogether, these observations suggest that neuronal commitment occurs in 
zebrafish retinal progenitors before the final mitosis, and that acquisition of neurogenic 
competence is favoured in progenitors whose nuclei move deeper into the basal side of the 
neuroepithelium. Given the proposed occurrence of Notch activity in the apical region, these 
progenitors would be less exposed to Notch signalling and have a higher tendency to enter 
differentiation. 
In the mouse cortex, disruption of actin-myosin motor forces by the use of a chemical 
inhibitor of Myosin II activity, blebbistatin, completely blocks the apical-to-basal movement 
of nuclei, but allows the basal-to-apical movement. Although there is no alteration in cell cycle 
parameters or in neuroepithelial cytoarchitecture, the prevention of apical-to-basal migration 
of nuclei leads to an increase in the number of neurogenic intermediate progenitors (Schenk 
et al., 2009). In this case, it is the accumulation of cells in the apical surface that increases 
neurogenesis, in agreement with data showing that Notch activity is weak near the lumenal 
surface of the mouse cortex, as revealed by the low levels of activated Notch in this region 
(Tokunaga et al., 2004; Ochiai et al., 2009). Therefore, although Notch activity occurs in a 
more basal region in the developing cortex, contrasting with the more apical activity of Notch 
in other systems, this data agrees with the model that progenitors with nuclei in regions with 
low Notch activity have higher tendency to enter neuronal differentiation. 
All these studies suggest that the position of the nucleus of a neural progenitor within the 
neuroepithelium influences its commitment to differentiation. When the nucleus stays longer 
in regions where progenitors show lower Notch activity, neurogenesis is favoured. It should 
be also mentioned that the microtubules and the actin-myosin are involved in endocytosis 
(Apodaca, 2001), a sensitive step of Notch signalling (as described in Section I.5.2.1). It 
therefore remains to be determined whether the increase in neurogenesis observed upon 
affecting microtubules or the actin cytoskeleton and their motor forces is due to the different 
migration of nuclei during INM or to the disruption of endocytosis and consequent 
disruption of Notch activity. 
Currently there is still no explanation of why Notch activity occurs preferentially in specific 
regions of the neuroepithelium. 
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I.5.5.4. Asymmetric cell divisions by differential Notch activity in siblings 
 
Even though the reason for the differential Notch activity observed in the different cell cycle 
phases is unknown, it is critical to determine the exact timing of Notch activation: since Notch 
signalling is involved in cell fate decisions, it is likely that the timing of Notch activation is 
crucial for those decisions. 
Many neocortical ventricular zone cells divide asymmetrically, with one daughter cell being 
maintained in this region as a proliferating progenitor and the other moving towards the 
subventricular zone, where it divides to generate two neurons. The intermediate progenitor 
that migrates to the SVZ expresses NGN2, starting 2h after birth, indicating its neurogenic 
potential. However, treatment of cells in mitosis with a Notch signalling inhibitor increases 
the number of cells expressing NGN2 in the SVZ, including clones in which both daughter 
cells express NGN2 (Ochiai et al., 2009). These results indicate that Notch activity after cell 
division can be important to define the fate of the daughter cells, including the establishment 
of cell fate asymmetry between sibling cells, where the cell activating Notch is maintained as 
an apical progenitor while the other sibling becomes an intermediate progenitor. 
It remains to be determined whether Notch activity can participate in such cell fate decisions 
in other vertebrate systems. In particular, if activation of Notch signalling in specific phases of 
the cell cycle of neural progenitors can underlie the cell fate decisions that distinguish P-P, P-
N and N-N divisions. 
 
I.5.6. Termination of Notch signalling and its dynamic activity 
 
The differential Notch activity during the cell cycle of neural progenitors suggests that Notch 
signalling is not always active during the life of these cells. Indeed, the rapid and strong 
activation of Notch signalling, followed by the rapid termination of its activity (as described in 
Section I.5.2), confers a highly dynamic character to this signalling pathway (reviewed in Fior 
and Henrique, 2009). 
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In the next Sections, I will also give examples on the dynamic activity of Notch signalling, 
focusing on the process of somitogenesis, and exploring the consequences of the short-lived 
Notch signal in the maintenance of vertebrate neural progenitors by lateral inhibition. Finally, 
I will describe some mechanisms that ensure the complete termination of Notch activity in 
differentiating neurons. 
 
I.5.6.1. Visualization of dynamic Notch activity in vertebrates 
 
The dynamic character of Notch signalling was first identified by the cyclic expression of 
genes in the pre-somitic mesoderm. Cells in the PSM are under the influence of FGF and Wnt 
signalling, the same signals that maintain the neural plate stem zone. However, as the embryo 
grows further posteriorly, PSM cells leave the influence of these signals and a new pair of 
somites forms. Each vertebrate species generates a characteristic number of somites at a 
specific rhythm, the zebrafish generating one new pair of somites every 30 minutes, the chick 
every 90 minutes and the mouse every 2 hours. The pace at which a new pair of somites forms 
depends on an underlying gene expression oscillator, the “segmentation clock”, which 
oscillates with the same period as that of somite formation, creating a posterior to anterior 
wave of gene expression in the PSM (reviewed in Lewis et al., 2009) (Fig. I.23). 
Genes from several signalling pathways, including FGF, Wnt and Notch in mouse, FGF and 
Notch in chick, and Notch in zebrafish, show an oscillatory expression in the PSM (reviewed 
in Dequeant and Pourquie, 2008), such as chick Hairy1 (Palmeirim et al., 1997). 
Many models based on negative feedback loops between genes that show oscillatory gene 
expression have been proposed for the pacemaker of the segmentation clock (reviewed in 
Giudicelli and Lewis, 2004). Surprisingly, mathematical modelling has shown that direct auto-
repression of Hes genes transcription by their own protein products is enough to generate 
sustained oscillations, as long as the lifetimes of the mRNA and protein are short in 
comparison to the sum of the transcriptional and translational delays (the time taken to 
synthesize mRNA and protein, respectively) (Lewis, 2003; Monk, 2003). The fulfilment of 
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these requirements has been supported by experimental data (Hirata et al., 2002; Hirata et al., 
2004; Giudicelli et al., 2007). 
 
 
 
 
Figure I.23: Segmentation clock. 
Somitogenesis is regulated by waves of expression of genes from the posterior to the anterior end of the 
segmental plates (unsegmented paraxial mesoderm), in defined time periods. After each wave, a new pair of 
somites is generated. This dynamic expression of genes underlies the molecular segmentation clock. In the chick 
embryo, a new pair of somites is generated every 90 minutes. Adapted from Gilbert (2000). 
 
 
The Notch signalling pathway is required for synchronization of cells in the PSM and its 
disruption causes somite malformation (reviewed in Lewis et al., 2009). Due to cell 
synchronization, the wave-like expression of Notch pathway genes can be visualized by the in 
situ hybridization technique, when the left or the right half of the embryo is fixed and the 
other half is left in culture. In the cultured half, an advance in the expression wave can be 
observed when compared to the fixed half (Palmeirim et al., 1997). Recently, these waves of 
expression have been visualized in the mouse PSM by time-lapse imaging using reporters for 
Lfng expression (Aulehla et al., 2008) or Hes1 expression (Masamizu et al., 2006). 
In the developing nervous system, fluctuations in Hes1 expression have also been visualized 
with an appropriate reporter (Shimojo et al., 2008), hinting also to a dynamic nature of the 
Notch pathway in neural progenitors. In contrast to cells in the PSM, neural progenitors are 
not synchronized and seem to have different levels of Notch activity, as shown by the 
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expression of Notch signalling components and the out-of-phase fluctuations of Hes1 reporter 
expression (Shimojo et al., 2008). However, as referred above, Hes1 responds also to signalling 
pathways other than Notch (reviewed in Sanalkumar et al., 2010), and the fluctuations 
observed are also dependent on JAK-STAT signalling (Shimojo et al., 2008), suggesting that 
the reporter might not reflect only Notch activity. 
 
I.5.6.2. Dynamic Notch activity in lateral inhibition in the vertebrate neuroepithelium 
 
The classical model of lateral inhibition explains how Notch signalling is able, for instance, to 
segregate only one cell from a group of equivalent neural progenitors and specify different 
fates (differentiating neuron vs. proliferating progenitors) (Fig. I.24A). This process occurs 
several times throughout development, until the progenitor pool is depleted and all neurons 
and glial cells are generated (reviewed in Bertrand et al., 2002; Kageyama et al., 2008b; Fior 
and Henrique, 2009). At first glance, it is conceivable that all neural progenitors have 
persistent activity of Notch, due to signalling from surrounding ligand-expressing 
differentiating cells. However, several lines of evidence point to a dynamic Notch activity: 
- Notch activity is short-lived (reviewed in Fior and Henrique, 2009); 
- At each given time, neural progenitors with activated Notch (NICD) are only a subset 
of the total number of cells expressing the Notch receptor (Tokunaga et al., 2004); 
- There are different levels of Notch activity across the apical-basal axis of the 
neuroepithelium, which correlate with different phases of the cell cycle (Murciano et 
al., 2002; Tokunaga et al., 2004; Cisneros et al., 2008; Del Bene et al., 2008); 
- There are different levels of expression of Notch targets between cells at any given 
moment (Baek et al., 2006; Cisneros et al., 2008; Shimojo et al., 2008); 
These lines of evidence suggest a situation in which the progression of neurogenesis might 
confer a dynamic character to Notch signalling in neural progenitors, as they go through 
sequential events of cell-fate decisions. Importantly, Notch activity seems to occur only in 
particular phases of the cell cycle, suggesting the existence of specific windows of opportunity 
for neural progenitors to receive signals from newborn neurons. 
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How is the expression of Notch components and proneural genes integrated, according to this 
dynamic view of lateral inhibition? The recent data from Ryoichiro Kageyama’s group 
(Shimojo et al., 2008) indicates that expression of Hes1 is dynamic in neural progenitors. Cells 
with low levels of HES1 are able to proliferate, express higher levels of proneural genes, such 
as NEUROG2, and consequently more DLL1. Indeed, analyses of expression of these three 
genes suggest an inverse correlation between Hes1 and Neurog2, and also between Hes1 and 
Dll1, although there seems to be co-expression in some cells (Shimojo et al., 2008). 
These observations suggest that not only the expression of HES1 is dynamic, but that the 
expression of NEUROG2 and DLL1 also behave similarly, although in an opposite phase to 
that of HES1. Expression of Neurog2 and Dll1 was also monitored in cultured tissues 
transfected with expression reporters for both genes, and it was found that fluctuations in 
levels of transcription of these genes also exist. However, it remains to be determined whether 
Neurog2 and Dll1 dynamic expression indeed occurs in a complementary pattern to that of 
Hes1. 
Lateral inhibition was therefore suggested to be a dynamic process, in which the levels of 
expression of Hes1 in one progenitor (reflecting Notch activity) are correlated with the levels 
of proneural gene activity (and of Dll1) in neighbouring progenitors. According to the 
proposed model, fluctuations of Hes1 and Neurog2 expression occur in neighbouring 
progenitors in opposite phases, so that one progenitor with high-Hes1/low-Neurog2 is 
surrounded by progenitors with low-Hes1/high-Neurog2. These fluctuations occur in groups 
of progenitors until one progenitor reaches a threshold in proneural activity, through 
unknown mechanisms, committing to differentiation while inhibiting their neighbours from 
adopting a similar fate. 
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Figure I.24: Different models of 
lateral inhibition. 
(A) In the classical model of 
lateral inhibition, cells with 
similar levels of differentiation 
potential acquire small differences 
in expression of proneural genes, 
Notch ligands and Notch 
receptors in a stochastic manner. 
These differences are then 
amplified, with one cell sending 
more signals to the neighbouring 
cells than the signals it receives. 
This cell then differentiates while 
the others are maintained as 
proliferating neural progenitors. 
(B) In an alternative model of 
lateral inhibition (by Ryoichiro 
Kageyama’s group), neural 
progenitors alternate between two 
states, one of high proneural 
protein and DLL1 expression and 
another of high HES1 expression. 
Notch and JAK/STAT signalling 
govern HES1 fluctuations, which 
in turn govern the 
proneural/DLL1 fluctuations in a 
complementary fashion: when 
HES1 expression is high, 
proneural/DLL1 expression is low, 
and vice-versa. Eventually, due to 
the action of an undetermined 
factor, one cell acquires higher 
levels of expression of proneural 
proteins and differentiates, while 
the others are maintained as 
progenitors since they express 
more HES1, due to signals from 
the differentiating cell. Adapted 
from Kageyama et al. (2008b). 
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I.5.6.3. Shutdown of Notch signalling during differentiation 
 
While the model described above suggests that proliferating neural progenitors undergo 
successive bursts of Notch activity, it is also important to mention that whenever a 
neuroepithelial cell commits to differentiation there must be an effective and long lasting 
down-regulation of Notch activity to ensure that neurogenesis can proceed. Several 
mechanisms cooperate to ensure the shutdown of Notch activity in differentiating neurons: 
- Ligands have been described to bind to Notch receptors expressed in the same cell (in 
cis), inhibiting their activity and expression (del Alamo and Schweisguth, 2009). The 
DLL3 ligand, which is expressed in mammalian differentiating neurons (Dunwoodie 
et al., 1997), but is unable to activate Notch in trans, can also inactivate the Notch 
receptors in cis, contributing to the inhibition of Notch signalling in newborn neurons 
(Ladi et al., 2005; Geffers et al., 2007). Thus, differentiating cells expressing Notch 
ligands can inhibit the Notch receptors in the same cell, preventing new Notch 
activations. 
- Proneural proteins can induce the expression of other factors that counteract Notch 
activity. For instance, in the developing mouse, NEUROG’s can induce the expression 
of HES6, which in turn inhibits the function of HES1 (Bae et al., 2000; Koyano-
Nakagawa et al., 2000; Gratton et al., 2003; Belanger-Jasmin et al., 2007). In the chick 
embryo, HES6-2 is also expressed downstream of NEUROG’s. In this case, the HES6-2 
protein represses the transcription of Hes5 genes (Fior and Henrique, 2005) (Fig. I.25). 
 
Figure I.25: Circuitry of Hes6-2/Hes5 negative feedback loops 
in the developing chick embryo. 
After activation of expression of the three Hes5 genes in neural 
progenitors of the developing chick embryo, HES6-2 and HES5 
proteins repress transcription of Hes genes, helping to terminate 
Notch activity. In differentiating cells, high levels of NEUROG’s 
further increase the expression of HES6-2, which more strongly 
down-regulates the expression of the three Hes5 genes, allowing 
differentiation to proceed. Later, HES6-2 also represses 
transcription of its own gene, switching off its own expression. 
Adapted from Fior and Henrique (2005). 
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I.6. AIMS AND SCOPE OF THIS THESIS 
 
In Chapter I, I started by describing the early embryonic development of the chick, which was 
used as an animal model to study the role of Notch signalling in vertebrate neurogenesis. I 
then described how the neural tissue is formed and patterned, how neurogenesis begins, how 
Notch signalling functions and is modulated, and how it can regulate nervous system 
development, in particular focusing on the lateral inhibition mechanism of Notch signalling 
that controls the rate of differentiation and proliferation in the vertebrate neural tube. 
The work described in this thesis was aimed at studying the mechanisms responsible for the 
shutdown of Notch activity in newborn neurons, and also at studying how Notch activity can 
affect the fates of neural progenitors. 
 
In Chapter II, I will describe the experimental procedures used during these studies. 
 
In Chapter III, I will describe my work on the chick Hes6-1 gene and how it is involved in the 
shutdown of Notch activity in differentiating neurons. 
The inhibition of HES proteins by HES6 is one of the mechanisms that differentiating cells use 
to switch off Notch activity (Bae et al., 2000; Gratton et al., 2003; Belanger-Jasmin et al., 2007). 
Two Hes6-like genes exist in chick, but only the function of cHes6-2 has been ascertained. 
cHES6-2 is involved in transcriptional repression of the three cHes5 genes, helping to release 
the cell from Notch signalling during neuronal differentiation (Fior and Henrique, 2005). 
The first aim of this thesis was to study the function of the other Hes6 gene in the chick, 
cHes6-1, and determine if this gene is also implicated in the termination of Notch activity. 
Sub-aims included: 
- comparison of the expression of the two chick Hes6 genes; 
- identification of their position in the cascade of genes during neuronal differentiation; 
- determination of whether the chick HES6 proteins have redundant of different 
functions. 
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In Chapter IV, I will describe my work on the generation of a new Notch reporter, and how I 
used it to monitor Notch activity in neural progenitors. 
Fluctuations in Hes1 expression have been monitored in somitogenesis and in neural 
progenitors (Masamizu et al., 2006; Shimojo et al., 2008). However, Hes1 expression is also 
dependent on signalling pathways other than Notch signalling (reviewed in Sanalkumar et al., 
2010) and it was not investigated if Notch effectors that mainly rely on Notch activity, such as 
Hes5 (de la Pompa et al., 1997; Lutolf et al., 2002), also show transcriptional fluctuations. 
Furthermore, Notch activity was not correlated with cell cycle phases or with cell fate 
decisions. 
The second main aim of this thesis was therefore to monitor the dynamic aspects of Notch 
activity during the neural progenitors’ cell cycle, through the use of a novel Notch reporter 
system. 
Sub-aims included: 
- confirmation of the dynamic nature of Notch activity by determining whether the 
expression of the Notch effector Hes5 fluctuates; 
- determination of whether Notch signalling is active throughout the cell cycle or only 
in specific phases; 
- determination of whether Notch signalling is implicated in the definition of the 
different types of cell division (P-P, P-N or N-N). 
 
Finally, in Chapter V, I shall discuss the importance of this work in increasing our knowledge 
on the development of the nervous system and what new experiments are being done to 
further investigate the role of Notch activity in the regulation of neurogenesis. 
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CHAPTER II – MATERIALS AND METHODS 
 
II.1. MOLECULAR BIOLOGY TECHNIQUES 
 
II.1.1. Preparation of chemically competent E.coli bacteria 
 
Preparation of chemically competent bacteria was based on the protocol described by Inoue et 
al. (1990). Cultures of Escherichia coli DH5T bacterial strain were made competent for 
transformation with plasmid DNA by treatment with calcium chloride (CaCl2). A single 
colony was placed in 25mL of SOB medium and grown overnight at 37ºC, with vigorous 
shaking. This starter culture was used to inoculate two 1L flasks (each containing 125mL of 
SOB medium), of which each received 1mL of the starter culture. Both flasks were incubated 
overnight (o/n) at 18-22ºC with vigorous shaking, until they reached an OD600nm=0.6 (it takes 
about 26 hours (h), measured in a GeneQuantpro spectrophotometer from GE Healthcare). 
Further growth of the bacteria was interrupted by cooling the culture on ice for 10 minutes 
(min). Both cultures were joined together in one tube and then centrifuged at 2500g for 10min 
at 4ºC. The pellet was gently resuspended in 80mL of ice-cold Inoue transformation buffer 
(55mM MnCl2, 15mM CaCl2, 250mM KCl, 10mM PIPES pH=6.7, filter sterilized), left on ice 
for 10min, centrifuged at 2500g for 10min at 4ºC and resuspended once more in 20mL of ice-
cold Inoue transformation buffer. After complete resuspension, 1.5mL of dymethyl sulfoxide 
(DMSO) was added to the solution and mixed by swirling. The cells were then aliquoted in 
100μL samples, frozen in liquid nitrogen and stored at -80ºC. 
 
II.1.2. Plasmid transformation of chemically competent E.coli bacteria 
 
For plasmid DNA transformation, frozen aliquots of competent cells were thawed on ice. 
Plasmid DNA was incubated with 100μL of cells on ice for 20min. The cells/DNA mix was 
heat-shocked for 45 seconds (s) in a water bath at 42ºC and then incubated on ice for 2min. 
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900μL of SOB medium was added to the mix, which was then incubated with shaking at 37ºC, 
for 1h. The mix was centrifuged for 1min on a bench centrifuge and 900μL of the supernatant 
solution were discarded. The cells were resuspended in the remaining volume (100μL) and 
plated on appropriate selective LB agar media and incubated o/n at 37ºC. 
 
If commercially available Invitrogen One Shot® MAX Efficiency® DH5α™-T1R Competent 
Cells were used, the following protocol was performed: for plasmid DNA transformation, 
frozen aliquots of competent cells were thawed on ice. Plasmid DNA was incubated with 
100μL of cells on ice for 30min. The cells/DNA mix was heat-shocked for 30s at 42ºC and then 
incubated on ice for 2min. 250μL of SOC medium was added to the mix, which was then 
incubated with shaking at 37ºC, for 1h. The mix was centrifuged for 1min and 250μL of the 
supernatant solution were discarded. The cells were resuspended in the remaining volume 
(100μL) and plated on appropriate selective LB agar media and incubated o/n at 37ºC. 
 
II.1.3. Plasmid DNA purification 
 
For economical and low quality small scale preparation of plasmid DNA (with an 
approximate yield of 5-10μg, “dirty-preps”), 2mL of a 3mL o/n bacterial culture of 
transformed competent cells, in the appropriate selective LB medium, was centrifuged for 
1min and the supernatant was discarded. The remaining pellet was resuspended in 0.75mL of 
STET buffer (8% glucose, 5% Triton X-100, 50mM EDTA, 50mM Tris, pH=8) to which 
lysozyme had been added (at a concentration of 1mg/mL). The mixture was then boiled at 
100ºC for 2min in a dry bath, centrifuged for 10min and the pellet was removed with a 
toothpick. After leaving the supernatant on ice for 5min, 0.75mL of isopropanol were added 
and the mixture was vortexed. After centrifuging for 10min, the DNA pellet was washed with 
0.5mL of 70% ethanol, dried and resuspended in TE buffer supplemented with RNase A at a 
concentration of 5μg/mL. 
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For high quality small scale preparation of plasmid DNA (with an approximate yield of 5-
10μg), 3mL of a 3mL o/n bacterial culture of transformed competent cells, in the appropriate 
selective LB medium, was processed using the Wizard Plus SV Minipreps DNA Purification 
System (Promega), according to the manufacturer’s instructions. 
 
For large scale preparations of plasmid DNA (200-400μg), 50mL of the selective LB medium 
was inoculated with 0.5mL of plasmid bacterial culture and shaken o/n at 37ºC and processed 
using the Genopure Plasmid Midi Kit (Roche), according to the manufacturer’s instructions. 
 
II.1.4. DNA quantification 
 
The concentration of DNA was determined by spectrophotometry using the NanoDrop 
spectrophotometer (Thermo Scientific). One A260 unit corresponds to 50μg/mL of double 
stranded DNA (Sambrook and Russell, 2001). The purity of the nucleic acid preparation was 
estimated by the ratio between the readings obtained at 260nm and 280nm (pure preparations 
of DNA show ratio values of 1.8). 
DNA was also quantified by running a small sample on an agarose gel in parallel to a sample 
with known concentration. 
 
II.1.5. DNA precipitation 
 
DNA had to be precipitated whenever a higher concentration was needed or when its volume 
had to be reduced. 
Precipitation was done by adding to the digestion mixture 1/10 of its volume of 3M sodium 
acetate and two volumes of 100% ethanol. After vortexing, the mixture was incubated at -20ºC 
for at least 1h and then centrifuged for 30min at maximum speed. The pellet was then washed 
with 500μL of 70% ethanol, centrifuged again for 10min and, after removing the supernatant, 
was dried at room temperature. Finally, the DNA was resuspended in the required amount of 
water, 10mM Tris pH=8 or TE buffer (10mM Tris, 1mM EDTA, pH=8). 
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II.1.6. Restriction digestions 
 
Enzymatic restriction of DNA was performed for approximately 1-2h using 5-10U of 
commercially available restriction enzymes and respective buffers (Promega, Roche, 
Fermentas, New England Biolabs). The volume of enzyme used in each reaction never 
exceeded 10% of the total reaction volume. The addition of BSA to the reaction mixture and 
the temperature at which it was performed depended on the enzyme used. 
 
II.1.7. Oligonucleotides 
 
The oligonucleotides used during the course of this work for cloning, as primers for PCR, or 
for cycle sequencing are listed in Table II.1. 
All the oligonucleotides were synthesized by Sigma Genosys. 
 
 
Table II.1: Oligonucleotides used during the course of this work 
 
Oligonucleotide Oligonucleotide sequence (5’ to 3’) 
Hes6-1FW CGGAATTCAGGATGGCGCCGTCCTTC 
Hes6-1REV CGGGATCCGTTACCACGGCCTCCACAT 
Hes6-1F2 AGGATGGCGCCGTCCTTCC 
Hes6-1delWRPWR TTACATGGACTTGGGCGAGC 
Hes6-1S175R CGCACGTCTCCTCACCGGA 
Hes6-1S175F TCCGGTGAGGAGACGTGCGCCGACTCGGACGAGGCG 
Hes6-1R2 TTACCACGGCCTCCACATGG 
Hes6-1RR3334AQR TGCGCCTTCTTCTCCACCAGCGGC 
Hes6-1RR3334AQF GCCGCTGGTGGAGAAGAAGGCGCAGGCGCGGATCAACGAGAGC 
Hes6-2F AGGATGACGGCCGCAGCCAT 
Hes6-2delWRPWR TTACATATCTAATGACCCCATACTAGGGTTG 
Hes6-2K59RR CTTTCCAGTTTAGACTGATCCAAGTGG 
Hes6-2K59RF CCACTTGGATCAGTCTAAACTGGAAAGAGCAGACATCCTGGAAATGAC
GG 
Hes6-2R TTACCATGGTCTCCACATATCTAATGAC 
Hes6-2RR3132AQR TGGGCCTTCCGTTCGATTAGAGGTTTCC 
Hes6-2RR3132AQF GGAAACCTCTAATCGAACGGAAGGCCCAGGAAAGGATTAACAACTGCT
TGG 
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mHes6F ACCATGGCTCCGTCCCAGGCG 
mHes6R TCACCAAGGCCTCCACACACTC 
PHes5-1FSalI AAAGGCAGCACATTGAGATGTCGAC 
P2Hes5R CATTATCCGAGAGCTGCTGTCAGC 
Ub1F GCTGACAGCAGCTCTCGGATAATGCAGATCTTCGTGAAGACTCTG 
Ub1REcoRISacII GTGAATTCCCGCGGCACACCTCTGAGACGGAGTACC 
Ub2FEcoRI TCGAATTCACCATGCAGATCTTCGTG 
Ub2RBamHI GGTGGATCCTGTCGTCCTAGCTTC 
VNPFBamHI CAGGATCCACCGGTCGCCACCATGGTGAGCAAGGGCGAGGAGCTG 
P4VNP-RXbaI CTAGTCTAGAGCGGCCGCACTAGTGATCTACAC 
5-1VNP3UTRFwd TCGGATAATGGTGAGCAAGG 
VNP3UTR-KBoxF TCGGATAATGGTGAGCAAGG 
Hes51R ATCGAATTCTTCTCTTTCAGG 
3UTR-KBoxR ATCGAATTCTTCTCTTTCAGG 
VNP3UTR-KBoxR TGCTGGCAGCCAGGTTTTG 
3UTR-KBoxF GAAAACCTGGCTGCCAGCACTGTACTGAGCATGCTCCAG 
NLSbsrGI-F1 GTACCCTTCCAAAAAAGAAGAGAAAGGTAGAAGACCCCTGATT 
NLSbsrGI-R1 GTACAATCAGGGGTCTTCTACCTTTCTCTTCTTTTTTGGAGG 
Venus-GPI-FW TCCACCGGTCGCCACCATGGTGAGCAAG 
Venus-GPI-REV CGCACTTGTACAGCTGCTCCATGC 
CherryNheIF CATAGCTAGCACCATGGTGAGCAAGGGCG 
Hes55’armFCCHindIII TATAAGCTTCTGCGCCTGTGGCCTCTG 
Hes55’armR GCACCACCCCGGTGAACAGCTCCTCGCCCTTGCTCACCATGCCTGGAG
CTCTGGAGGCG 
VNP-CherryNLSF ATGGTGAGCAAGGGCGAGGA 
VNPRCCEcoRI ATGAATTCCTACACATTGATCCTAGCAGAAGCAC 
Hes53’armFCCBamHI TATGGATCCCCCAGCGGCCGACCGGTG 
Hes53’armRCCNotI ATCACTCATAGCGGCCGCACCTTGAGGTGAGGCCCCATG 
Dll15’armFCCXhoIF TATACTCGAGAGTCCTTGCCACCACCGTTC 
Dll15’armR TGATGATGGCCATGTTATCCTCCTCGCCCTTGCTCACCATGGTACCGC
TGGACGCCCT 
CherryNLSRCCREcoRI ATGAATTCTCAGGGGTCTTCTACCTTTCTCTTC 
Dll13’armFCCBamHI TATGGATCCGATGGAAGCGATGTGGCAAAATT 
Dll13’armRCCSacII TATACCGCGGGAACGTCACAAAATACTCAAGCTTTACAG 
NEO-stopXBA-REV GCTCTAGATTAGAAGAACTCGTCAAG 
NEO-xho-atg-DIR CGCTCGAGATGATTGAACAAGATGGATTG 
Hes5FVB5armF TCCTCTGGAAGTCGCTGTCT 
Hes5FVB5armR AGATCAGCTTCAGGGTCAGC 
Hes5FVB3armF GTGGGCTCTATGGCTTCTG 
Hes5FVB3armR TTAAGGATCATCGTGGAGACC 
Dll1FVB5armF ATGGCATTGGCTGAATTCTT 
Dll1FVB5armR AAGCGCATGAACTCCTTGAT 
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Dll1FVB3armF TCTGAGGCGGAAAGAACCA 
Dll1FVB3armR ATAGTCACATAGACCCGAAGTGC 
cHes5-1F ATGGCACCCAGCGCTCTCTC 
cHes5-1T7R TAATACGACTCACTATAGGGCTACCAAGGCCTCCAGAGGTTG 
cDelta1probeF GGAGGGCGATGCACTGACAA 
cDelta1T7R TAATACGACTCACTATAGGGTTACACCTCAGTTGCTATGATGCAC 
 
 
II.1.8. Annealing reactions of oligonucleotides 
 
Single stranded oligonucleotides that were used directly for cloning had to be annealed to 
generate double stranded oligonucleotides. Equimolar amounts of complementary forward 
and reverse oligonucleotides were joined together in TEN buffer (10mM Tris, 1mM EDTA, 
100mM NaCl, pH=8) in a total volume of 50μL. The reaction mixture was incubated at 95ºC 
for 10min in a dry bath and then the block was allowed to slowly cool down to room 
temperature (in approximately 1h). 
 
II.1.9. Polymerase Chain Reaction (PCR) 
 
To produce inserts for cloning in several DNA vectors or to generate templates for probe 
synthesis, PCR primers were designed for the specific target sequences. 
Reactions were prepared in a final volume of 25μL (1ng of template plasmid DNA, 1x buffer, 
0.2mM dCTP, 0.2mM dGTP, 0.2mM dATP, 0.2mM dTTP, 25pmol of each primer and the 
necessary amount of Polymerase). In some circumstances, additives were added to the 
reaction mixtures to improve the product yield. In other cases, they were absolutely necessary 
for the execution of the PCR. These additives were either DMSO at 10%, formamide at 5% or 
glycerol at 10%. 
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The cycling times varied according to the enzyme used. 
 
- Standard PCR using Taq DNA Polymerase (GE Healthcare) – used for the generation 
of templates for in situ hybridization probe synthesis: 
Amplification was performed with an initial denaturation step at 94ºC for 5min, 
followed by 35 cycles at 94ºC for 1min, annealing at 60ºC for 90s, 72ºC for 1min/kb, 
followed by 10min at 72ºC and 5min at 4ºC. 
 
- Standard PCR using Pfu DNA Polymerase (Fermentas or Stratagene) – used for 
generation of inserts for cloning reactions: 
Amplification was performed with an initial denaturation step at 94ºC for 5min, 
followed by 25 cycles at 94ºC for 1min, annealing at 60ºC for 90s, 72ºC for 2min/kb, 
followed by 10min at 72ºC and 5min at 4ºC. 
 
- Standard PCR using Phusion DNA Polymerase (Finnzymes) – used for generation of 
inserts for cloning reactions: 
Amplification was performed with an initial denaturation step at 98ºC for 30s, 
followed by 25 cycles at 98ºC for 10s, annealing at 60ºC for 30s, 72ºC for 15s/kb, 
followed by 10min at 72ºC and 5min at 4ºC. 
 
Specific parameters of these general cycling programs, especially the annealing temperature, 
were adjusted for each primer and template set. 
 
II.1.10. Dephosphorylation 
 
Before ligation of the inserts to the vector backbone, the vector was dephosphorylated to 
prevent its self-ligation and reduce the number or negative clones. Dephosphorylation was 
performed on 3-10μg of digested vector at 37ºC during 1.5h, using 2U of Calf Intestinal 
Phosphatase (Promega) with the appropriate buffer, in a total volume of 50μL. 
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II.1.11. Phosphorylation 
 
Inserts derived from oligonucleotide annealing, or PCRs that remained blunt-ended until the 
time of ligation, had to be phosphorylated before ligation with the dephosphorylated vectors. 
Phosphorylation was performed on approximately 1μg of blunt-ended DNA at 37ºC for 
45min, using 10U of Polynucleotide Kinase (Fermentas) with the appropriate buffer and 1mM 
ATP, in a total volume of 30μL. 
 
II.1.12. Analysis and isolation of DNA by agarose gel electrophoresis 
 
To separate, estimate the size of DNA fragments and purify them, agarose gel electrophoresis 
was carried out. Gels were prepared by heating agarose (SeaKem® LE Agarose, Lonza) until 
complete dissolution in 1x TAE buffer (40mM Tris, 1mM EDTA, 0.35% glacial acetic acid). 
The final agarose concentration depended on the size of DNA to be resolved. This was 2% 
(w/v) for fragments with sizes inferior to 0.5kb and 1% (w/v) for fragments between 1kb and 
10kb. To distinguish between fragments inferior to 200bp that only differed a few base pairs in 
length, MetaPhor® agarose was used (for example, when cloning small oligonucleotides). 
DNA was visualized by the addition of ethidium bromide (GibcoBRL) to the gel, to a final 
concentration of 0.4μg/mL. DNA samples were mixed with loading buffer (60% Glycerol 
(v/v), 10mM EDTA, 0.2% OrangeG (Sigma)) in a 5:1 proportion and electrophoresis was 
carried out in 1x TAE buffer at 5-10V/cm of gel length, until the desired resolution was 
achieved. DNA was visualized under an ultraviolet light at 260nm or 365nm and the size of 
the fragments was estimated by comparison with linear DNA strands of known molecular 
weight (1kb Plus DNA Ladder, Invitrogen, or 2-Log DNA Ladder, New England Biolabs). At 
this stage the gels were either photographed (analytical gels) or DNA was extracted from them 
(preparative gels). In the case of the preparative gels, the region of the gel containing the DNA 
fragment of interest was excised under ultraviolet light at 365nm and purified using Wizard 
Plus SV Gel and PCR Clean-up System (Promega), according to the manufacturer’s 
instructions. 
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II.1.13. DNA Ligation Reactions 
 
Ligations were performed o/n at 15ºC in a final volume of 10μL, using 5U of T4 DNA Ligase 
(Fermentas) and the respective ligation buffer. The proportion between backbone vector and 
the insert to be cloned was 1:3, based on DNA concentrations assessed by visualizing the 
fragments after agarose gel electrophoresis. Generally, 1μL of vector (approximately 25ng) was 
used. 
 
II.1.14. Cycle sequencing 
 
The DNA samples to be sequenced were processed according to a protocol provided by the 
Genomics Unit from Instituto Gulbenkian de Ciência (IGC). 2μL of Terminator Ready 
Reaction Mix and 2μL buffer (supplied by Genomics Unit), 600ng of double stranded DNA 
and 3.2pmol of the desired primer were mixed in a final volume of 10μL and submitted to 
thermal cycling. Cycle sequencing was performed with the following conditions: a 
denaturation step at 96 ºC for 1 min, followed by 25 cycles at 96ºC for 10s, 50ºC for 5s, 60ºC 
for 4min and a final step at 4ºC until ready to precipitate. The samples were precipitated with 
ethanol at room temperature for 30min, centrifuged for 30min at 4ºC, washed with 25μL of 
70% ethanol and the dry pellets were then sent to the Genomics Unit from IGC for analysis 
with ABI PRISM 377 DNA Sequencer Applied Biosystem. 
Alternatively, samples were sequenced at Stabvida. 
 
II.1.15. DNA constructs 
 
Several plasmid constructs were used during the course of this work with several purposes, 
including functional studies and live-imaging experiments using fluorescent reporters. All 
newly generated plasmid constructs were verified by at least 3 independent restriction 
digestions and analysis on agarose gel electrophoresis. Whenever Polymerase Chain Reactions 
were involved in the generation of these plasmids, the final plasmid sequences were also 
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confirmed by sequencing as described above. Once the sequences of plasmids were confirmed, 
400μL of an o/n-grown bacterial culture carrying the plasmids were mixed with 400μL of LB 
containing 30% glycerol and stored at -80ºC as bacterial stocks. 
 
II.1.15.1. DNA constructs already available 
 
Although the majority of plasmids used in the experiments described in this thesis were 
generated by me, some were already available, such as the following: 
 
cHes6-2@pCAGGSIRESGFP 
Was previously used in the laboratory in functional studies (Fior and Henrique, 2005). 
 
NICD@pCAGGSIRESGFP 
Was previously used in the laboratory in functional studies (Fior and Henrique, 2005). 
 
Ngn2@pCIG (a.k.a. Neurog2@pCIG) 
Was previously used in the laboratory in functional studies (Fior and Henrique, 2005). 
 
X-Su(H)DBM@pCIG (a.k.a. CSLDN@pCIG) 
Was kindly provided by Dr. Andy McMahon (Megason and McMahon, 2002). 
 
Phes5-1VNP3’UTR 
Was previously used in the laboratory in live-imaging experiments (Fior, 2006). 
 
Phes5-1VNP3’UTRPolyA (a.k.a. pHes5-VNP) 
Was previously used in the laboratory in live-imaging experiments (Fior, 2006). 
 
VNP@pCAGGS (a.k.a. pCAG-VNP) 
Was previously used in the laboratory in live-imaging experiments (Fior, 2006). 
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II.1.15.2. DNA constructs generated for functional studies and live-imaging experiments 
 
Several plasmid constructs that were used in the HES6 functional studies and the Notch 
reporter live-imaging experiments, described in this thesis, were generated by me (Table II.2). 
 
 
Table II.2: Plasmid constructs generated for the functional studies and the live-imaging experiments. 
 
Construct Construct backbone Experiment where it was used
cHes6-1 pCIG Functional studies 
cHes6-1S175A pCIG Functional studies 
cHes6-1ΔWRPW pCIG Functional studies 
cHes6-1AQ pCIG Functional studies 
cHes6-1AQΔWRPW pCIG Functional studies 
cHes6-2 pCIG Functional studies 
cHes6-2K59R pCIG Functional studies 
cHes6-2ΔWRPW pCIG Functional studies 
cHes6-2AQ pCIG Functional studies 
cHes6-2AQΔWRPW pCIG Functional studies 
mHes6 pCIG Functional studies 
PHes5-1Ub1 pBluescript II KS Live-imaging experiments 
Ub2VNP pBluescript II KS Live-imaging experiments 
PHes5-1Ub1Ub2VNP3’UTR pBluescript II KS Live-imaging experiments 
PHes5-1Ub1Ub2VNP3’UTRPolyA pBluescript II KS Live-imaging experiments 
VNP3’UTR pCAGGSMCSKS Live-imaging experiments 
VNP3’UTRΔ20 pCAGGSMCSKS Live-imaging experiments 
CherryNLS pCAGGSMCSKS Live-imaging experiments 
CherryGPI pCAGGSMCSKS Live-imaging experiments 
CherryTub 
derived from 
pEYFPTub 
Live-imaging experiments 
 
 
For the generation of these constructs, I have used 3 vectors: 
 
pBluescript II KS 
The commercially available bacterial cloning vector pBluescript II KS (Stratagene) was used 
for sub-cloning procedures. 
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pCIG 
This is an eukaryotic expression vector kindly provided by Dr. Andy McMahon (Megason and 
McMahon, 2002). pCIG was made by linker insertion of three nuclear localization sequences 
(NLS) into pIRES2-EGFP (Clontech) and then by transferring a fragment of this new plasmid 
into pCAGGS (Niwa et al., 1991), an eukaryotic expression vector derived from pBluescript. 
Order of elements in pCAGGS: human cytomegalovirus immediate early promoter (CMV-
IE), chicken β-actin/rabbit β-globin hybrid promoter (AG), multiple cloning site (MCS), 
rabbit β-globin polyadenylation signal (β-globin poly(A)), simian virus 40 polyadenylation 
signal (SV40 poly(A)). pCIG contains an additional internal ribosomal entry site (IRES) 
followed by a nuclear enhanced green fluorescent protein (EGFP) downstream of the 
polylinker, which are then followed by a stop codon in each frame, allowing coupled 
expression of the proteins of interest with EGFP. 
 
pCAGGSMCSKS 
This vector is a pCAGGS vector that was modified by Dr. Evguenia Bekman to contain the 
MCS of pBluescript II KS (unpublished). 
 
These vectors were used to generate the following constructs: 
 
cHes6-1@pCIG 
Amplified cHes6-1 coding region (CR) from cHes6-1 expressed sequence tag (EST, GenBank 
Acc: BI393243) with primers Hes6-1FW and Hes6-1REV. After phosphorylation, cloned this 
fragment into pCIG digested with EcoRV and which had been dephosphorylated. 
 
cHes6-1S175A@pCIG 
Amplified cHes6-1 CR from cHes6-1 EST (GenBank Acc: BI393243) with primers Hes6-1F2 
and Hes6-1S175AR. Also amplified with primers Hes6-1S175AF and Hes6-1R2. Ligated both 
fragments by PCR using primers Hes6-1F2 and Hes6-1R2. After phosphorylation, cloned this 
fragment into pCIG digested with EcoRV and which had been dephosphorylated. 
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cHes6-1ΔWRPW@pCIG 
Amplified cHes6-1 CR without the C-terminal tetrapeptide (WRPW) from cHes6-1 EST 
(GenBank Acc: BI393243) with primers Hes6-1F2 and Hes6-1delWRPWR. After 
phosphorylation, cloned this fragment into pCIG digested with EcoRV and which had been 
dephosphorylated. 
 
cHes6-1AQ@pCIG 
Amplified cHes6-1 CR from cHes6-1 EST (GenBank Acc: BI393243) with primers Hes6-1F2 
and Hes6-1RR3334AQR. Also amplified with primers Hes6-1RR3334AQF and Hes6-1R2. 
Ligated both fragments by PCR using primers Hes6-1F2 and Hes6-1R2. After 
phosphorylation, cloned this fragment into pCIG digested with EcoRV and which had been 
dephosphorylated. 
 
cHes6-1AQΔWRPW@pCIG 
Amplified cHes6-1 CR from cHes6-1 EST (GenBank Acc: BI393243) with primers Hes6-1F2 
and Hes6-1RR3334AQR. Also amplified with primers Hes6-1RR3334AQF and Hes6-
1delWRPWR. Ligated both fragments by PCR using primers Hes6-1F2 and Hes6-
1delWRPWR. After phosphorylation, cloned this fragment into pCIG digested with EcoRV 
and which had been dephosphorylated. 
 
cHes6-2K59R@pCIG 
Amplified cHes6-2 CR from cHes6-2 EST (GenBank Acc: BU106413) with primers Hes6-2F 
and Hes6-2K59RR. Also amplified with primers Hes6-2K59RF and Hes6-2R. Ligated both 
fragments by PCR using primers Hes6-2F and Hes6-2R. After phosphorylation, cloned this 
fragment into pCIG digested with EcoRV and which had been dephosphorylated. 
 
cHes6-2ΔWRPW@pCIG 
Amplified cHes6-2 CR without the C-terminal tetrapeptide (WRPW) from cHes6-2 EST 
(GenBank Acc: BU106413) with primers Hes6-2F2 and Hes6-2delWRPWR. After 
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phosphorylation, cloned this fragment into pCIG digested with EcoRV and which had been 
dephosphorylated. 
 
cHes6-2AQ@pCIG 
Amplified cHes6-2 CR from cHes6-2 EST (GenBank Acc: BU106413) with primers Hes6-2F 
and Hes6-2RR3132AQR. Also amplified with primers Hes6-2RR3132AQF and Hes6-2R. 
Ligated both fragments by PCR using primers Hes6-2F and Hes6-2R. After phosphorylation, 
cloned this fragment into pCIG digested with EcoRV and which had been dephosphorylated. 
 
cHes6-2AQΔWRPW@pCIG 
Amplified cHes6-2 CR from cHes6-2 EST (GenBank Acc: BU106413) with primers Hes6-2F 
and Hes6-2RR3132AQR. Also amplified with primers Hes6-2RR3132AQF and Hes6-
2delWRPWR. Ligated both fragments by PCR using primers Hes6-2F and Hes6-
2delWRPWR. After phosphorylation, cloned this fragment into pCIG digested with EcoRV 
and which had been dephosphorylated. 
 
mHes6@pCIG 
Amplified mHes6 CR from mHes6 EST (GenBank Acc: W66929) with primers mHes6F and 
mHes6R. After phosphorylation, cloned this fragment into pCIG digested with EcoRV and 
which had been dephosphorylated. 
 
PHes5-1Ub1@pKS 
Amplified the 3’ end of PHes5-1 from PHes5-1VNP3’UTRPolyA with primers PHes5-1FSalI 
and P2Hes5R. Also amplified Ubiquitin from UbG76V-GFP (kindly provided by Dr. Maria 
Masucci (Dantuma et al., 2000)) with primers Ub1F and Ub1REcoRISacII. Ligated both 
fragments by PCR using primers PHes5-1FSalI and Ub1REcoRISacII. After digestion with SalI 
and EcoRI, ligated the fragment with pBluescript II KS also digested with SalI and EcoRI, and 
which had been dephosphorylated. 
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Ub2VNP@pKS 
Amplified Ubiquitin from UbG76V-GFP with primers Ub2FEcoRI and Ub2RBamHI and 
then digested with EcoRI and BamHI. Also amplified Venus-NLS-PEST (VNP) from 
VNP@pKS (Fior, 2006) with primers VNPFBamHI and P4VNP-RXbaI and then digested with 
BamHI and XbaI. In the end, ligated both fragments together with pBluescript II KS digested 
with EcoRI and XbaI, and which had been dephosphorylated 
 
PHes5-1Ub1Ub2VNP3’UTR 
Digested PHes5-1VNP3’UTR with SalI and XbaI and removed the 3’ end of PHes5-1 and 
VNP, keeping the remaining of the plasmid, which was dephosphorylated. Then, digested 
PHes5-1Ub1@pKS with SalI and EcoRI to recover the 3’end of PHes5-1 and Ub1 and digested 
Ub2VNP@pKS with EcoRI and XbaI to recover Ub2 and VNP. Both fragments were then 
ligated with the remaining of the PHes5-1VNP3’UTR plasmid. 
 
PHes5-1Ub1Ub2VNP3’UTRPolyA (a.k.a. pHes5-UbVNP) 
Digested pCAGGSMCSKS with EcoRV and HindIII to obtain the SV40 poly(A) signal and 
inserted it in PHes5-1Ub1Ub2VNP3’UTR digested with the same enzymes and which had 
been dephosphorylated. 
 
VNP3’UTR@pCAGGSMCSKS (a.k.a. pCAG-VNP) 
VNP3’UTR was amplified from PHes5-1VNP3’UTRPolyA using primers 5-1VNP3UTRFwd 
and Hes51R. After phosphorylation, ligated this fragment with pCAGGSMCSKS digested 
with EcoRV and which had been dephosphorylated. 
 
VNP3’UTRΔ20@pCAGGSMCSKS (a.k.a. pCAG-VNPΔ20) 
VNP and the 5’ end of 3’UTR were amplified from PHes5-1VNP3’UTRPolyA using primers 
VNP3’UTR-KboxF and VNP3’UTR-KboxR (that were already phosphorylated). The 3’end of 
the 3’UTR was amplified from PHes5-1VNP3’UTRPolyA using primers 3’UTR-KboxF and 
3’UTR-KboxR (that were already phosphorylated). Ligated both fragments by PCR using 
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primers VNP3’UTR-KboxF and 3’UTR-KboxR. This fragment was ligated with 
pCAGGSMCSKS digested with EcoRV and which had been dephosphorylated. 
 
CherryNLS@pCAGGSMCSKS (a.k.a pCAG-CherryNLS) 
Annealed oligonucleotides NLSbsrGI-F1 and NLSbsrGI-R1 to generate a double stranded 
DNA molecule. After phosphorylation, ligated this DNA fragment into 
mCherry@pCAGGSMCSKS (Evguenia Bekman, unpublished) digested with BsrGI and which 
had been dephosphorylated. 
 
CherryGPI@pCAGGSMCSKS (a.k.a pCAG-CherryGPI) 
Amplified mCherry from mCherry@pKS (Evguenia Bekman, unpublished) using primers 
Venus-GPI-FW and Venus-GPI-REV. After digestion with AgeI and BsrGI, ligated this 
fragment with GFPGPI@pCAGGSMCSKS (Afonso and Henrique, 2006), which had 
previously been digested with AgeI and BsrGI to remove GFP and then dephosphorylated. 
 
 
CherryTub (a.k.a pCAG-CherryTub) 
Amplified mCherry from mCherry@pKS (Evguenia Bekman, unpublished) with primers 
CherryNheIF and Venus-GPI-REV. After digestion with NheI and BsrGI, ligated this 
fragment with pEYFP-Tub (Clontech), which had previously been digested with NheI and 
BsrGI to remove EYFP and then dephosphorylated. 
 
II.1.16. Bacterial Artificial Chromosome Recombinogenic Engineering 
 
During the course of my work, I have engineered cassettes that allowed the manipulation of 
bacterial artificial chromosomes (BAC) DNA by homologous recombination using 
recombinogenic engineering (recombineering, reviewed in Copeland et al., 2001). I have 
generated two BACs containing genes encoding fluorescent reporters (VNP and 
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mCherryNLS) in place of the coding regions of two genes involved in Notch signalling (Hes5 
and Dll1, respectively). These BACs will be used in the future to generate transgenic cell lines. 
 
First, two targeting cassettes for recombineering were generated using the molecular biology 
techniques described above. 
 
Hes5 targeting cassette (5’armVNPNeo3’arm@pKS) 
Amplified the ~500bp upstream of the coding region of the mouse Hes5 gene from BAC 
RP24-345H15 with primers Hes55’armFCCHindIII and Hes55’armR. Amplified VNP from 
VNP@pKS (Fior, 2006) with primers VNP-CherryNLSF and VNPRCCEcoRI. Ligated both by 
PCR with primers Hes55’armFCCHindIII and VNPRCCEcoRI and digested the fragment 
with HindIII and EcoRI. At the same time, a Neo resistance cassette (loxP, PGK promoter 
EM7 promoter, Neomycin resistance, poly(A) signal, loxP) was obtained from digestion of the 
PL452 plasmid, kindly provided by Dr. Neal Copeland (Liu et al., 2003) with EcoRI and 
BamHI. In parallel, amplified the ~500bp downstream of the coding region of the mouse Hes5 
gene from BAC RP24-345H15 with primers Hes53’armFCCBamHI and Hes53’armRCCNotI 
and digested the fragment with BamHI and NotI. The 3 fragments were then ligated with 
pBluescript II KS digested with HindIII and NotI and which had been dephosphorylated. 
When used for recombineering, the Hes5 targeting cassette was digested with HindIII and 
NotI, to obtain the cassette without the pBluescript II KS vector backbone, and purified. 
 
Dll1 targeting cassette (5’armCherryNLSNeo3’arm@pKS) 
Amplified the ~500bp upstream of the coding region of the mouse Dll1 gene from BAC RP23-
64I11 with primers Dll15’armFCCXhoI and Dll15’armR. Amplified mCherryNLS from 
CherryNLS@pCAGGSMCSKS with primers VNP-CherryNLSF and CherryNLSRCCEcoRI. 
Ligated both by PCR with primers Dll15’armFCCXhoI and CherryNLSRCCEcoRI and 
digested the fragment with XhoI and EcoRI. At the same time, a Neo resistance cassette (FRT, 
PGK promoter EM7 promoter, Neomycin resistance, poly(A) signal, FRT) was obtained from 
digestion of the PL451 plasmid, kindly provided by Dr. Neal Copeland (Liu et al., 2003) with 
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EcoRI and BamHI. In parallel, amplified the ~500bp downstream of the coding region of the 
mouse Dll1 gene from BAC RP23-64I11 with primers Dll13’armFCCBamHI and 
Dll13’armRCCSacII and digested the fragment with BamHI and SacII. The 3 fragments were 
then ligated with pBluescript II KS digested with XhoI and SacII and which had been 
dephosphorylated. When used for recombineering, the Dll1 targeting cassette was digested 
with XhoI and SacII, to obtain the cassette without the pBluescript II KS vector backbone, and 
purified. 
 
After the cassettes were generated, recombineering was first performed on the BAC DNA with 
pPISceAmp (kindly provided by Dr. Nicolleta Kessaris) digested with XhoI and BamHI. This 
step removed a loxP site and added a PISceI restriction site and an Ampicillin resistance gene 
to the BAC DNA vector backbone. A second and final recombineering step was then 
performed using the Hes5 or Dll1 targeting cassettes. 
 
II.1.16.1. Addition of the Lambda Phage to the BAC DNA bacterial host 
 
The bacterial strain host for BAC DNA was DH10B. To prepare these host cells for 
recombineering, a defective Lambda Phage (λ) was added to their genome based on the 
protocol described by Chan et al (Chan et al., 2007). To produce a phage lysate, λ lysogen in 
LE392 bacterial cells (kindly provided by Donald Court) was induced by shifting an 
exponentially growing culture (grown at 37ºC in LB supplemented with 12.5μg/μL 
tetracycline) to 42ºC for 15min, and then shifting to 39ºC until cell lysis (60–90min). For long 
term storage, the λ lysate was prepared by centrifuging the lysed culture with a couple of drops 
of added chloroform and kept at 4ºC until use. To make DH10B cells suitable to receive λ, 
1mL of an o/n grown culture of DH10B (grown at 37ºC in LB supplemented with 12.5μg/μL 
chloramphenicol and 1% maltose) was centrifuged and resuspended in 1mL of 10mM MgSO4. 
The cell suspension was then centrifuged and resuspended again in 100μL of 10mM MgSO4. 
After adding 1μL of previously prepared λ lysate to the cell suspension, the mixture was 
incubated at 32ºC for 20min. After this time, 1mL of LB was added and cells were incubated at 
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32ºC for 1h under constant shaking. Cells were then plated on LB plates supplemented with 
12.5μg/μL chloramphenicol and 12.5μg/μL tetracycline and incubated o/n at 32ºC. 
 
II.1.16.2. Preparation of electrocompetent cells and electroporation 
 
To prepare electrocompetent DH10B λ-infected cells, a 10mL LB-low salt culture was grown 
overnight with vigorous shaking, from an isolated colony. 1mL of this culture was used as pre-
inoculum for a 50mL LB-low salt culture which was grown at 32ºC until an OD600 of 0.5-0.6 
was reached (it takes about 3h, measured in a GeneQuantpro spectrophotometer from GE 
Healthcare). 10mL of this culture were placed in a 50mL Falcon tube at 42ºC under constant 
shaking for 15min and then incubated on ice for 5min. Cells were then centrifuged at 3500g 
for 8min at 4ºC and the pellet was resuspended in 1mL of ice-cold water. Bacteria were then 
centrifuged again for 1min and the pellet was resuspended in 1mL ice-cold water, this process 
being repeated three more times. At the last time, cells were resuspended instead in 100μL ice-
cold water. 50μL of these bacteria were incubated with 300ng of the linear targeting DNA 
cassette and placed in a 0.1cm electroporation cuvette. The electroporation was performed 
under 1800V, 25μF and 200Ω, with the time constant being usually 4.5-5ms (Bio-Rad Gene 
Pulser System). After this step, bacteria were kept on ice for 5min, after which 500μL of LB 
were added and the culture was incubated at 32ºC for 1.5h under constant shaking. Cells were 
then plated on LB plates supplemented with 12.5μg/μL chloramphenicol, 12.5μg/μL 
tetracycline, 10μg/μL ampicillin (after the first and second recombineering steps) and 10μg/μL 
kanamycin (after the second recombineering step) and incubated o/n at 32ºC. 
 
II.1.16.3. BAC DNA purification 
 
For small scale preparation of BAC DNA, an isolated colony was grown o/n at 32ºC in 10mL 
of appropriate selective LB medium. Alkaline lysis was then performed. The culture was 
centrifuged and the pellet was resuspended in 400μL of resuspension buffer (P1, Roche). 
Then, 600μL of lysis buffer (P2, Roche) were added, the tubes were inverted to mix and 
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incubated for 5min at room temperature. After lysis, 600μL of neutralization buffer (P3, 
Roche) were added and the tubes were inverted to mix and incubated for 10min on ice. The 
suspension was then centrifuged for 10min at maximum speed at 4ºC. The supernatant was 
split into two 2mL tubes (about 750μL for each tube) and 750μL of isopropanol were added to 
precipitate the DNA. After 5min of incubation at room temperature, the mixture was 
centrifuged for 20min at 4ºC, followed by the removal of the supernatant. The pellet was 
washed with 750μL of 70% ethanol, centrifuged for 10min, dried at room temperature and 
resuspended in 50μL of TE buffer. BAC DNA was quantified as previously described for 
plasmid DNA preparations. 
 
II.1.16.4. BAC restriction digestions 
 
Enzymatic restriction of BAC DNA was performed for approximately 4h in a final volume of 
30μL, with 10μL of BAC DNA, and using 20U of commercially available restriction enzymes 
and respective buffers (Promega, Roche, Fermentas, New England Biolabs). The addition of 
BSA to the reaction mixture and the temperature at which it was performed depended on the 
enzyme used. 
 
II.1.16.5. Pulse Field Gel Electrophoresis 
 
To perform pulse field gel electrophoresis (PFGE) a Bio-Rad Chef-DRII System was used. Two 
hours before the run, the electrophoresis chamber was loaded with distilled water and the 
pump was turned on for cleaning. After 1h, water was replaced by running buffer (0.5x TBE: 
45mM Tris-Borate, 1mM EDTA). Gels were prepared by heating agarose (SeaKem® LE 
Agarose, Lonza) until complete dissolution in 0.5x TBE buffer, with the final agarose 
concentration being 1%. Gels were placed in the electrophoresis chamber filled with 0.5x TBE 
buffer and allowed to cool to 14ºC for 1h. DNA samples were mixed with loading buffer (60% 
Glycerol (v/v), 10mM EDTA, 0.2% OrangeG (Sigma)) in a 5:1 proportion and electrophoresis 
was carried out for 14h, with initial pulse time of 1s, final pulse time of 2s, and with field 
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strength of 6V/cm. The BAC DNA was visualized after staining, by immersion of the gel in 
water containing 1μg/mL ethidium bromide (GibcoBRL) and shaking for 1h. At this stage the 
gels were photographed. 
 
II.1.16.6. Confirmation of recombineering events by PCR 
 
After the recombineering events with the Hes5 or Dll1 targeting cassettes, besides the newly 
acquired bacteria resistance to kanamycin and restriction analysis to confirm the maintenance 
of the BAC DNA integrity, I have used other techniques to confirm that homologous 
recombination occurred in the correct place of the BAC DNA. 
If these events occurred in the correct place, then a PCR using the same primers that were 
used to amplify the 5’ 500bp homology arm will produce a smaller fragment than a PCR using 
a primer that anneals upstream of the 5’arm in the BAC and a primer that anneals in the 
beginning of VNP/mCherryNLS. Also, a PCR using the same primers that were used to 
amplify the 3’ 500bp homology arm will produce a smaller fragment than a PCR using a 
primer that anneals in the end of the Neo cassette and a primer that anneals downstream of 
the 3’arm in the BAC. To generate these analytical fragments, the following primers were 
used. For the Hes5 5’arm, Hes5FVB5armF and Hes5FVB5armR; for the Hes5 3’arm, 
Hes5FVB3armF and Hes5FVB3armR; for the Dll1 5’arm, Dll1FVB5armF and Dll1FVB5armR; 
for the Dll1 3’arm, Dll1FVB3armF and Dll1FVB3armR. All 8 PCRs were performed using the 
BAC DNA before or after the recombineering event and analysed by conventional gel 
electrophoresis. 
 
II.1.16.7. Confirmation of recombineering events by Southern Blot 
 
After the three previously described techniques to confirm that BAC DNA occurred as 
expected (bacterial growth in the presence of kanamycin, restriction analysis and PCRs), non-
radioactive Southern Blots were performed as a final confirmation step using DIG High Prime 
DNA Labeling and Detection Starter Kit II (Roche). First, a DIG-labelled probe for the 
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neomycin resistance gene was made according to the manufacturer’s instructions, using 
primers NEO-xho-atg-DIR and NEO-stopXBA-REV to generate a PCR product that served as 
template to generate the probe. In parallel, BAC restriction digestions and PFGE were 
performed as described and the DNA was then transferred to a positively charged Nylon 
membrane (Amersham) by contact blot. First, a glass recipient was filled with 20x SSC (0.3M 
sodium citrate, 3M sodium chloride, pH=7) and a glass plate is placed on top, covering two 
sides of the recipient and leaving two open sides. Second, two 3mm chromatography papers 
(Whatman) were placed on top of the glass plate, but with their sides immersed in the 20x SSC 
in the open sides of the recipient. Third, the gel was placed on top of the two 3mm papers. 
Fourth, a positively charged Nylon membrane was placed on top of the gel. Fifth, three 3mm 
chromatography papers were placed on top of the Nylon membrane. Sixth, all space around 
the gel, including the bottom two 3mm papers were covered with parafilm and glad. Seventh, 
many cleaning tissues (over 100) were placed on top of the three 3mm chromatography 
papers. Eighth and last, a new glass plate was placed on top of the cleaning tissues and a 500g 
weight was placed on top of this glass to apply pressure. This apparatus was left overnight and 
the next day the Nylon membrane was recovered and the DNA was fixed to it by UV 
crosslinking using a UV Fixator (Uvitec). Hybridization of the membrane with the probe was 
done in a Mini Hybridization Oven (Biometra) and signal detection was then performed 
according to the kit manufacturer’s instructions. 
 
II.1.16.8. Next steps for the generation of the novel reporter 
 
At this moment, two BAC DNAs are ready for preparation for ES cell electroporation. RP24-
345H15 was modified using the Hes5 targeting cassette, replacing the Hes5 coding region with 
VNP. RP23-64I11 was modified using the Dll1 targeting cassette, replacing the Dll1 coding 
region with CherryNLS. For electroporation of these BACs in ES cells, a larger preparation of 
BAC DNA will have to be performed. This DNA will have to be purified using 
phenol/chloroform extraction. The purified BAC DNA will then be linearized with PISceI 
restriction digestions (besides linearizing the BAC DNA at the vector backbone, it also 
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removes it). The linearized BAC will then be run on a PFGE and the correct BAC band will be 
extracted from the gel, leaving the vector backbone behind. The BAC DNA will be extracted 
from the agarose after β-agarase digestion (New England Biolabs) and will be purified after 
dialysis. This DNA will then be ready to be electroporated in ES cells. After electroporation, 
the cell lines will be fully validated by testing them for ES morphology, karyotype, cell growth, 
BAC integration, copy number and correct spatio-temporal expression. After validation, these 
ES cell lines will be time-lapse imaged. 
 
II.2. CHICK EMBRYO MANIPULATION 
 
II.2.1. In ovo chick embryo electroporation 
 
For in ovo chick embryo electroporation, embryos were injected using capillary needles made 
from borosilicate glass capillaries GC120-10 (Harvard Apparatus) pulled with a 
flaming/brown micropipette puller model P-87 (Sutter Instrument Co.) and using the 
Inject+Matic (Genève) or FemtoJet (Eppendorf) injectors, and were electroporated using an 
Electro Square PoratorTM ECM830 (BTX). 
- For the NICD, CSLDN and Neurog2 constructs, super-coiled plasmid DNA was 
injected into neural tubes of chicken embryos staged HH11-HH13 or HH16-HH17 
(Hamburger and Hamilton, 1951) at 2μg/μL in PBS and fast green was used for 
contrast. Platinum electrodes (Nepagene CUY613P5), distanced 4mm apart, were 
placed parallel to the neural tube under the embryo. Using an Electro Square 
PoratorTM ECM830 (BTX), 4 pulses of 35V for 50ms were applied. Embryos were 
incubated for 16h or 24h at 38ºC and then harvested and fixed in a solution of 4% 
paraformaldehyde (PFA) in PBS, at 4ºC, o/n. 
- For the Hes6 constructs, super-coiled plasmid DNA was injected into neural tubes of 
chicken embryos staged HH8-HH11 at a concentration of 1μg/μL in PBS and fast 
green was used for contrast. Gold plated electrodes (BTX Genetrode 512), distanced 
4mm apart, were placed parallel to the neural tube on the top of the embryo and few 
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drops of PBS were added. Using an Electro Square PoratorTM ECM830 (BTX), 4 pulses 
of 25V for 50ms were applied. Embryos were incubated for 6h or 24h at 38ºC and then 
harvested and fixed in 4% PFA in PBS, at 4ºC, o/n. 
- For the VNP constructs and pCIG, when analysis of fixed tissue was to be done, super-
coiled plasmid DNA encoding VNP was injected into neural tubes of chicken embryos 
staged HH11-HH13 at a concentration of 1μg/μL in PBS and fast green was used for 
contrast. In some cases, pCAG-CherryNLS, pCAG-CherryGPI or pCAG-CherryTub 
DNA was co-injected at a concentration of 0.2μg/μL. Platinum electrodes (Nepagene 
CUY613P5), distanced 4mm apart, were placed parallel to the neural tube under the 
embryo. Using an Electro Square PoratorTM ECM830 (BTX), 4 pulses of 25V for 50ms 
were applied. Embryos were incubated for 24h or 48h at 38ºC and then harvested and 
fixed in a solution of 4% PFA in PBS, at 4ºC, o/n. 
- For the VNP constructs, to reduce the amount of electroporated plasmids, especially 
when live imaging was to be performed afterwards, super-coiled plasmid DNA 
encoding VNP was injected into neural tubes of chicken embryos staged HH8-HH11 
at a concentration of 0.6μg/μL in PBS and fast green was used for contrast. In some 
cases, pCAG-CherryNLS, pCAG-CherryGPI or pCAG-CherryTub DNA was co-
injected at a concentration of 0.06μg/μL. Gold plated electrodes (BTX Genetrode 512), 
distanced 4mm apart, were placed parallel to the neural tube on the top of the embryo 
and few drops of PBS were added. Using an Electro Square PoratorTM ECM830 (BTX), 
3 pulses of 10V for 50ms were applied. For sectioning of fixed tissue, embryos were 
incubated at 38ºC for 24h and then harvested and processed as described above. For 
live-imaging experiments embryos were incubated at 38ºC for 4h or 12h and then 
harvested and processed for live imaging. 
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II.2.2. In ovo chick embryo BrdU treatment 
 
For 5-bromo-2-deoxyuridine (BrdU) treatment in E4 chicken embryos, 100μL (12.5mg/mL) 
were injected close to the heart through an opening in the vitelline membrane. Embryos were 
incubated for 30min or 3h at 38ºC and then harvested and fixed in a solution of 4% PFA in 
PBS, at 4ºC, o/n. 
 
II.2.3. In ovo chick embryo LY411575 treatment 
 
To chemically inhibit Notch activity in ovo, 100μL of the γ-secretase inhibitor LY411575 (Eli 
Lilly and Company), at 10 μM in PBS and fast green (for contrast), were injected under 3-8-
somite-staged embryos. These embryos were incubated for 3h or 7h at 38ºC and then 
harvested and fixed in a solution of 4% PFA in PBS, at 4ºC, o/n. The results were stronger at 
7h after injection and all data is shown for that time. Control was done with similar injections 
of PBS and fast green alone. 
 
II.2.4. Tissue embedding and preparation of cryostat sections 
 
After fixation, the tissue was washed in 1x PBS, passed first through a solution of 15% sucrose 
in PBS, followed by a solution of 30% sucrose in PBS for cryoprotection. The tissue was then 
embedded in a solution containing 7.5% gelatine and 15% sucrose in PBS, and frozen in cold 
isopenthane (-70ºC). Frozen embedded embryos were stored at -80ºC until sectioned in a 
cryostat (Leica CM 3050). Embryonic tissue was sectioned at 10-16μm and collected on 
Superfrost slides. Sections were de-gelatinized and processed for immunohistochemistry or in 
situ hybridization by incubating the slides immersed in PBS at 37ºC until gelatine was 
completely dissolved. 
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II.3. IN SITU HYBRIDIZATION 
 
II.3.1. Antisense RNA probe synthesis 
 
During the course of this work several RNA antisense probes were used for in situ 
hybridization on whole-mount or cryostat sections of chick embryos. Digoxigenin- (DIG) and 
Fluorescein- (FLUO) labelled RNA antisense probes were synthesized in vitro by T3 or T7 
RNA polymerase, from several plasmid templates containing cDNAs (Table II.3). 
 
II.3.1.1. DNA template preparation 
 
DNA template preparation was performed as follows: 10μg of plasmid DNA were linearized in 
a final volume of 100μL, using 50U of the appropriate restriction enzyme, for 2h at 37ºC. After 
confirmation of complete digestion, the reaction was interrupted by adding 5μL of 10% SDS 
(w/v) and 1μL of Proteinase K (20mg/mL - Sigma) and incubating the sample for 15min at 
55ºC. To exclude proteins, the DNA template was subjected to column purification using 
Wizard Plus SV Gel and PCR Clean-up System (Promega). 
In alternative, when an in situ hybridization was performed after an electroporation for 
functional studies and to avoid probe cross-hybridizations with the electroporated plasmid, 
DNA templates were generated by PCR in a 50μL reaction as described in Section II.1.9. For 
the generation of the cHes5-1 template, cHes5-1 CR was amplified from cHes5-1 EST 
(GenBank Acc: BU224462) with primers cHes5-1F and cHes5-1T7R. For the generation of the 
cDelta1 template, a portion of the cDelta1 CR was amplified from cDelta1 EST (GenBank Acc: 
NM_204973) with primers cDelta1probeF and cDelta1T7R. To exclude proteins, the DNA 
templates were subjected to column purification using Wizard Plus SV Gel and PCR Clean-up 
System (Promega). The templates used in this thesis for in vitro transcription reactions are 
listed in Table II.3. 
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Table II.3: Constructs used as templates for in vitro transcription reactions. 
EST clones were supplied by the MRC GeneService (Cambridge, UK) and RIKEN Institute (Japan). 
 
Probe Linearization site RNA polymerase References 
Hes5-1 NotI T3 GenBank Acc: BU224462 
Hes5-1 
coding region NotI T3 
Hes5-1CR@pKS 
(Fior, 2006) 
Hes5-1 PCR N/A – PCR product T7 
GenBank Acc: 
BU224462 
Hes5-2 NotI T3 
GenBank Acc: 
BU225817 
Hes5-3 NotI T3 
GenBank Acc: 
BU254264 
Hes6-1 EcoRI T7 
GenBank Acc: 
BI393243 
Hes6-2 NotI T3 
GenBank Acc: 
BU106413 
Delta1 NotI T3 
GenBank Acc: 
NM_204973 
Delta1 PCR N/A – PCR product T7 
GenBank Acc: 
NM_204973 
Notch1 BamHI T3 
GenBank Acc: 
XM_415420 
Neurog1 EcoRI T7 
GenBank Acc: 
NM_204883 
Neurog2 HindIII T3 
GenBank Acc: 
NM_204796 
NeuroM HindIII T3 
GenBank Acc: 
Y09597 
VNP BamHI T3 
VNP@pKS 
(Fior, 2006) 
mCherry EcoRI T7 
mCherry@pKS 
(Evguenia Bekman, 
unpublished) 
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II.3.1.2. Probe synthesis 
 
Antisense transcripts were produced by using 1μg of linearized plasmid DNA and 20U of the 
appropriate RNA polymerase in the presence of 30mM DTT, 1x DIG/FLUO-NTP mix (1mM 
ATP, CTG, GTP, 0.65mM UTP and 0.35mM DIG/FLUO-UTP), 40U RNasin (Promega) and 
1x Transcription Buffer (Stratagene), in a final volume of 25μL. After incubating at 37ºC for 
3hrs, the samples were precipitated by adding 20.5μL of RNAse-free water, 2μL of 0.5M EDTA 
(pH=8.0), 2.5μL of 8M LiCl and 150μL of ethanol, incubating for at least 1h at -20ºC. After 
centrifugation, the RNA precipitate was washed with 70% ethanol, resuspended in 100μL of 
10mM EDTA and stored at -20ºC until necessary. To quantify the probe, 2μL were mixed with 
loading buffer containing formamide and, after brief denaturation for 10min at 70ºC, checked 
by agarose gel electrophoresis. 
 
II.3.2. In situ hybridization on cryostat sections 
 
For in situ hybridization on cryostat sections, embryos were fixed o/n in a 4% PFA solution in 
PBS at 4ºC and embedded as described in Section II.2.4. Hybridization on cryostat sections 
was done as previously described (Myat et al., 1996), with modifications, the procedure being 
similar to the one described for the double in situ hybridizations. Double in situ hybridization 
on cryostat sections was done by hybridizing a combination of DIG- and FLUO-labelled 
antisense RNA probes, after which post-hybridization washes and blocking were carried out 
as described in (Myat et al., 1996). Sections were then incubated with anti-DIG-AP or anti-
FLUO-AP (Roche, 1:2000). After o/n incubation at 4ºC, sections were washed with three 
times for 10min in TBST and the staining reaction for AP (alkaline phosphatase) was 
performed using Fast Red (Roche) for 1-2h at 37ºC. After the development of the first probe, 
sections were washed in PBS and incubated with the antibody that specifically recognizes the 
second probe (anti-FLUO-POD or anti-DIG-POD, Roche, 1:500). After o/n incubation with 
the POD-conjugated antibody at 4ºC, sections were washed three times for 10min in TNT 
(0.1M Tris-HCl, 0.15M NaCl, 0.05% Tween-20, pH=7.5) and the staining reaction for POD 
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(peroxidase) was performed using Tyramide-FITC in amplification buffer (1:50, TSA™-Direct, 
NEN™ Kit, Perkin Elmer) for 10min at room temperature. Sections were then washed three 
times for 5min in TNT, counterstained with 0.15% (w/v) 4',6-diamidino-2-phenylindole 
(DAPI, Sigma) for 5min, washed three times in PBS for 5min and mounted with Mowiol® 
mounting medium (0.1% Mowiol® (Calbiochem), 33% glycerol, 0.1M Tris, pH=8.5). 
For each double in situ hybridization, signal development was swapped. The results were 
always consistent and therefore I only show one mRNA stained with FITC-Tyramide and the 
other mRNA stained with Fast Red. 
For the analysis of HES6 electroporations in the neural tube, cDelta1 and cHes5-1 riboprobes 
have been synthesized from specific PCR fragments, to avoid any plasmid regions in the 
probes and eliminate regions of putative cross reactivity between the probes and transgenes. 
When in situ hybridizations were performed to detect any mRNA produced by an 
electroporated plasmid, the electroporated DNA had to be removed to prevent the recognition 
of the plasmid DNA by the RNA probe (Arede and Tavares, 2008). This was done by 
treatment with DNaseI, as follows. Briefly, before hybridization of the probes with the 
sections, gelatine was removed by incubating the slides in PBS for 30min at 37ºC. Slides were 
then washed with DNaseI buffer (1M NaCl, 20mM Tris-HCl, 10mM MnCl2, pH=7) for 5min 
and then incubated with 0.18 Kunitz Units DNaseI (Roche) in 100μL DNaseI buffer (under a 
coverslip) for 1h at room temperature. The slides were then washed twice with water for 5min 
and then washed for 5min in PBS. From here onward, sections were hybridized with the probe 
and processed as described above, except that DAPI counterstaining couldn’t be performed, 
since all DNA was digested by DNaseI and washed away following post-hybridization washes. 
 
II.3.3. In situ hybridization on whole-mount embryos 
 
For in situ hybridization on whole-mount embryos, these were fixed o/n in a solution of 4% 
PFA in PBS at 4ºC. Hybridization on whole-mount embryos was carried out as previously 
described (Henrique et al., 1995). 
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II.4. IMMUNOHISTOCHEMISTRY 
 
II.4.1. Antigen retrieval for BrdU-treated embryos 
 
Detection of BrdU incorporation was performed as follows: cryosections were incubated in a 
50% formamide : 1x SSC solution for 1hr at 70ºC (when not subjected previously to in situ 
hybridization), rinsed in PBS and then incubated in 2N HCl for 30min at 37ºC. After acidic 
treatment, the slides were neutralized with four 5min washes in 0.1M Tris-HCl (pH=8) and 
three 5min washes in 1x PBS. From here onward, sections were blocked and processed as 
described in Section II.4.2. 
 
II.4.2. Immunofluorescence on cryostat sections of embryonic tissue 
 
After gelatine removal or in situ hybridization, immunofluorescence was performed as 
follows: sections were washed in PBS and blocked with 10% Fetal Bovine Serum (FBS) in PBS 
for 1hr at room temperature. Primary antibodies were diluted in blocking solution and 
incubated o/n at 4ºC. After primary antibody binding, sections were washed three times in 
PBS for 5min. Appropriate secondary antibodies were diluted in blocking solution and 
incubated for 1hr at room temperature. All sections were counterstained with 0.15% (w/v) 
DAPI (Sigma) for 5min, washed three times in PBS for 5min and mounted with Mowiol® 
mounting medium (0.1% Mowiol® (Calbiochem), 33% glycerol, 0.1M Tris, pH=8.5). 
Primary antibodies used were: mouse anti-BrdU (Sigma, 1/1000), rabbit anti-GFP (Abcam, 
1/500), mouse anti-HuC/D (Molecular Probes, 1/500) or mouse anti-Tuj1 (Covance, 1/500). 
Secondary antibodies used were Alexa488/594-conjugated goat anti-mouse or goat anti-rabbit 
(Molecular Probes, 1/400). 
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II.4.3. Immunofluorescence on whole-mount embryos 
 
After whole-mount in situ hybridization, but before refixing, immunofluorescence was 
performed as follows: whole-mount embryos were washed three times in PTW for 5min and 
blocked with 10% FBS in PTW for 1h at room temperature. Rabbit anti-GFP antibody 
(Abcam, 1/500) was diluted in blocking solution and incubated o/n at 4ºC. After primary 
antibody binding, embryos were washed three times in PBS for 20min. Alexa488-conjugated 
goat anti-rabbit (Molecular Probes, 1/400) was diluted in blocking solution and incubated for 
4h at room temperature. Embryos were then washed three times in PTW for 5min and refixed 
in a solution of 4% PFA and 0.1% glutaraldehyde in PTW for 1h at room temperature. Finally, 
embryos were washed three times in PTW for 5min and stored at 4ºC in 0.1% sodium azide in 
PTW. 
 
II.5. IMAGING AND IMAGE ANALYSIS 
 
II.5.1. Fixed tissue imaging 
 
Bright field images of fixed whole-mount embryos were acquired using the stereoscope Leica 
Z6APO equipped with a Leica DFC490 digital camera. Fluorescent images of fixed whole-
mount embryos were acquired using the stereoscope Leica MZ10F equipped with a Media 
Cybernetics Evolution MP Color digital camera. 
Bright field images of fixed sections were acquired using the microscope Leica DMR, 
equipped with a Leica DC500 digital camera. Fluorescent images of fixed sections were 
acquired using the microscope Leica DM5000B equipped with a Leica DC350F digital camera 
or a DeltaVision Spectris microscope workstation (Applied Precision). Confocal fluorescent 
images of fixed sections were acquired using the laser scanning confocal microscope Zeiss 
LSM510 Meta. 
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II.5.2. Live imaging 
 
Embryo slices were prepared and cultured for live imaging as described in (Wilcock et al., 
2007), with modifications. Culture dishes were prepared the day before, as follows: the 
coverslip of coverslip-based Petri dishes (WillCo-dish® glass-bottom dish, Intracel) was coated 
with poly-L-lysine (Sigma) for 5min; excess poly-L-lysine was removed and the coverslip was 
washed three times with water and once with 70% ethanol, and allowed to dry overnight. 
Embryos were then electroporated as described in Section II.2.1. After 4h or 12h of incubation 
at 38ºC, electroporated embryos were screened under a fluorescent dissecting stereo 
microscope and the ones that showed fluorescence in the neural tube were selected. 
Fluorescent embryos were then harvested, stretched and sliced into approximately 150μm 
slices in L-15 medium using with a microknife. These slices were embedded in rat tail collagen 
type I (300μL of type I rat collagen (Sigma), 100μL of 5x L-15, 100μL of acetic acid, 17.5μL of 
sodium bicarbonate (Sigma)) on the coverslip-based Petri dish coated with poly-L-lysine. 
Embryo slices were then cultured in Neurobasal medium, without phenol red (Gibco), 
supplemented with B-27 (Gibco) to a final 1x concentration, and with 0.5mM L-glutamine 
(Gibco) and 50μg/mL gentamycin (Invitrogen). 
Slices were imaged on a DeltaVision Spectris microscope workstation (Applied Precision) in 
an environmental chamber kept at 37°C (Solent). The chamber stage was buffered with 5% 
CO2/95% air mix and maintained in a humid environment. Images were captured using a 40x 
oil objective lens (Olympus, 1.35NA) with the Hg-arc lamp. Thirty optical sections (50-100ms 
exposure time, 512x512 pixels, binning=2), spaced by 1.5μm, were imaged at 10min intervals 
for up to 48h. The point-visiting function in the SoftWorX software (Applied Precision) 
allowed up to nine slices to be imaged during each experiment. Slices electroporated with the 
Notch reporter pHes5-VNP (five slices) were always imaged in the same dish as slices 
electroporated with the pCAG-VNP control (four slices). 
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II.5.3. Image processing and analysis 
 
Image analysis on data acquired from fixed tissue using the confocal microscope was done by 
first processing the data obtained using the Zeiss LSM Image Browser to convert the images to 
the TIFF format. These and other images acquired in fixed tissue were then treated for noise 
reduction and colour adjustments in Adobe Photoshop. 
 
For the analysis of Hes5-1 3’UTR, photos of embryonic sections were used to quantify VNP 
expression in embryos electroporated with pCAG-VNPΔ3UTR, pCAG-VNP and pCAG-
VNPΔ20. Areas where the neural tube showed extensive and homogeneous signal for 
CherryNLS were selected. Mean fluorescence intensities of both red (CherryNLS) and yellow 
(VNP) channels were quantified in ImageJ (http://rsbweb.nih.gov/ij) and manually exported 
to Microsoft Excel, where charts were drawn. 
 
Analysis of data acquired from live-imaging experiments using the DeltaVision Spectris 
workstation was performed as follows. First, data was deconvolved as described (Wilcock et 
al., 2007) and maximum intensity projections were obtained from these deconvolved files 
using the SoftWorX software. These projections were then analysed using the Omero software 
(http://www.openmicroscopy.org/site/products/omero). All cells showing yellow fluorescence 
(which corresponds to VNP expression) were identified and labelled in Omero. Times for the 
appearance of the cell, mitotic events, disappearance of the cell and appearance or 
disappearance of fluorescence (in the red (CherryNLS) and yellow (VNP) channels) were 
identified and labelled in Omero. Data regarding the times for these events were then 
manually transferred to the Excel software and analysed by direct visualization. Cells that were 
imaged for over 10h without disappearing, that expressed VNP and CherryNLS without 
showing fluorescence saturation, and divided during the imaging period, were selected for 
further analysis in non-projected deconvolved data. To select these lineages, special attention 
was given to those cells which showed an increase in the levels of fluorescence in the yellow 
channel (cells that registered an appearance event in the yellow channel, but not in the red 
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channel). These cells were manually tracked in Omero by identifying the Z plane presenting 
the highest fluorescence intensity at each time point. A circle of defined size (a single click 
with “ellipse ROI” tool) was delineated in each nucleus in the chosen Z plane, and the levels of 
red and yellow fluorescence were quantified in Omero by measuring the mean fluorescent 
intensities in the outlined nucleus area of the selected frames. This process was repeated for 
each time frame and the levels of CherryNLS and VNP expression were plotted against time in 
Microsoft Excel, covering at least a mitotic event, thereby allowing the definition of cell 
lineages with different VNP expression patterns. Still images and movies presented in this 
thesis correspond to maximum intensity projections generated in SoftWorX and converted to 
TIFF and AVI files in ImageJ. 
 
II.6. CONTROLS AND STATISTICAL ANALYSIS 
 
II.6.1. In ovo chick embryo electroporation 
 
II.6.1.1. Functional analysis of HES6 
 
Embryos were analysed by in situ hybridization and immunofluorescence and scored for 
phenotypes. Number of independent experiments and embryos analysed for each construct 
are shown in Table II.4. Images presented in figures are representative of each experiment. 
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Table II.4: Number of independent experiments and embryos analysed in the functional analysis of Hes6 
genes. 
 
 Analysed with Hes5-1 probe 
Construct Experiments Embryos 
cHes6-1 9 54 
cHes6-1S175A 3 25 
cHes6-1ΔWRPW 3 19 
cHes6-1AQ 3 19 
cHes6-1AQΔWRPW 3 12 
cHes6-2 8 63 
cHes6-2K59R 3 20 
cHes6-2ΔWRPW 2 13 
cHes6-2AQ 3 22 
cHes6-2AQΔWRPW 4 37 
mHes6 2 14 
 
 
II.6.1.2. Functional analysis of Hes5-1 3’UTR 
 
For each electroporated construct, a total of 32 sections from 4 embryos from 2 independent 
experiments were analysed for VNP expression. To normalize VNP expression to the 
electroporation efficiency (measured by CherryNLS expression), the ratio of yellow/red 
fluorescence intensities was obtained. Relative fluorescence intensities of embryos 
electroporated with pCAG-VNPΔ3UTR, pCAG-VNP and pCAG-VNPΔ20 were compared to 
the intensity of embryos electroporated with pCAG-VNPΔ3UTR. Statistical analysis of 
presented results was done using the Student’s t test, considering N=4 (4 embryos from 2 
independent experiments). 
 
II.6.2. In ovo chick embryo LY411575 treatment 
 
When performing the whole-mount Notch inhibition in ovo with LY411575 at 3-8 somites 
stage embryos, these were harvested at either 3h or 7h following injection. Results were 
stronger at 7h after injection and all data is shown for that time. Control was done with 
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similar injections of PBS alone (17 embryos for the asymmetry study, 23 for the pancreatic 
progenitors and 23 for the neural tube). Three independent experiments were done for the 7h 
treatment. After 7h of treatment, control embryos had 8-14 somites, showing an average 
increase of 5 somites, as expected (standard deviation = 1.062). In contrast, LY411575-treated 
embryos only had 6-11 somites, showing an average increase of 3 somites (standard deviation 
= 0.947). This significant difference in the rate of somite formation between control and 
LY411575 treated embryos (t-test; p-value<0.001), suggests that the drug was effective in 
inhibiting Notch signalling during somitogenesis (reviewed in Kageyama et al., 2007a). 
 
II.6.3. Live-imaging experiments 
 
For live-imaging experiments, lineages from several independent experiments were analysed. 
In slices electroporated with the Notch reporter pHes5-VNP, from 12 independent 
experiments, with a total of 36 electroporated embryos, 704 VNP expressing cells could be 
identified, of which 175 lineages could be extracted. 33 lineages were defined where the onset 
of VNP expression could be traced. 
In slices electroporated with the pCAG-VNP control, from 7 independent experiments, with a 
total of 21 electroporated embryos, 12 cell lineages were analysed in detail. 
 
II.7. BIOINFORMATICS 
 
II.7.1. Data mining 
 
DNA, mRNA and protein sequences were obtained from the NCBI 
(http://www.ncbi.nlm.nih.gov/) and Ensemble (http://www.ensembl.org/index.html) 
databases. 
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II.7.2. HES6 proteins accession numbers 
 
HES6 protein sequences aligned in Fig. III.2 were obtained in Ensemble or NCBI and have the 
following accession numbers. Homo sapiens: HES6, ENSP00000272937. Mus musculus: HES6, 
ENSMUSP00000084062. Ornithorhynchus anatinus: HES6-1, ENSOANP00000004848. Gallus 
gallus: HES6-2, ENSGALP00000008850. Xenopus tropicalis: HES6-1, ENSXETP00000013003; 
HES6-2, NP_001072210. Oryzias latipes: HER13.1, ENSORLP00000020797; HER13.2, 
ENSORLP00000019320; HER8, ENSORLP00000019320. Danio rerio: HER13.1, 
ENSDARP00000012990; HER13.2 ENSDARP00000021078; HER8.1, ENSDARP00000010206; 
HER8.2, ENSDARP00000103093. Accession number of Gallus gallus HES6-1 is unavailable, 
but can be identified in GenBank (BI393243). Accession number of Ornithorhynchus anatinus 
HES6-2 is unavailable, but protein sequence can be obtained by joining sequences from 
ENSOANP00000017554 and ENSOANP00000017555. 
 
II.7.3. Sequence analysis 
 
Multiple sequence alignments were performed with ClustalW and HES6 proteins 
phylogenetic tree was constructed using Neighbour-Joining showing branch lengths 
(http://align.genome.jp/). 
Regions of homology in aligned sequences were highlighted with BOXSHADE 
(http://www.ch.embnet.org/software/BOX_form.html). 
Protein translation from DNA or mRNA sequences was performed with Expasy Translate 
Tool (http://www.expasy.ch/tools/dna.html). 
Creation of Reverse/Complement sequences from previous sequences was performed with 
Reverse Complement tool (http://www.bioinformatics.org/sms/rev_comp.html). 
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II.7.4. Primer design 
 
Primer sequences were designed and analysed using: 
- Netprimer (http://www.premierbiosoft.com/netprimer/index.html); 
- Primer3 (http://frodo.wi.mit.edu/primer3/). 
 
II.7.5. Sequencing results analysis 
 
Sequencing results were analysed with ClustalW alignments, by comparing the sequencing 
data with the expected sequence. 
Sequencing .ab1 files were visualized with Trev (a component of the Staden Package, 
http://staden.sourceforge.net/). 
 
 
 
 
 
 
 
 
 
 
CHAPTER III 
 
HES6-1 and HES6-2 Function Through 
Different Mechanisms During neuronal 
Differentiation 
 
 
 
 
 
 
 
 
 
Most of the results presented in this Chapter have been published in the paper: 
Vilas-Boas, F. and Henrique, D. 2010. HES6-1 and HES6-2 Function Through 
Different Mechanisms During Neuronal Differentiation. PlosOne. DOI: 
10.1371/journal.pone.0015459 
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CHAPTER III – HES6-1 AND HES6-2 FUNCTION THROUGH DIFFERENT 
MECHANISMS DURING NEURONAL DIFFERENTIATION 
 
III.1. ABSTRACT 
 
Notch signalling plays a central role in the mechanisms regulating neuronal differentiation in 
the vertebrate nervous system. The transcriptional repressors encoded by Hes genes are the 
main effectors of this pathway, acting in neural progenitors during the lateral inhibition 
process to repress proneural genes and inhibit differentiation. However, Hes6 genes seem to 
behave differently: they are expressed in differentiating neurons and facilitate the activity of 
proneural genes in promoting neurogenesis. Still, the molecular mechanisms underlying this 
unique function of Hes6 genes are not yet understood. 
Here, I identify two subgroups of Hes6 genes that seem conserved in most vertebrate species, 
and characterize a novel Hes6 gene in chicken: cHes6-1. The embryonic expression pattern of 
cHes6-1 suggests roles for this gene in the formation of the pancreas, nervous system and in 
the generation of body asymmetry. I show that cHes6-1 is negatively regulated by Notch 
signalling in the developing embryonic spinal cord and in pancreatic progenitors, but requires 
Notch for the observed asymmetric expression in the lateral mesoderm. Functional studies by 
ectopic expression in the chick embryonic neural tube revealed that cHES6-1 up-regulates the 
expression of cDelta1 and cHes5 genes, in contrast with overexpression of cHES6-2, which 
represses the same genes. I show that this activity of cHES6-2 is dependent on its capacity to 
bind DNA and repress transcription, while cHES6-1 seems to function by sequestering other 
HES proteins and inhibit their activity as transcriptional repressors. 
My results indicate that the two chick HES6 proteins act at different phases of neuronal 
differentiation, contributing to the progression of neurogenesis by different mechanisms: 
while cHES6-2 represses the transcription of Hes genes, cHES6-1 acts later, sequestering HES 
proteins. Together, the two cHES6 proteins progressively shut down the Notch-mediated 
progenitor program and ensure that neuronal differentiation can proceed. 
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III.2. INTRODUCTION 
 
The vertebrate central nervous system derives from an embryonic structure called the neural 
tube. In this tissue, dividing neural progenitors reside in the ventricular zone (VZ), near the 
lumen of the tube. Progenitor cells have attachments at the apical and basal sides of the 
neuroepithelium and their nuclei show a characteristic interkinetic nuclear movement, with 
mitotic nuclei being always located apically (Sauer, 1935; reviewed in Fujita, 2003). After 
division, neuroepithelial cells either remain as progenitors in the VZ or commit to 
differentiation, moving out of the VZ to a more basal region called the mantle layer, where 
neuronal differentiation proceeds. During neurogenesis, there is a balance between progenitor 
proliferation and differentiation, which maintains a resident population of progenitors to 
ensure that neurogenesis can progress and produce the correct number (and types) of 
neuronal cells during development. This balance is regulated by Notch signalling (reviewed in 
Louvi and Artavanis-Tsakonas, 2006), a pathway that is based on cell-cell interactions: after 
the contact between a membrane bound ligand (Delta or Serrate) of one cell and a membrane 
bound Notch receptor on another cell, the receptor suffers a proteolytic cleavage catalyzed by 
γ-secretase, releasing the intracellular domain (NICD) from the membrane. The NICD 
protein then translocates to the nucleus where it binds CSL (CBF1, Suppressor of Hairless, 
Lag-1) and Mastermind (MAM), turning CSL from a transcriptional repressor into a 
transcriptional activator. The tripartite NICD/CSL/MAM complex activates the transcription 
of several downstream targets, the best characterized being the Hes genes (Drosophila Hairy 
and Enhancer of Split homologues), which encode basic helix-loop-helix (bHLH) 
transcriptional repressors (reviewed in Kageyama et al., 2008a). HES proteins contain a basic 
region for DNA-binding and a helix-loop-helix region for homo- or heterodimerization, as 
well as an Orange domain involved in protein interaction specificity and a C-terminal 
tetrapeptide (WRPW) for interactions with the co-repressor Groucho/TLE (reviewed in Davis 
and Turner, 2001; Fischer and Gessler, 2007). HES proteins normally act as dimers, bind to 
specific sequences named N- or E- boxes in target promoters, recruit the co-repressor TLE 
and repress the transcription of target genes. Known targets include the proneural genes, 
  120
Chapter III – HES6 and Neuronal Differentiation 
which promote neuronal differentiation. During neurogenesis, newborn neurons express high 
levels of proneural factors, which promote expression of the ligands Delta or Serrate. These 
ligands signal to neighbouring Notch-expressing progenitors, where Notch activation leads to 
HES protein expression and a block on the activity of proneural genes, thereby preventing 
progenitor differentiation, in a process called lateral inhibition (reviewed in Fischer and 
Gessler, 2007; Kageyama et al., 2008a; Kageyama et al., 2008b). 
In the developing vertebrate nervous system, HES proteins usually function as Notch 
effectors, inhibiting neuronal differentiation. However, studies in mouse, Xenopus and in vitro 
have shown that one particular Hes gene, Hes6, acts differently, as it is negatively regulated by 
Notch signalling (Koyano-Nakagawa et al., 2000) and promotes neurogenesis when 
ectopically expressed (Bae et al., 2000; Koyano-Nakagawa et al., 2000; Cossins et al., 2002; 
Gratton et al., 2003; Jhas et al., 2006). Moreover, neurogenesis is impaired upon Hes6 
knockdown (Jhas et al., 2006). HES6 seems to promote neuronal differentiation by increasing 
the expression and activity of proneural proteins, such as Neurogenins, in cells where they are 
already expressed. In turn, Neurogenins increase HES6 levels in a positive feedback-loop 
(Koyano-Nakagawa et al., 2000), thus reinforcing the activity of the proneural differentiation 
cascade. Another proneural protein, ASCL1, was also shown to bind to the mHes6 promoter 
(Hu et al., 2004; Poitras et al., 2007), suggesting a similar positive regulation of mHES6 
expression by this proneural protein. In the chick embryo, one of the HES6 proteins, cHES6-
2, has been shown to cooperate with the proneural proteins to promote neuronal 
differentiation, being negatively regulated by Notch signalling (Fior and Henrique, 2005). 
Besides cHES6-2, the chick genome encodes a second HES6 protein, cHES6-1 (Fior and 
Henrique, 2005), but its function is unknown. 
In this study, I investigate the expression and function of cHES6-1 and show that it is 
expressed in all three germ layers of the chick embryo, particularly in the nervous system, 
heart, and pancreas. cHes6-1 is asymmetrically expressed in the mesoderm lateral to the 
primitive streak, suggesting a role for this gene in the formation of body asymmetry. cHes6-1 
expression is negatively regulated by Notch signalling in the embryonic spinal cord and 
pancreas. However, in the mesoderm lateral to the primitive streak, cHes6-1 expression 
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requires Notch activity, suggesting different regulation of this gene in distinct tissues. In the 
embryonic spinal cord, the two chick Hes6 genes are transiently expressed in differentiating 
neurons and are part of the genetic cascade that regulates neuronal differentiation, acting by 
different mechanisms. While cHES6-2 functions as a transcriptional repressor, cHES6-1 
functions by sequestering and inhibiting other HES proteins. Together, the two chick HES6 
proteins regulate neurogenesis by releasing differentiating neurons from Notch signalling. 
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III.3. RESULTS 
 
III.3.1. HES6 proteins are divided in two subgroups 
 
Previous work from the laboratory described the existence of two Hes6-like genes in the chick 
genome, cHes6-1 and cHes6-2 (Fior and Henrique, 2005). A more detailed analysis of available 
genomic data reveals that the two genes are linked in chromosome 9, close to the Period2 gene 
(Ensemble ref. ENSGALG00000005521) (Fig. III.1). 
 
 
 
Figure III.1: Hes6 chromosomal location. 
Schematic representation of location and orientation of the single mouse Hes6 and the two chick Hes6 genes in 
chromosomes 1 and 9, respectively. In both genomes, Hes6 genes are present in close proximity to the Period2 
gene. 
 
Two different Hes6 genes are equally present in the genomes of zebrafish, medaka, frog and 
platypus, while only one Hes6 gene is present in mice and humans. Alignment of the various 
HES6 proteins reveals that they can be classified into two distinct subgroups, with unique 
structural features (Fig. III.2 and Fig. III.3). These include a particular serine residue 
specifically present in all HES6-1 proteins (position 175 of cHES6-1, present in the SPXSS-
SDXE domain included in the PEST domain), reported to be important for mouse HES6-
dependent induction of neurogenesis (Gratton et al., 2003), and a lysine residue present in the 
bHLH domain of all HES6-2 proteins (position 59 of cHES6-2), suggested to be essential for 
transcriptional repression ability of HES proteins (Ishii et al., 2008). However, the major 
structural difference between the two subgroups of HES6 proteins concerns the shorter loop 
in the bHLH domain of HES6-1 proteins, when compared with the HES6-2 subgroup. All 
analysed HES6 proteins have shorter loops than the ones described for other HES proteins, a 
feature that is likely to impair DNA-binding (Bae et al., 2000). 
  123
Chapter III – HES6 and Neuronal Differentiation 
 
Figure III.2: Comparison of the HES6 protein sequences. 
Sequence alignments of HES6 proteins from different species. Shaded areas represent regions of homology. The 
HES6 proteins are divided in two subgroups: HES6-1 and HES6-2. The main protein domains are indicated. The 
EDED, LNHLL, PEST, SPXXSP and SPXSS-SDXE domains are indicated based on amino acid positions 
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described for mouse HES6 protein sequence. Amino acid residues that were mutated in the experiments 
described below are marked with asterisks. h: human; m: mouse; pla: platypus; c: chick; x: Xenopus (frog); meda: 
medaka; zf: zebrafish. 
 
 
 
Figure III.3: HES6 phylogenetic tree. 
Neighbour-joining phylogram showing 
branch lengths and indicating the two 
subgroups of HES6 proteins. Chick HES6 
proteins are boxed. h: human; m: mouse; 
pla: platypus; c: chick; x: Xenopus (frog); 
meda: medaka; zf: zebrafish. 
 
 
 
 
 
 
 
 
 
 
 
Other domains have been described for mouse HES6, such as the LNHLL domain, which was 
proposed to have a role in the inhibition of gliogenesis (Jhas et al., 2006), an acidic EDED 
motif, which was proposed to modulate the formation of dimers (Belanger-Jasmin et al., 
2007), and a SPXXSP domain, reported to be a MAPK phosphorylation site (Belanger-Jasmin 
et al., 2007). Both the EDED and SPXXSP domains were also reported to be required for the 
anti-gliogenic activity of mHES6 (Belanger-Jasmin et al., 2007). Although the LNHLL domain 
is conserved in the majority of the HES6 proteins analysed, including chick HES6-1 and 
HES6-2, the EDED domain is only conserved in mammals and the SPXXSP domain is only 
present in mHES6. These observations suggest that chick HES6-1 and HES6-2 do not have 
anti-gliogenic activities. 
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III.3.2. cHes6-1 expression pattern 
 
The expression pattern of cHes6-1 throughout chick embryonic development was determined 
by in situ hybridization on whole-mount embryos and cryostat sections. At HH4 (Hamburger 
and Hamilton stages (Hamburger and Hamilton, 1951)), cHes6-1 is expressed in the epiblast 
and Hensen’s node (Fig. III.4A). As the node starts regressing at HH5, expression of cHes6-1 
is also detected in the emerging head process (Fig. III.4B). During gastrulation, cHes6-1 is 
always expressed around Hensen’s node and in the forming notochord. Other sites of cHes6-1 
expression in early embryos (HH6-19) include the neural folds and neural tube, the cranial 
placodes, the infundibulum, the prospective heart, the prospective eye, the olfactory pit, the 
otic vesicle, the tail bud and the rhombomeres (Fig. III.4C-M). Later on expression is also 
found in the retina and in muscle fibres (Fig. III.4N-O). 
Expression can also be detected in the lateral mesoderm flanking the regressing node in 5-
somite embryos, but only in the left side (arrow in Fig. III.4E). This asymmetric expression 
continues throughout HH9 and HH10 and finally equalizes in both sides at HH11 (Fig. III.4F-
H), suggesting that cHes6-1 participates in the mechanisms regulating the establishment of 
left-right asymmetry in the embryo. The signalling molecule NODAL is known to play a 
central role in these mechanisms, being asymmetrically expressed in the left lateral plate 
mesoderm, where it induces the expression of its downstream targets Nkx3.2 and Pitx2 to 
implement normal body asymmetry (Logan et al., 1998; Piedra et al., 1998; Ryan et al., 1998; 
Yoshioka et al., 1998; Schneider et al., 1999; reviewed in Raya and Belmonte, 2004). 
Expression of Nodal occurs sequentially in a wave-like fashion along the anterior-posterior 
axis (Fig. III.5A-D), and reaches the posterior end of the embryo at the 5 somite stage, 
coinciding with the onset of expression of cHes6-1 in this region (Fig. III.4E and Fig. III.5B). 
In addition, when Nodal expression in the posterior lateral mesoderm is extinguished at late 
HH10, asymmetric expression of cHes6-1 also starts to fade out (Fig. III.4H and Fig. III.5D). 
This correlation between the expression of Nodal and cHes6-1 suggests that this gene is a 
downstream target of Nodal signalling in the left mesoderm and might play a role in left-right 
asymmetry. 
  126
Chapter III – HES6 and Neuronal Differentiation 
 
 
Figure III.4: cHes6-1 expression pattern. 
(A-M) Expression of cHes6-1 at stages (A) HH4, (B) HH5, (C) HH6, (D) HH8 with 3 somites, (E) HH8 with 5 
somites, (F) HH9 (dorsal view), (G) HH9 (ventral view), (H) HH10, (I) HH13, (J) HH13, (K) HH15, (L) HH16, 
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(M) HH19. (b1-b4) Sections through the regions marked with the white dashed lines in HH5 embryo in (B). (g1) 
Magnification of the selected area in (G). (h1-h6) Sections through the regions marked with the white dashed 
lines in HH10 embryo in (H). (i1) Section through the region marked with the white dashed line in HH13 
embryo in (I). (j1) Section through the region marked with the white dashed line in HH13 embryo in (J). Arrows 
in (E-G) point to the asymmetric expression of cHes6-1 in the mesoderm lateral to the primitive streak. (N,O) 
Expression of cHes6-1 (red) in the retina (E4 embryo) (N) and in muscle fibres (E7 embryo) (O). Nuclei were 
counterstained with DAPI (blue). cp: cranial placodes; e: eye; ep: epiblast; h: heart; hf: head fold; Hn: Hensen’s 
node; hp: head process; i: infundibulum; m: muscle; mlps: mesoderm lateral to the primitive streak; n: notochord; 
nf: neural folds; nt: neural tube; op: olfactory pit; ov: otic vesicle; p: pancreatic progenitors; r: retina; rh: 
rhombomeres; sr: sinus rhomboidalis. 
 
 
 
 
 
 
Figure III.5: Expression of genes in the lateral mesoderm and in pancreatic progenitors. 
(A-D) Expression of Nodal in embryos with 4 (A), 5 (B), 7 (C) or 10 (D) somites, showing beginning of 
expression of Nodal in the mesoderm lateral to the primitive streak at the 5 somite stage and ending in embryos 
with 10 somites. (c1) Section through the region marked with the white dashed line in 7-somite embryo in (C). 
Arrows in (A-D) point to mesoderm lateral to the primitive streak. (E,F) Ventral view of embryos showing 
expression of (E) cHes6-2 at HH12 and (F) cDelta1 at HH10 in pancreatic progenitors, identified by arrows. 
mlps: mesoderm lateral to the primitive streak. 
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At 7 somites, expression of cHes6-1 is also detected in a salt-and-pepper pattern in the 
endoderm, in the region between the 3rd and 5th somites (Fig. III.4G). This expression expands 
and shifts more posteriorly as the embryo grows: for instance, in embryos with 18 somites, 
expression extends up to the 13th somite level and spans around 6 somites. This expression of 
cHes6-1 in the endoderm resembles the location of pancreatic precursors in 1.5-day-old chick 
embryos, as determined by fate mapping (Matsushita, 1996; Rawdon, 2001) and expression of 
the pancreatic markers Nkx6-1,2,3, Nkx2.2 and Pdx1 (Pedersen et al., 2005). Since Notch 
signalling has been previously reported to be involved in pancreatic development (Apelqvist et 
al., 1999), the expression of other components of the Notch pathway were also analysed in this 
region of the endoderm. cHes6-2 is the only other Hes gene expressed in the same region, as 
the expression of cHes5-1, cHes5-2, cHes5-3, cHairy1 or cHairy2 could not be detected (Fig. 
III.5E and previous work from the laboratory). The expression of Notch ligands was also 
assessed and it was found that only cDelta1 is expressed with a similar spatio-temporal pattern 
to cHes6-1 in the endoderm (Fig. III.5F and previous work from the laboratory). 
 
III.3.3. Regulation of cHes6-1 expression by Notch signalling 
 
To determine whether cHes6-1 expression in the embryo is under Notch control, Notch 
signalling was inhibited in ovo by treating embryos with a highly specific γ-secretase inhibitor 
(LY411575) (Lanz et al., 2004) and the effect on cHes6-1 expression was assessed. In the 
absence of Notch activity, cHes6-1 expression in the lateral mesoderm is strongly reduced 
(28/32 treated embryos, compare Fig. III.6C with 6A), showing that cHes6-1 requires Notch 
signalling to be asymmetrically expressed in this region of the embryo. In the endoderm, on 
the contrary, inhibition of Notch activity leads to an increase in cHes6-1 expression (30/34 
treated embryos, compare Fig. III.6D with 6B), revealing that Notch signalling negatively 
regulates cHes6-1 expression in the prospective pancreas. This is consistent with a study 
showing that cHes6-1 is down-regulated in the developing pancreas of later stage embryos 
after overexpression of an active form of the Notch receptor (Ahnfelt-Ronne et al., 2007). In 
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the neural tube, inhibition of Notch activity also leads to an increase in cHes6-1 expression 
(21/30 treated embryos, compare Fig. III.6E with 6A), showing that Notch signalling 
negatively regulates cHes6-1 expression in this region of the embryo. 
Together, these results show that cHes6-1 is differently regulated in distinct regions of the 
developing chick embryo. 
 
 
 
 
Figure III.6: cHes6-1 response to Notch inhibition. 
(A-E) Expression of cHes6-1 in embryos treated with PBS (A,B) or with the Notch signalling inhibitor LY411575 
(C-D). Upon treatment with LY411575, down-regulation of cHes6-1 expression can be detected in the mesoderm 
lateral to the primitive streak (C, dorsal view) and up-regulation of cHes6-1 can be detected in pancreatic 
progenitors (D, ventral view) and neural tube (E, dorsal view), when compared to control embryos treated with 
PBS (A, dorsal, and B, ventral view). Arrows point to regions of the embryo where cHes6-1 expression if affected 
by Notch signalling inhibition. 
 
 
III.3.4. cHes6-1 is expressed in post-mitotic cells in the outer ventricular zone of the spinal 
cord 
 
Analysis by whole-mount in situ hybridization shows that cHes6-1 is expressed throughout 
the developing nervous system and that the start of its expression coincides with the onset of 
neurogenesis at neural plate stages (Sechrist and Bronner-Fraser, 1991) (Fig. III.4). To further 
examine the expression of cHes6-1 in the neural tube, in situ hybridizations were performed in 
cryostat sections of E3-E7 embryos. While in E3 embryos, cHes6-1 expression is located 
throughout the spinal cord and expressing cells are mostly basal (Fig. III.7A), in E4 embryos it 
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is expressed in cells located at the border between the VZ and the mantle layer, across the 
whole dorso-ventral axis, (Fig. III.7B). From E4 to E7, cHes6-1 expression progressively 
disappears from the ventral region, correlating with the completion of neurogenesis in this 
region (Fig. III.7C). 
To determine the proliferative status of cHes6-1-expressing cells in the neural tube, embryos 
were treated in ovo with a 30 minutes pulse of 5-bromo-2-deoxyuridine (BrdU, a thymidine 
analogue) to mark cells in S-phase. Following immunohistochemistry for BrdU and in situ 
hybridization to detect cHes6-1 expression, it was found that cells expressing cHes6-1 do not 
incorporate BrdU (Fig. III.7D-F’), indicating that the gene is expressed in post-mitotic cells in 
the developing neural tube. Furthermore, the same results are obtained after a 3h pulse of 
BrdU, which labels S/G2/M phases of the cell cycle, confirming the post-mitotic character of 
cHes6-1-expressing cells (Fig. III.7G-I’). However, double-labelling with Tuj-1, which marks 
early born neurons (Lee et al., 1990), does not show co-expression of cHes6-1 (Fig. III.7J-L’), 
indicating that this gene is expressed transiently during the initial phases of neuronal 
differentiation in the spinal cord. Nonetheless, a clear co-localization between cHes6-1 
expression and Tuj-1 in cranial ganglia and in dorsal root ganglia is observed (Fig. III.7M-R’), 
revealing a different timing for cHes6-1 expression during peripheral neurogenesis. 
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Figure III.7: Expression of cHes6-1 in differentiating cells of the spinal cord. 
(A-C) Expression of cHes6-1 (red) in spinal cord sections of (A) E3, (B) E4 and (C) E7 embryos. Nuclei were 
counterstained with DAPI (blue). (D-R’) cHes6-1 (red) is expressed in post-mitotic cells of spinal cord of E4 
embryos, as shown by the absence of strong BrdU incorporation (green) in these cells after 30 minutes (D-F’) or 
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3 hours pulse (G-I’). However, cHes6-1-expressing cells are not fully differentiated, as demonstrated by absence 
of Tuj-1 co-labelling (green) (J-L’). By contrast, in cranial ganglia (M-O’) and dorsal root ganglia (P-R’) cHes6-1 
is expressed in Tuj-1+ differentiated neurons. (F’), (I’), (L’), (O’), (R’) are magnifications of the selected areas in 
(F), (I), (L), (O), (R), respectively. Arrows identify cells where cHes6-1 expression coincides with Tuj-1 labelling. 
drg: dorsal root ganglion; n: notochord; nt: neural tube. 
 
 
III.3.5. cHes6-1 is part of the neuronal differentiation cascade of bHLH genes 
 
During vertebrate neurogenesis, a cascade of expression of proneural and neuronal 
differentiation genes encoding bHLH transcriptional regulators, such as Neurogenins, 
NEUROM and NEUROD1, regulate consecutive steps of differentiation (reviewed in 
Kageyama and Nakanishi, 1997; Bertrand et al., 2002; Gibert and Simpson, 2003; Kageyama et 
al., 2005). To relate the expression of cHes6-1 with the cascade of proneural bHLH expression, 
double in situ hybridization was performed with probes for cHes6-1 and various bHLH-
encoding genes, starting with the proneural gene cNeurog1 (Ma et al., 1996). cNeurog1 is 
mainly expressed in the ventral region of the developing spinal cord, with an additional dorsal 
stripe (dI2, reviewed in Helms and Johnson, 2003) (Fig. III.8B). Analysis of in situ data 
revealed that cells in the VZ have different levels of cNeurog1 expression and that cells with 
higher levels of cNeurog1 are present more basally in the VZ, co-expressing cHes6-1 (Fig. 
III.8A-C’). Next, expression of the proneural gene cNeurog2 (Sommer et al., 1996) was 
analysed. cNeurog2 expression is very similar to that of cNeurog1 in the ventral region, with 
higher expressing cells also located more basally and co-expressing cHes6-1 (Fig. III.8D-F’). In 
the dorsal part of the neural tube, cNeurog2-expressing cells are uniformly located at the basal 
part of the VZ and show extensive co-expression of cHes6-1 (Fig. III.8D-F’). The finding that 
cHes6-1-expressing cells show the highest levels of Neurogenin expression is in agreement 
with previous findings that show activation of HES6 expression by Neurogenins and 
cooperativity between both to promote neuronal differentiation (Koyano-Nakagawa et al., 
2000; Fior and Henrique, 2005) 
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Figure III.8: cHes6-1 expression relative to expression of various genes involved in neurogenesis. 
(A-O’) Double in situ hybridization shows partial overlapping patterns and co-expression between cHes6-1 
(green) and the following genes in spinal cord of E4 embryos: cNeurog1 (A-C’), cNeurog2 (D-F’), cNeuroM (G-
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I’), cHes6-2 (J-L’) and cDelta1 (M-O’) (red). (C’), (F’), (I’), (L’), (O’) are magnifications of the selected areas in 
(C), (F), (I), (L), (O), respectively. Arrows indicate cells where genes are co-expressed. Horizontal lines in (F) 
and (F’) separate the dorsal and ventral domains of the spinal cord. (P) Neuronal differentiation is a step-wise 
process: differentiating neural progenitors exit the IVZ (inner ventricular zone) and sequentially activate 
neuronal differentiating genes during migration to the ML (mantle layer). cHes6-1 is transiently expressed in the 
OVZ (outer ventricular zone), where it is co-expressed with various genes involved in neurogenesis. 
 
 
Subsequently, cHes6-1 expression was compared to that of cNeuroM, which is expressed in 
differentiating neurons (Roztocil et al., 1997). Double in situ hybridization shows co-
expression of cHes6-1 and cNeuroM along the dorso-ventral axis, with cells co-expressing 
both genes located more apically than cells expressing only cNeuroM (Fig. III.8G-I’). This 
suggests that cNeuroM expression persists longer in differentiating neurons, after cHes6-1 
expression is extinguished. Together, these results point to the following order of expression 
in differentiating neurons of the ventral spinal cord: cNeurog1/cNeurog2 → 
cNeurog1/cNeurog2/cNeuroM/cHes6-1 → cNeuroM (Fig. III.8P). 
A circuitry of cHes5 and cHes6-2 acts during chick neurogenesis, with cHes6-2 functioning as 
a regulator of the three cHes5 genes (Fior and Henrique, 2005). Therefore, the expression of 
cHes6-1 was compared to that of cHes6-2 in these early steps of neuronal differentiation in the 
developing spinal cord. It was found that the majority of cHes6-1-expressing cells are located 
more basally than cells expressing cHes6-2, although the two cHes6 genes are co-expressed in 
some cells (Fig. III.8J-L’). This indicates that expression of cHes6-1 in newborn neurons 
occurs later than cHes6-2 expression. In relation to cDelta1, which has been reported to be 
expressed after cHes6-2 (Fior and Henrique, 2005), it was found that this gene is expressed in 
cells located more apically than cHes6-1-expressing cells, again with some cells showing co-
expression of the two genes (Fig. III.8M-O’). Together, these results suggest the following 
sequence for the expression of these three genes in cells entering differentiation and initiating 
their migration out of the VZ: cHes6-2 → cDelta1 → cHes6-1 (Fig. III.8P). 
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III.3.6. Regulation of cHes6-1 in the spinal cord 
 
The results described above show that cHes6-1 expression occurs in cells that have already 
committed to neuronal differentiation. Therefore, cHes6-1-expressing cells should not present 
Notch activity, which is only present in progenitors to maintain their undifferentiated state. 
This is in agreement with the non-overlapping expression domains of cHes6-1 and cNotch1 in 
the developing spinal cord (Fig. III.9A-C’). Here, the two genes are transcribed in cells located 
in different regions of the neuroepithelium, cNotch1 in apical progenitors at the ventricular 
zone and cHes6-1 in differentiating cells located at the border between the VZ and the mantle 
layer. 
As cHes6-1 is expressed in differentiating neurons, interfering with neurogenesis should lead 
to alterations in its pattern of expression. To assess this, the expression of cHes6-1 was 
examined in the spinal cord of embryos where neurogenesis is blocked or accelerated, by 
manipulating Notch activity in the neuroepithelium. To block neurogenesis by increasing 
Notch activity, chick embryos were electroporated with a plasmid encoding a constitutively 
active form of the NOTCH1 receptor, NICD. Analysis of cHes6-1 expression in the spinal 
cord of these embryos shows that the number of cells expressing cHes6-1 is reduced when 
neurogenesis is blocked by ectopic Notch activation (Fig. III.9D-I’). To accelerate 
neurogenesis by reducing Notch activity, chick embryos were electroporated with a plasmid 
encoding a dominant-negative form of CSL (CSLDN). Analysis of cHes6-1 expression in the 
spinal cord of these embryos shows that the number of cells expressing cHes6-1 is increased 
when neurogenesis is accelerated due to Notch inactivation (Fig. III.9J-O’). This is in 
agreement with the results obtained when embryos were treated with the γ-secretase inhibitor 
(LY411575) (Fig. III.6E). 
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Figure III.9: Regulation of cHes6-1 expression. 
(A-C) Double in situ hybridization for cHes6-1 (green) and cNotch1 (red), showing no co-expression of the two 
genes in spinal cord of E4 embryos. (D-F’,J-L’) The rate of neurogenesis decreases after ectopic expression of 
NICD (D-F’) and increases after ectopic expression of CSLDN (J-L’), as revealed by the down- or up-regulation 
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of cDelta1 expression, respectively. (G-I’,M-R’) Expression of cHes6-1 in the neural tube decreases after ectopic 
expression of NICD (G-I’), and increases after ectopic expression of CSLDN (M-O’) or NEUROG2 (P-R’). (C’), 
(F’), (I’), (L’), (O’), (R’) are magnifications of the selected areas in (C), (F), (I), (L), (O), (R) respectively. Arrows 
pinpoint electroporated cells (GFP+) with increased expression. 
 
 
The correlation of cHes6-1 expression levels with the rate of neurogenesis confirms that 
cHes6-1 is expressed in cells committed to neuronal differentiation, a process driven by the 
activity of proneural genes. Given the previous finding that cHes6-1 and the proneural gene 
Neurog2 are co-expressed in various domains of the developing spinal cord (Fig. III.8D-F’), it 
was next asked whether NEUROG2 can regulate cHes6-1 expression. To answer this, a 
plasmid encoding NEUROG2 was electroporated into the chick neural tube. Upon 
NEUROG2 overexpression, a cell-autonomous increase in cHes6-1 expression is observed 
(Fig. III.9P-R’), implying that cHes6-1 is expressed downstream of proneural genes during the 
process of neuronal differentiation in the developing spinal cord. 
 
III.3.7. Overexpression of cHES6-1 or cHES6-2 results in opposite outcomes 
 
Previous work with cHes6-2 revealed that this gene is active in differentiating neurons and 
serves to repress transcription of the three cHes5 genes encoding Notch effectors, helping to 
release differentiating cells from Notch activity (Fior and Henrique, 2005). The finding that 
cHes6-1 is also expressed in differentiating neurons, starting later than cHes6-2, but still 
overlapping with it (Fig. III.8J-L’), suggests that cHes6-1 is also part of the mechanisms acting 
to cease Notch activity and promote neuronal differentiation. 
To assess if cHes6-1 promotes neuronal differentiation, this gene was ectopically expressed in 
the embryonic chick neuroepithelium and the expression of the early neuronal marker 
cDelta1 (Henrique et al., 1995) was analysed. Upon cHes6-1 overexpression, a cell-
autonomous up-regulation of cDelta1 is observed (80% of electroporated embryos, n=44) 
(Fig. III.10A-C’), indicating that cHES6-1 promotes entry into neuronal differentiation in a 
cell-autonomous fashion. This contrasts with the activity of cHES6-2, which represses cDelta1 
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(Fior and Henrique, 2005). cHES6-2 is also a repressor of the cHes5 genes (49% of 
electroporated embryos for cHes5-1, n=63) (Fig. III.11D,E,H and Fior and Henrique (2005)), a 
result which again contrasts with the outcome of cHES6-1 overexpression: a cell-autonomous 
up-regulation of all three cHes5 genes (89% of electroporated embryos for cHes5-1, n=54) 
(Fig. III.10D-L’ and Fig. III.11B,C,H). Together, these results suggest that cHes6-1 and cHes6-
2 act at different steps of the neuronal differentiation cascade and through different molecular 
mechanisms. 
Later markers for neuronal differentiation, like Tuj-1, are not induced by cHes6-1 
overexpression (Fig. III.10M-O’), suggesting that cells do not progress further into 
differentiation. Possible explanations for this observation will be discussed later, in Section 
III.4.2.1. 
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Figure III.10: cHES6 overexpression phenotypes. 
(A-L) Overexpression of cHES6-1 causes up-regulation of cDelta1 (A-C’), cHes5-1 (D-F’), cHes5-2 (G-I’) and 
cHes5-3 (J-L’), detected 6hpe (hours post electroporation), but not an increase in Tuj-1 labelling 24hpe (M-O’). 
(C’), (F’), (I’), (L’), (O’) are magnifications of the selected areas in (C), (F), (I), (L), (O), respectively. Arrows 
pinpoint electroporated cells (GFP+) with increased expression. 
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III.3.8. cHES6-1 and cHES6-2 have different structural properties 
 
Comparison of the two subgroups of HES6 proteins reveals that a major structural difference 
is the size of the loop region in the bHLH domain, with the HES6-1 subgroup including 
proteins with shorter loops than HES6-2 proteins. The chick HES6-1 protein is particular in 
this aspect, as it contains the shortest loop (6 amino acids only) among all known vertebrate 
HES6 proteins (Fig. III.2). This unique structural feature might underlie the functional 
difference with cHES6-2 (which has a 10 amino acids loop) detected in the electroporation 
assay. Actually, previous work on the mouse counterpart of cHES6-1, mHES6, containing a 8 
amino acid loop, revealed that this protein is unable to bind DNA due to its short loop, acting 
mainly through heterodimerization with other HES proteins to inhibit their DNA-binding-
dependent transcriptional repressor activity (Bae et al., 2000; Koyano-Nakagawa et al., 2000; 
Gratton et al., 2003; Jhas et al., 2006; Belanger-Jasmin et al., 2007). 
Two other structural features might contribute to the different activities of cHES6 proteins. 
First, there is a specific serine residue in cHES6-1 (position 175), conserved in the HES6-1 
subgroup but absent from HES6-2 proteins. Previous work on mHES6 has shown that 
phosphorylation of this serine (at position 183 of mHES6, within a putative PEST domain) by 
Casein Kinase 2 leads to proteolytic degradation of the mHES6-mHES1 heterodimer, thereby 
contributing to the assayed neurogenic ability of mHES6 (Gratton et al., 2003). The second 
feature is the presence of a conserved lysine in HES6-2 (K59 in cHES6-2), conserved in all 
mouse HES proteins with the exception of HES6, which contains an asparagine residue in 
similar position. This lysine was shown to be essential for the transcriptional repressive 
activity of mHES7, using in vitro transcription assays (Ishii et al., 2008), and its absence in 
mHES6 was suggested to contribute also for the inability to repress transcription (Ishii et al., 
2008). 
The short loop of cHES6-1, which might prevent DNA-binding, the presence of serine 175, 
which might have a function in inactivation of binding partners, and the absence of the lysine, 
probably required for transcriptional repression, suggest that cHES6-1 does not bind DNA 
directly to repress transcription, but rather binds other proteins to inactivate them. By 
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contrast, the longer loop of cHES6-2, the absence of the serine, and the presence of lysine 59, 
all suggest that cHES6-2 functions by direct DNA-binding and transcriptional repression. 
These observations raise the hypothesis that the functional differences between cHES6-1 and 
cHES6-2 in the electroporation assay arise from the different DNA-binding abilities of the two 
proteins, with cHES6-2 being able to bind DNA and acting as a transcriptional repressor of 
cHes5 genes, and cHES6-1 working by forming inactive heterodimers with HES5 proteins. 
These latter proteins are known to bind DNA and repress their own transcription (Fior and 
Henrique, 2005), so interference with their activity by ectopic cHES6-1 expression might 
underlie the observed up-regulation of cHes5 gene transcription. 
 
III.3.9. cHES6-1 and cHES6-2 exert their function through different molecular 
mechanisms 
 
To test if cHES6-2 functions as a DNA-bound transcriptional repressor and cHES6-1 
functions by protein inactivation, several variants of cHES6-1 and cHES6-2 proteins were 
engineered (Fig. III.11A) and their activities were evaluated in the electroporation assay, using 
the expression of cHes5-1 as read-out. 
The first variant to be tested involved the substitution of lysine 59 of cHES6-2 by an arginine, 
as a similar mutation in lysine 55 of mHES7 abolished its ability to repress transcription (Ishii 
et al., 2008). Ectopic expression of cHES6-2K59R leads to down-regulation of cHes5-1 (65% of 
electroporated embryos, n=20), a phenotype similar to that obtained upon overexpression of 
normal cHES6-2 protein (Fig. III.11H). This result suggests that lysine 59 of cHES6-2 is not 
important for the function of this protein in the electroporation assay. 
A variant of cHES6-1 was next generated where serine 175 is replaced by an alanine. A similar 
mutation in serine 183 of mHES6 was shown to impair the ability to target other HES binding 
partners for degradation (Gratton et al., 2003). Ectopic expression of cHES6-1S175A leads 
however to up-regulation of cHes5-1 (88% of electroporated embryos, n=25), similar to 
overexpression of normal cHES6-1 (Fig. III.11H). This result suggests that serine 175 of 
cHES6-1 is not required for the activity of cHES6-1 in the electroporation assay. 
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It was then tested whether removal of the C-terminal WRPW domain, which is known to be 
required for the transcriptional repressor activity of HES proteins by recruiting the TLE co-
repressor (Fisher et al., 1996; Grbavec and Stifani, 1996), affects the function of chick HES6 
proteins. Ectopic expression of cHES6-2ΔWRPW leads to up-regulation of cHes5-1 
expression (54% of electroporated embryos, n=13) (Fig. III.11H), clearly contrasting with the 
activity of the non-modified protein that normally represses cHes5-1 transcription (49% of 
electroporated embryos, n=63) (Fig. III.11D,E,H). In turn, electroporation of cHES6-
1ΔWRPW gives the same phenotype as normal cHES6-1, causing up-regulation of cHes5-1 
transcription (95% of electroporated embryos, n=19) (Fig. III.11H). Together, these results 
show that the ability of cHES6-2 to repress transcription is compromised by its incapacity to 
recruit the co-repressor TLE, while cHES6-1 activity is not affected by the absence of the 
WRPW motif, supporting the hypothesis that cHES6-1 is not working as a DNA-bound 
transcriptional repressor in the developing spinal cord. 
To directly test whether DNA-binding is involved in the differential activities of cHES6-1 and 
cHES6-2, variants of these proteins were constructed, where two arginines from the C-
terminus of the basic domain were replaced by uncharged amino acids (AQ), an alteration 
that has been shown to abolish the DNA-binding activity of several bHLH proteins (Davis et 
al., 1990; Turner and Weintraub, 1994; Farah et al., 2000; Gowan et al., 2001; Sun et al., 2001; 
Lee and Pfaff, 2003; Nakada et al., 2004; Jhas et al., 2006; Belanger-Jasmin et al., 2007). A 
similar mutant of mHES6 (HES6AQ), in particular, was shown to lose the capacity to bind to 
Enhancer of Split E (ESE) motifs (Jhas et al., 2006; Belanger-Jasmin et al., 2007), a specific type 
of E box recognized by the Drosophila Enhancer of Split proteins (Jennings et al., 1999) that 
can also be recognized by mHES6 (Cossins et al., 2002; Jhas et al., 2006; Belanger-Jasmin et al., 
2007). When cHES6-2AQ is electroporated in the embryonic neural tube, an increase in 
cHes5-1 transcription is observed (77% of electroporated embryos, n=22), contrasting with 
the repressive activity of the normal cHES6-2 protein (Fig. III.11H). In turn, electroporation 
of cHES6-1AQ leads to an increase in cHes5-1 expression (89% of electroporated embryos, 
n=19), similar to what is observed when misexpressing unmodified cHES6-1 (Fig. III.11H). 
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These results further suggest that cHES6-2 requires DNA-binding for its transcriptional 
repression ability and that cHES6-1 functions independently of DNA-binding. 
In addition, variants lacking both the WRPW domain and the ability to bind DNA (RR→AQ 
mutations) were generated and named cHES6-1AQΔWRPW and cHES6-2AQΔWRPW. 
Electroporation of cHES6-2AQΔWRPW leads to up-regulation of cHes5-1 transcription (78% 
of electroporated embryos, n=37), again contrasting with the repressive activity of the normal 
cHES6-2 protein (Fig. III.11H). In turn, electroporation of cHES6-1AQΔWRPW leads to up-
regulation of cHes5-1 (75% of electroporated embryos, n=12), similar to what is observed with 
the normal cHES6-1 overexpression (Fig. III.11H). 
Altogether, these results offer further support to the hypothesis that the two cHES6 proteins 
act through distinct molecular mechanisms to modulate cHes5 transcription in the 
electroporation assay, with cHES6-2 acting as a direct transcriptional repressor while cHES6-1 
acts by preventing cHES5 proteins from repressing transcription of their own genes. 
The proposed mechanism for cHES6-1 function is similar to that described for mouse HES6, 
which does not require DNA-binding to inhibit HES1-mediated transcriptional repression, 
acting instead by forming inactive heterodimers with HES1 (Bae et al., 2000; Koyano-
Nakagawa et al., 2000; Gratton et al., 2003; Jhas et al., 2006; Belanger-Jasmin et al., 2007). 
Therefore, mouse HES6 function in the electroporation assay was also tested and it was found 
that its overexpression in chick embryos causes the same phenotype as cHES6-1 (and opposite 
to cHES6-2), leading to similar up-regulation of cHes5-1 expression (79% of electroporated 
embryos, n=14) (Fig. III.11F-H). 
Altogether, these results show that cHES6-1 does not require DNA-binding nor the ability to 
recruit repressors for its function in regulating cHes5 expression, suggesting that it normally 
acts by directly sequestering the HES5 proteins. By contrast, DNA-binding ability and 
recruitment of TLE are absolutely essential for cHES6-2 to function as a transcriptional 
repressor of cHes5 genes. 
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Figure III.11: Phenotypical analysis of overexpressed cHES6 variants. 
(A) Schematic representation of various modified HES6 proteins overexpressed in the chick neural tube. Altered 
functional domains are depicted in red. (B-G) Whole-mount analysis of cHes5-1 expression in electroporated 
embryos shows that overexpression of cHES6-2 down-regulates cHes5-1 (D,E), contrasting with the up-
regulation caused by cHES6-1 (B,C) or mHES6 overexpression (F,G). (H) Percentage of embryos showing up- or 
down-regulation of cHes5-1 expression upon transfection with the different variants of cHES6-1 (black bars), 
cHES6-2 (grey) and mHES6 (white). 
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III.4. DISCUSSION 
 
In this Chapter, I describe the investigation of a particular group of vertebrate Hes genes, 
named Hes6, and identify two subgroups that are present in zebrafish, medaka, frog, platypus 
and chick, which I named Hes6-1 and Hes6-2 (Fig. III.2 and III.3). In contrast, only one Hes6 
gene is present in the mouse and human genomes, belonging to the Hes6-1 subgroup. The two 
chick Hes6 genes have been previously identified (Fior and Henrique, 2005) but only the 
function of cHes6-2 has been investigated. I describe here the expression pattern and 
functional characterization of cHes6-1 during early embryonic development. My results 
indicate that cHes6-1 shares a common function during neurogenesis with cHes6-2, both 
contributing to release differentiating neurons from Notch activity, although through 
different molecular mechanisms. 
 
III.4.1. cHes6-1 expression and regulation 
 
Characterization of cHes6-1 expression pattern reveals that this gene is active in all three germ 
layers, namely in the developing nervous system, pancreatic progenitors and, asymmetrically, 
in the left lateral mesoderm flanking the regressing node. 
 
III.4.1.1. Asymmetric cHes6-1 expression in the mesoderm 
 
The expression of cHes6-1 in the left lateral mesoderm flanking the regressing node suggests 
that cHes6-1 participates in the mechanisms regulating the establishment of left-right 
asymmetry in the embryo. Expression of Nodal occurs sequentially in a wave-like fashion 
along the anterior-posterior axis, reaching the posterior end of the embryo at the 5-somite 
stage, coinciding with the onset of expression of cHes6-1 in this region, and being 
extinguished at late HH10, when asymmetric expression of cHes6-1 also starts to fade out. The 
correlation between the expression of both genes suggests that cHes6-1 is a downstream target 
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of Nodal signalling in the left mesoderm, in agreement with previous results showing that 
Hes6 expression is downstream of Nodal signalling in Xenopus early gastrula embryos (Murai 
et al., 2007), and that that it might play a role in left-right asymmetry. 
Notch signalling is also known to be an important player in left-right asymmetry, at the time 
when this asymmetry is first established around the Hensen’s node (Krebs et al., 2003; 
Przemeck et al., 2003; Raya et al., 2003). However, it is not known if Notch also plays a role 
during the later stages when cHes6-1 is expressed. My results show that asymmetric 
expression of cHes6-1 in the lateral mesoderm is dependent on Notch activity, thus revealing 
that this signalling pathway continues to be active during the process of generating left-right 
asymmetry in the embryo. 
The transient and asymmetric expression of cHes6-1 raises the question of which asymmetric 
structures arise from the lateral mesoderm region expressing this gene. The position of cHes6-
1-expressing cells in the posterior mesoderm at HH10 suggests that these cells will end up 
flanking somites 18 and forward, as development proceeds. This region (between somites 18 
and 21 of stage HH14 embryos) has been previously fate-mapped to be the main source of 
gonadal cells (Rodemer et al., 1986). In the female chick the right gonad is developmentally 
retarded when compared to the left (Mittwoch, 1998; Guioli and Lovell-Badge, 2007; Ishimaru 
et al., 2008; Rodriguez-Leon et al., 2008). However, during chick development the male 
gonads are also asymmetric (Mittwoch, 1998). It is thus possible that the transient and 
asymmetric cHes6-1 expression in the lateral mesoderm might contribute to gonad 
asymmetry in chick development. In mouse, Hes6 expression appears not to be asymmetric, 
correlating with the similar development of the left and right gonads. However, as all mHes6 
expression studies dealt with later stage embryos (Bae et al., 2000; Koyano-Nakagawa et al., 
2000; Pissarra et al., 2000; Vasiliauskas and Stern, 2000; Cossins et al., 2002), it remains to be 
determined whether cHes6-1 asymmetric expression is conserved in mammals. 
Although it is likely that the cHes6-1 asymmetric expression in the mesoderm contributes to 
the asymmetry of a mesodermal derivative, it is also possible that it contributes to the 
asymmetry of tissues in close contact with the cHes6-1 expressing cells. The gut is known to be 
asymmetric, with the splanchnic mesoderm being responsible for this asymmetry (reviewed in 
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Burn and Hill, 2009). As the endoderm adjacent to cHes6-1-expressing cells originates the 
ileum, the large intestine and the cloaca (Matsushita, 1999), and the mesoderm lateral to the 
1st to 10th somites contributes to the wall of the anterior gut (Matsushita, 1995), it is possible 
that the mesoderm posterior to 10th somite-level (expressing cHes6-1) contributes to the 
posterior gut wall, contributing to the asymmetry of the gut. 
Whether chick Hes6-1 asymmetric expression in the mesoderm lateral to the primitive streak 
in HH9-11 embryos contributes to the asymmetry of the underlying endoderm, generating 
the gut loop, or contributes to the asymmetry of the intermediate mesoderm, generating 
gonads asymmetry, will only be determined after fate mapping this region of the embryo. 
 
III.4.1.2. cHes6-1 is expressed in pancreatic progenitors 
 
Early cHes6-1 expression also occurs in the ventral endoderm in a salt-and-pepper pattern, 
starting at 6-7-somite stage. The position of cHes6-1-expressing cells suggests that they are 
pancreatic progenitors, although one of the first known markers of these cells, Pdx1, only 
starts to be expressed at the 9-10-somite stage (Kumar et al., 2003). However, pancreatic 
progenitors are known to have been already specified at the 6-somite stage (Kumar et al., 
2003; Kimura et al., 2007) and my results suggests that cHes6-1 is an early marker for these 
cells, before Pdx1. This agrees with the findings that mouse Hes6 is also expressed in 
pancreatic cells and that its overexpression causes up-regulation of Pdx1 expression (Ball et 
al., 2007). 
I have found that cDelta1 and cHes6-2 are also expressed in pancreatic progenitors at these 
early stages, suggesting that Notch signalling plays a role in the early stages of pancreatic cell 
fate specification. However, the finding that cHes6-1 expression is negatively regulated by 
Notch activity in prospective pancreatic cells indicates that this gene does not function as a 
Notch effector in the process. Instead, as suggested by studies of pancreatic cell differentiation 
at later stages (Ahnfelt-Ronne et al., 2007), cHes6-1 is likely to be downstream of NEUROG3, 
participating in the cascade of bHLH proteins that regulate pancreatic differentiation. Since 
Notch signalling leads to repression of Neurog3 expression during pancreas development 
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(Apelqvist et al., 1999; Ahnfelt-Ronne et al., 2007), this might explain the observed down-
regulation of cHes6-1 expression by Notch activity. 
In the recent work by Ahnfelt-Ronne and colleagues (Ahnfelt-Ronne et al., 2007), which refers 
to stage HH22 and HH31 chick embryos, it was shown that cHes6-2 is not expressed in the 
developing pancreas. By contrast, I have detected cHes6-2 expression in the prospective 
pancreas at stage HH9 embryos (Fig. III.5E). The contrasting observations in the two studies 
suggests that the very early and the later development of the pancreas are differently regulated. 
 
III.4.1.3. cHes6-1 is expressed in differentiating cells in the developing spinal cord 
 
In the developing spinal cord, cHes6-1 is transiently expressed during neuronal 
differentiation, in post-mitotic cells that co-express proneural transcription factors. My 
expression analyses show that cHes6-1 and cHes6-2 are expressed at different steps of the 
neuronal differentiation cascade, with cHes6-2 being expressed before cDelta1, and cHes6-1 
after, although co-expression of the two cHes6 genes can still be observed in some cells. I 
further show that cHes6-1 expression is downstream of proneural transcription factors and is 
not a direct target of Notch signalling, being instead repressed by Notch activity, like in the 
prospective pancreas. Overall, my results suggest the existence of three consecutive stages in 
neuronal differentiation in the developing chick spinal cord: proneural proteins and cHES6-2 
act first during the decision to commit to neurogenesis, followed by the expression of the 
Notch ligand cDelta1 to inhibit neighbouring progenitors from differentiating and, finally, by 
the expression of cHES6-1 and NEUROM to regulate subsequent differentiation steps (Fig. 
III.8P). 
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III.4.2. cHES6-1 and cHES6-2 have different mechanisms of action 
 
III.4.2.1. Ectopic expression of cHES6-1 promotes commitment to neuronal differentiation 
 
To investigate the functional role of cHES6-1 during neurogenesis, I used gain-of-function 
studies in the chick embryo, by ectopically expressing the protein in the spinal cord 
neuroepithelium. My findings reveal that ectopic expression of cHES6-1 promotes 
commitment to neuronal differentiation, as suggested by the cell-autonomous up-regulation 
of cDelta1 expression. However, later markers for neuronal differentiation, like Tuj-1, are not 
induced by cHes6-1 overexpression (Fig. III.10M-O’), suggesting that cells do not progress 
further into differentiation. This is likely due to the fact that transcription of cHes5 genes is 
also up-regulated by cHes6-1 expression, thereby repressing the neuronal differentiation 
cascade. Furthermore, the high levels of proneural gene expression required to trigger 
neuronal differentiation are not yet reached in all neural progenitors at the embryonic stages 
used for electroporation, a fact that might also explain why these cells are not able to 
terminally differentiate when electroporated with cHes6-1. 
 
III.4.2.2. cHES6-1 and cHES6-2 have different functions and different structural properties 
 
The results of cHes6-1 misexpression are in striking contrast to the activity of the closely 
related gene cHes6-2 in the same assay. These functional differences are likely due to the 
unique structural features of each cHES6 protein. These include: 
- a particular serine residue specifically present in all HES6-1 subgroup proteins 
(position 175 of cHES6-1), reported to be essential for mHES6-dependent induction 
of neurogenesis (Gratton et al., 2003); 
- a lysine residue present in the bHLH domain of all HES6-2 subgroup proteins 
(position 59 of cHES6-2), suggested to be essential for transcriptional repression 
ability of HES proteins (Ishii et al., 2008); 
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- the different sizes of the loop region within the bHLH domain, which is known to 
constrain the DNA-binding capacity of HES proteins (Bae et al., 2000). 
Given the short loop of cHES6-1 (6 amino acids), I predicted that this protein is unable to 
bind DNA and might work mainly through protein interactions, as suggested by the finding 
that mHES6, the mouse counterpart of cHES6-1 with a 8 amino acid loop, does not bind DNA 
and functions by sequestering mHES1 in a transcriptionally inactive complex, no longer able 
to repress mHES1 targets (Bae et al., 2000; Koyano-Nakagawa et al., 2000; Gratton et al., 2003; 
Jhas et al., 2006). In contrast, the longer loop of cHES6-2 (10 amino acids) might allow it to 
function as a DNA-bound transcriptional repressor. 
 
III.4.2.3. cHES6-1 and cHES6-2 exert their function by different mechanisms 
 
To test whether cHES6-2 binds directly DNA and represses transcription, whereas cHES6-1 
acts by protein interactions, I generated several variants of the two cHES6 proteins that 
predictably affect their DNA-binding capacity and/or their ability to repress transcription, 
and used these variants in the chick electroporation assay. My results show that variants of 
cHES6-2 lacking the DNA-binding ability, and/or the ability to recruit the co-repressor TLE, 
lose the capacity to repress cHes5-1 transcription, implying that cHES6-2 works normally as a 
DNA-bound transcriptional repressor. In contrast, similar variants of cHES6-1, whose ability 
to bind DNA and/or to recruit co-repressors is missing, are still able to up-regulate cHes5-1 
transcription, like normal cHES6-1, showing that this protein does not require DNA-binding 
nor transcriptional repression activity to function. This is further supported by the finding 
that overexpression of mHES6, a known protein titrator that does not require DNA-binding 
nor the WRPW domain for its neurogenic activity (Bae et al., 2000; Koyano-Nakagawa et al., 
2000; Gratton et al., 2003; Jhas et al., 2006), causes also up-regulation of cHes5-1 transcription, 
like cHES6-1. 
Interestingly, I have observed that variants of cHES6-2 lacking the DNA-binding ability, 
and/or the capacity to recruit the co-repressor TLE, not only lose the repressor function but 
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also cause up-regulation of cHes5-1 in our assay. Two explanations can be advanced to explain 
this: 
- First, the cHES6-2 variants could behave like dominant-negative proteins, binding to 
and inhibiting the function of endogenous cHES6-2 proteins. In this case, the 
inhibition of endogenous cHES6-2 proteins would de-repress cHes5-1 transcription, 
up-regulating their expression. 
- Another possibility is that cHES6-2 normally works both by transcriptional repression 
of cHes5-1 and by HES5 protein sequestering. In this second hypothesis, the 
overexpression of the cHES6-2 ΔWRPW and AQ variants would cause only the 
inhibition of endogenous HES5-1 proteins, but not transcriptional repression of Hes5-
1. This would generate an effect that is similar to cHES6-1 overexpression, abolishing 
HES5-1 repressive function on its own gene and increasing its transcription. 
I have also generated a variant of cHES6-2 where lysine in position 59 is replaced by an 
arginine. I found that cHES6-2K59R behaves similarly to the normal cHES6-2 protein in the 
electroporation assay, repressing the transcription of cHes5-1. This shows that lysine 59 of 
cHES6-2 is not essential for the function of this protein in the electroporation assay. 
In addition, I have generated a variant of cHES6-1 where serine in position 175 is replaced by 
an alanine. I found that cHES6-1S175A behaves similarly to the normal cHES6-1 protein in 
the electroporation assay, causing up-regulation of cHes5-1 expression. This shows that serine 
175 of cHES6-1 is not essential for the function of this protein in the electroporation assay, 
suggesting that phosphorylation and proteolytic degradation of cHES6-1/cHES5 heterodimers 
is not an absolute requirement for cHES6-1 activity. Another indication that serine 175 of 
cHES6-1 might not have the same role as the serine in similar position of mouse HES6 comes 
from the fact that the amino acid context around the conserved serine, which has been 
implicated in mouse HES6 function (Gratton et al., 2003), is very dissimilar in chick HES6-1 
(Fig. III.2). However, although a similarly mutated form of mHES6 (mHES6S183A) revealed 
no pro-neurogenic activity in a different assay using in vitro culture of cortical progenitors, 
proteolytic degradation of HES1 could still be detected in the presence of mHES6S183A 
(Gratton et al., 2003). In our assay, we didn’t measure the neurogenic activity of cHES6-1 and 
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the target is a different anti-neurogenic HES protein (HES5), so it is likely that serine 
phosphorylation of cHES6-1 could still be important in a different context where heterodimer 
formation with HES1 is the main mechanism to promote neurogenesis. It is also possible that 
a role of serine 175 might have been masked by the heterodimerization between cHES6-
1S175A and HES5 in the electroporation assay, which could still inhibit HES5 transcriptional 
repressor function on its own gene independently of the function of S175, causing up-
regulation of expression of Hes5. Therefore, I cannot discard the hypothesis that serine 175 of 
HES6-1 is required for the normal function of this protein in vivo under physiological 
conditions. 
Together, my results support the hypothesis that, like its mouse counterpart mHES6 (Bae et 
al., 2000; Gratton et al., 2003; Jhas et al., 2006; Belanger-Jasmin et al., 2007), cHES6-1 works by 
binding to other HES proteins to inhibit their transcriptional repressive activity. In the 
electroporation assay, where most of the electroporated cells are cHes5-expressing neural 
progenitors, the ectopic expression of cHES6-1 (or mHES6) would prevent cHES5 proteins 
from repressing transcription of their own genes, breaking this negative feedback loop and 
causing an increase in cHes5 transcription. 
The related cHES6-2 protein, however, requires the presence of the WRPW domain and an 
intact DNA-binding region to effectively repress cHes5 transcription, strongly suggesting that 
this member of the HES6 family works as a classical DNA-bound transcriptional repressor. 
Thus, unlike the mouse, which contains a single HES6 gene, encoding a protein that works 
mainly by interfering with the anti-neurogenic activity of other HES proteins, the chick 
embryo contains two clustered HES6 genes that function through different but 
complementary mechanisms to regulate neuronal differentiation. 
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III.4.3. cHES6-1 and cHES6-2 cooperate during neurogenesis to release the differentiating 
cell from Notch signalling 
 
Mouse HES6 has been described to be involved in the inhibition of gliogenesis (Jhas et al., 
2006; Belanger-Jasmin et al., 2007). However the EDED and the SPXXSP domains, which are 
reported to be essential for the inhibition of gliogenesis by mHES6 (Belanger-Jasmin et al., 
2007), are absent in both cHES6-1 and cHES6-2, thus being unlikely that these proteins are 
involved in the inhibition of gliogenesis. 
Instead, during the normal process of neurogenesis, I have shown that cHes6-1 is expressed in 
differentiating neurons, which normally do not express cNotch1 or any cHes5 gene. However, 
it is possible that cHES5 proteins perdure in cells committing to differentiation, even if their 
mRNAs cannot be detected anymore, and cHES6-1 would ensure that any remaining cHES5 
activity is blocked. 
Another possible target of cHES6-1 is cHES6-2, as the encoding mRNAs can be detected in 
the same cells during neuronal differentiation (Fig. III.8J-L’). Furthermore, cHES6-2 is a 
common repressor of all three cHes5 genes (Fior and Henrique, 2005), and its inactivation by 
cHES6-1 would explain how cHes5-3 is up-regulated upon cHES6-1 ectopic expression 
despite the fact that none of the three cHES5 proteins can repress cHes5-3 expression (Fior 
and Henrique, 2005) (Fig. III.12A). Moreover, cHes6-2 expression is increased upon cHES6-1 
ectopic expression (Fig. III.12B-C) and that can also be explained by inhibition of cHES6-2 
repressor function on its own gene. 
I thus propose that cHES6-1 functions to inhibit the activity of cHES6-2, as part of the cascade 
of gene expression during neuronal differentiation. It was shown previously that cHES6-2 
helps to release differentiating neurons from Notch signalling, although its activity in the 
absence of proneural proteins could also lead to a block in neurogenesis (Fior and Henrique, 
2005). It is therefore important to inhibit cHES6-2 for neuronal differentiation to proceed and 
this function might be accomplished by cHES6-1, which is expressed later than cHES6-2 in 
differentiating neurons (Fig. III.8J-L’). I thus suggest that the two cHes6 genes are part of a 
mechanism that functions to ensure that Notch signalling is completely turned off when 
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neuroepithelial cells enter differentiation (Fig. III.13). During this process, cHes6-2 acts first as 
a transcriptional repressor of the progenitor program by repressing transcription of the cHes5 
genes encoding Notch effectors. This might lead to a major increase in proneural gene 
expression which reinforces cHes6-2 transcription and activates cHes6-1. Finally, cHES6-2 
activity is turned off by the activity of cHES6-1 and also because it represses transcription of 
its own gene (Fior and Henrique, 2005). Together, the two cHES6 proteins progressively and 
effectively shut down the Notch-mediated progenitor program, making sure that neuronal 
differentiation can proceed. 
 
 
 
Figure III.12: Repression between chick Hes genes. 
(A) The three chick Hes5 genes encode proteins that repress 
Hes6-2 transcription. In turn, HES6-2 represses the 
expression of the three Hes5 genes. All four represented 
HES proteins can repress the transcription of their own 
genes, except for HES5-3. Furthermore, HES5-1 and HES5-
2 repress transcription of each other’s genes, but not Hes5-3 
expression. This indicates that the only known repressor of 
Hes5-3 is HES6-2. Adapted from Fior and Henrique (2005). 
(B,C) Ectopic expression of HES6-1 causes up-regulation of 
Hes6-2 expression. 
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Figure III.13: Model of cHES6-1 and cHES6-2 function during neurogenesis. 
During neuronal differentiation in the developing spinal cord, cHES6-1 and cHES6-2 act sequentially to relieve 
the cell from Notch signalling: cHES6-2 acts first to repress the transcription of cHes5 genes, and cHES6-1 
subsequently sequesters and inactivates cHES5 and cHES6-2 proteins. 
 
 
 
III.4.4. “Id-like function” of cHES6-1 during neurogenesis 
 
The Notch effector HES1 has been reported to repress the transcription of proneural gene 
Ascl1 and to inhibit the function of the protein encoded by this gene through formation of 
inactive HES1/E47 heterodimers. Both mechanisms of action of HES1 block ASCL1-mediated 
progression of neurogenesis (Sasai et al., 1992; Chen et al., 1997). The function of E proteins, 
which are the binding partners of proneural proteins and are required for neuronal 
differentiation, is also inhibited by ID proteins (inhibitors of differentiation). The ID proteins 
are HLH proteins lacking the basic domain required for DNA-binding and have been 
described to form non-functional heterodimers with E proteins (reviewed in Tzeng, 2003). 
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Thus, HES and ID proteins inhibit the function of proteins responsible for neuronal 
differentiation by forming inactive heterodimers, thereby blocking neurogenesis and 
maintaining neural progenitors in the undifferentiated state. 
My observation that HES6-1 acts by protein-protein interactions, probably blocking the 
function of other HES proteins, indicates that HES6-1 acts like the ID proteins, but in a 
different context: while IDs are responsible for progenitor maintenance, HES6-1 is responsible 
for the progression of neurogenesis. 
 
III.4.5. Evolution of HES6 proteins – loss of HES6-2 during mammalian evolution 
 
I have shown that some functional domains of mammalian HES6 are not present in cHES6-1, 
like a completely conserved SPXSS-SDXE domain, reported to be required for the induction 
of neurogenesis, and the EDED and SPXXSP domains, reported to be required for the 
inhibition of gliogenesis. This indicates that mammalian HES6 has acquired other functional 
domains than chick HES6-1. 
My observation of the existence of two HES6 subgroups of proteins in zebrafish, medaka, frog, 
chick and platypus and only one type of HES6 proteins in mouse and human, belonging to the 
HES6-1 subgroup, points to a deletion of a Hes6-2 homologue during mammalian evolution, 
which occurred after the appearance of platypus. Interestingly, although zebrafish has four 
Hes6 homologues, other fish such as medaka and pufferfish have less copies, with the existing 
copies being from the Hes6-1 subgroup (Fig. III.3 and Gajewski et al. (2006)). 
My work has identified different expression patterns and mechanisms of action for the two 
chick HES6 proteins, indicating that these two proteins do not have redundant functions. The 
loss of Hes6-2 in the mammalian lineage suggests several hypotheses: 
- HES6-2 function might no longer be required in mouse and human since its targets 
have changed; 
- another protein has appeared in evolution, replacing HES6-2 function; 
- HES6-1 has acquired other functions that can replace HES6-2 function. 
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Two explanations can be advanced to explain the reason for the loss of the Hes6-2 gene: 
- Chick HES6-2 is a repressor of the three Hes5 genes and is involved in neurogenesis 
(Fior and Henrique, 2005). In mammals, only one Hes5 gene is present (the cHes5-1 
homologue), with the other two cHes5 genes, cHes5-2 and cHes5-3, probably having 
evolved to mammalian Hes2 and Hes3, which are unable to respond to Notch 
activation (Nishimura et al., 1998; Fior and Henrique, 2005). This suggests that, 
although cHES6-2 and cHES6-1 probably have to deal with the transcriptional 
repression and protein inhibition of the three cHES5s, the existence of only one HES5 
in mammals could have led to less selective pressure for the maintenance of cHes6-2 
in the genome. 
- The Dll3 gene, which is present in mammals, but absent in fish, frog and avians, is 
expressed in the nervous system in differentiating neurons (Dunwoodie et al., 1997). 
mDLL3 is unable to activate Notch in trans and has a Notch cis-inhibitory function 
(Ladi et al., 2005 Geffers et al., 2007). It is thus possible that mammalian HES6, 
together with DLL3, are enough to allow the progression of neurogenesis by 
inhibiting the function of Notch. 
 
If the main function of chick HES6-1 in the nervous system is the inhibition of cHES6-2, so 
that neurogenesis can proceed, then it is possible to speculate that in mammals, which do not 
have a Hes6-2 gene, Hes6-1 function might be unnecessary. This is in agreement with the fact 
that a mammalian Hes6 knockout has no apparent phenotype (Koyano-Nakagawa et al., 
2000). Furthermore, mammalian HES1 and HES5 repress the transcription of their own genes 
(Takebayashi et al., 1994; Takebayashi et al., 1995), and it has been shown that the mHES1 
proteins and mHes1 mRNAs are short-lived (Hirata et al., 2002). Although the half-lives of 
mHES5 proteins and mHes5 transcripts have not yet been determined, it is possible that these 
intrinsic features of Hes genes are enough to switch off the activity of HES proteins from 
differentiating cells, not needing HES6 function for this effect. In this case, the only existing 
mouse HES6 protein could have a function of fine tuning the differentiation process, ensuring 
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that all HES proteins are inactivated in due time. It would be interesting to see if neurogenesis 
in Hes6 knockout embryos is as coordinated as in the wild-type or if it is delayed. 
 
It is also worth mentioning that all studies done with mouse used the function of HES1 as a 
readout of HES6 activity (Bae et al., 2000; Koyano-Nakagawa et al., 2000; Gratton et al., 2003; 
Jhas et al., 2006; Belanger-Jasmin et al., 2007), while only a previous work (Fior and Henrique, 
2005) and this study used chick Hes5 expression as a read-out of HES6 activity. It would be 
interesting to determine whether mouse HES6 also inhibits HES5 or if its activity is restricted 
to HES1 inhibition. Indeed, bHLH proteins are known to have binding specificity to other 
bHLH proteins, but they are also promiscuous, in that they can bind several partners, with the 
binding partner being important for the dimer function (Grove et al., 2009). Therefore, 
binding to different partners can confer different functional properties. Changes of HES6-1 or 
HES6-2 binding partners during evolution might have also contributed to the disappearance 
of the Hes6-2 gene during mammalian evolution. Determination of the binding partners of 
HES6 proteins in different species could therefore provide new insights into the reasons 
underlying the disappearance of the Hes6-2. 
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CHAPTER IV – REAL-TIME SINGLE-CELL ANALYSIS INDICATES STOCHASTIC 
NOTCH ACTIVATION AND PROVIDES NEW INSIGHTS INTO THE MECHANISMS 
UNDERLYING CELL FATE DECISIONS DURING VERTEBRATE NEUROGENESIS 
 
IV.1. ABSTRACT 
 
Notch signalling plays important roles in cell fate decisions during embryonic development 
and in particular maintains the progenitor cell state in the vertebrate neural tube. Critical to 
understanding how this is achieved is analysis of Notch signalling dynamics during 
neurogenesis. Here I describe the design and validation of a novel reporter with unique 
features that allow measurement of Notch activity in individual cells within the vertebrate 
neuroepithelium. Introduction of this reporter into the chick neural tube and subsequent 
long-term time lapse imaging in embryo slices allowed monitoring Notch activity in neural 
progenitors as they progress through the cell cycle. Notch signalling was detected before cell 
division, with the two daughter cells keeping identical levels of Notch activity, suggesting that 
these cells acquire the same fate. However, Notch activation after mitosis was also observed, 
with sibling cells exhibiting distinct Notch signalling profiles, suggesting that activation of 
Notch signalling after mitosis prefigures generation of daughter cells with distinct cell fates. In 
contrast with previous studies, Notch signalling was detected in all cell cycle phases, indicating 
a stochastic activation of Notch in the vertebrate neuroepithelium. These findings reveal novel 
and complex patterns of Notch activation, which provide new insights into the role and 
regulation of Notch signalling during vertebrate neurogenesis.  
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IV.2. INTRODUCTION 
 
The ventricular zone of the neural tube of developing vertebrates consists of a pseudo-
stratified epithelial structure containing neural progenitors. Upon neuronal differentiation, 
cells migrate to a more basal region called the mantle layer. During the cell cycle, the nucleus 
of proliferating neural progenitors shows a characteristic interkinetic nuclear movement, 
being displaced apically when preparing for mitosis and returning basally after cytokinesis. 
(Sauer, 1935; reviewed in Fujita, 2003). Neural progenitors can undergo symmetric cell 
divisions that originate two progenitors (P-P divisions) or two neurons (N-N divisions), or 
asymmetric cell divisions giving rise to one progenitor and one neuron (P-N divisions) 
(reviewed in Gotz and Huttner, 2005). To generate the correct number and types of neurons 
during development, a pool of proliferating progenitors must be maintained throughout 
neurogenesis to sustain a continuous production of new neurons. Therefore, the number of 
each type of division (P-P, P-N and N-N) is likely to be important during neurogenesis. 
Notch signalling is one of the main mechanisms that control the number of progenitors in the 
developing vertebrate neural tissues (reviewed in Louvi and Artavanis-Tsakonas, 2006). Using 
this signalling pathway, newborn neurons signal to neural progenitors and prevent their 
differentiation in a process called lateral inhibition (reviewed in Fischer and Gessler, 2007; 
Kageyama et al., 2008a; Kageyama et al., 2008b). Notch signalling is based on cell-cell 
interactions, as both the ligands (Delta or Serrate) and receptor (Notch) are transmembrane 
proteins, indicating that differentiating cells can only signal to neighbouring cells in the 
neuroepithelium. Upon contact between a membrane-bound ligand of one cell and a 
membrane-bound Notch receptor of a neighbouring cell, the receptor is cleaved by γ-
secretase, releasing the Notch intracellular domain (NICD) from the membrane. NICD then 
translocates to the nucleus where it binds CSL (CBF1, Suppressor of Hairless, Lag-1) and 
Mastermind, forming a ternary complex and turning CSL from a repressor into a 
transcriptional activator (reviewed in Louvi and Artavanis-Tsakonas, 2006). The best 
characterized downstream targets of Notch signalling are the Hes genes (Drosophila Hairy and 
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Enhancer of Split homologues), which encode transcriptional repressors that act as Notch 
effectors to inhibit neuronal differentiation (reviewed in Kageyama et al., 2008a). 
During neurogenesis, neural progenitors will stop dividing and give rise to neurons, a process 
requiring that Notch activity is switched off in these cells. Indeed, forced activation of Notch 
in neural progenitors freezes them in an undifferentiated state, and neurogenesis only 
progresses when these cells are released from Notch activity (Mizutani and Saito, 2005). After 
release from Notch activity, newborn neurons will signal to their neighbours, inhibiting their 
differentiation. However, differentiating cells leave the ventricular zone and migrate towards 
the mantle layer, suggesting that after differentiation of one cell, the levels of Notch activity in 
neural progenitors may be altered, giving them also the opportunity to differentiate. This also 
suggests that after migration of a newborn neuron to the mantle layer and consequent 
reduction of Notch activity in adjacent neural progenitors, these cells are able to respond to 
new signals that activate Notch, implying that Notch signalling is reiterative and that 
signalling events in the Notch pathway are short-lived to allow signal receiving cells to reset 
their potential and to decide again their fate. Indeed, several mechanisms have been described 
to contribute for the termination of Notch activity (reviewed in Fior and Henrique, 2009). 
Besides negative regulation at the level of the Notch receptor, other mechanisms ensure the 
termination of this pathway at the level of its downstream targets: Hes genes encode short-
lived mRNAs and proteins and the HES proteins repress transcription of their own genes in 
negative feedback loops (Davis et al., 2001; Hirata et al., 2002; Bessho et al., 2003; Gajewski et 
al., 2003; Hirata et al., 2004; Giudicelli et al., 2007). 
The activation of Notch signalling and the subsequent termination by intrinsic mechanisms of 
the pathway make it a very dynamic process. Indeed, during the process of somitogenesis, 
cells in the pre-somitic mesoderm (PSM) experience oscillations in Notch activity in a 
synchronized manner, a finding first revealed by the cyclic expression of Hes genes in these 
cells (Palmeirim et al., 1997; reviewed in Kageyama et al., 2007a). These PSM cells are 
therefore subjected to continuous bursts of activation and termination of Notch signalling, a 
process that has been visualized in vivo by time-lapse imaging of a Notch activity reporter in 
the developing PSM (Masamizu et al., 2006). In the developing nervous system, fluctuations of 
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Notch activity have also been observed (Shimojo et al., 2008), revealing the dynamic nature of 
this signalling pathway also in these cells. However, in contrast to cells in the PSM, 
fluctuations of Notch activity in neural progenitors are not synchronized and progenitors 
seem to have different levels of Notch activity, as shown by the differential expression of 
Notch signalling target genes (Shimojo et al., 2008). In that study, although the reporter used 
requires Notch signalling for its expression, the fluctuations observed are also dependent on 
JAK-STAT signalling (Shimojo et al., 2008), suggesting that the reporter might not reflect only 
Notch activity. It therefore remains to be determined whether Notch activity by itself can be 
reiterated in neural progenitors and if intermittent Notch activations are fluctuation of 
oscillation-driven. Surprisingly, fluctuations of Dll1 and Neurog2 expression in 
neuroepithelial cells were also detected, suggesting a dynamic mechanism for the lateral 
inhibition process (Shimojo et al., 2008; reviewed in Kageyama et al., 2008b). 
Even though Notch signalling is required for neural progenitor maintenance, a link between 
Notch activity and symmetric P-P, asymmetric P-N or symmetric N-N divisions has not yet 
been resolved. To correlate levels of Notch activity with cell fate decisions it is necessary to 
monitor activity at different phases of the life of a neural progenitor. 
The different levels of Notch activity can also be observed as an apical-basal gradient of Notch 
activity across the neuroepithelium. In chick, Notch activity has been reported to occur 
mainly near the apical surface where mitosis is taking place, due to Notch1 mRNA instability 
during S-phase when cells are near the basal surface (Murciano et al., 2002; Cisneros et al., 
2008). In agreement, Notch activity has also been detected in the apical region of the zebrafish 
neuroepithelium, mainly starting before cells enter mitosis (Del Bene et al., 2008). Thus, it is 
likely that cells with highest Notch activity are in the G2/M/G1 phases of the cell cycle, when 
the nucleus of the cell is apically localized, suggesting that cell fate decisions, concerning 
whether neural progenitors differentiate or not, occur during this window of the cell cycle. 
Even though Notch signalling is required for neural progenitor maintenance, it is not known 
whether activation of Notch in specific phases of the cell cycle of neural progenitors can 
underlie the cell fate decisions that distinguish P-P, P-N and N-N divisions. It is therefore 
important to correlate Notch activity with cell cycle at the single-cell level. Time-lapse 
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imaging of neural progenitors where Notch signalling is monitored by the use of reporters 
would be best suited to visualize the influence of Notch activity in the generation of similar or 
different fates for sibling cells. 
To visualize the dynamic Notch signalling process at the single-cell level, reporters must have 
features that allow detection of alterations in signalling either during the ascending or 
decreasing phases of the signalling. However, the majority of the existing Notch reporter 
systems, which are GFP-based, provide a long-lived response, because either the protein 
and/or mRNA used as reporter is too stable and perdures in the cells long after Notch 
signalling is extinguished (Zhang and Gridley, 1998; Davis et al., 2001; Kohyama et al., 2005; 
Lamar and Kintner, 2005; Hansson et al., 2006; Nelson et al., 2006; Ohtsuka et al., 2006; 
Souilhol et al., 2006; Basak and Taylor, 2007; Mizutani et al., 2007; Tomishima et al., 2007; Yeo 
et al., 2007; Placantonakis et al., 2009; Imayoshi et al., 2010). An alternative reporter generated 
by Masamizu and colleagues (Masamizu et al., 2006) does have short-lived reporter mRNA 
and protein and is expressed in the nervous system (Shimojo et al., 2008). However, in this 
study, Luciferase was used as a reporter protein, which does not allow single-cell resolution. 
This means that no Notch reporters are available that can accurately monitor dynamic 
changes in Notch activity in the nervous system, with single-cell resolution. 
For the generation of reporters, an appropriate promoter must be selected to drive expression 
of the reporter proteins. Notch reporters have been built using synthetic promoters (minimal 
promoters coupled to tandem repeats of CSL binding sites) (Kohyama et al., 2005; Hansson et 
al., 2006; Souilhol et al., 2006; Mizutani et al., 2007), or using promoters of Notch target genes 
(Zhang and Gridley, 1998; Davis et al., 2001; Kohyama et al., 2005; Lamar and Kintner, 2005; 
Masamizu et al., 2006; Nelson et al., 2006; Ohtsuka et al., 2006; Basak and Taylor, 2007; 
Tomishima et al., 2007; Yeo et al., 2007; Aulehla et al., 2008; Placantonakis et al., 2009; 
Imayoshi et al., 2010). As the synthetic CSL promoter does not reflect all Notch activity in the 
developing embryo (Souilhol et al., 2006), promoters of Notch target genes appear to be better 
choices for drivers of Notch reporters. Among the main Notch target genes, Hes1 
transcription in the neural tube does not overlap with that of Notch1 and seems unaffected by 
inactivation of the Notch pathway in the developing embryo (de la Pompa et al., 1997; Lutolf 
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et al., 2002), being regulated by signalling pathways other than Notch signalling (reviewed in 
Sanalkumar et al., 2010). In contrast, Hes5 transcription is severely reduced in these mutants 
(de la Pompa et al., 1997; Lutolf et al., 2002), suggesting that the Hes5 gene is a bona fide target 
of Notch activity in the developing nervous system. 
In the current work, I have developed a new Notch reporter to monitor Notch signalling in 
the neural tissue of chick embryos. Expression of this novel reporter mimics endogenous 
Notch activity and increases upon ectopic Notch activation, suggesting that it is a good read-
out of Notch signalling. Using this reporter, I monitored Notch signalling in cell lineages of 
the developing chick spinal cord. My data provides new insights into the Notch signalling 
dynamics and into the mechanisms underlying cell fate decisions in neural progenitors. 
 
 
 
  168
Chapter IV – Real-Time Imaging of Notch Signalling Dynamics 
IV.3. RESULTS 
 
One of my aims is the generation of a Notch reporter that allows monitoring of the dynamic 
changes of Notch activity in vivo, through the different phases of the life of a neural 
progenitor, to determine whether: 
- Notch activity can be reiterated in neural progenitors (i.e. a neural progenitor can 
experience more than one Notch activation throughout its life), and if this activity is 
fluctuation or oscillation-driven; 
- Notch activity occurs preferentially in a specific phase of the cell cycle of neural 
progenitors or whether cells can activate Notch independently of the cell cycle phase; 
- Notch activity can be correlated with cell fate decisions. 
To allow detection of dynamic Notch activity, a reporter had been previously generated in the 
laboratory, using an appropriate promoter that responds to Notch signalling linked to a 
cDNA encoding a reporter protein to allow visualization of the promoter’s transcriptional 
activation. This reporter can be electroporated in chick embryos, allowing detection of Notch 
activity in vivo and with single-cell resolution. 
In Section IV.3.1, I describe the general features of this reporter. In the following Sections I 
describe my work to validate and improve the Notch signalling reporter and how I used it to 
accomplish my aims. 
 
IV.3.1. Design of a novel reporter of Notch activity 
 
To design a reporter system that allows monitoring of Notch activity during neurogenesis, an 
appropriate promoter that responds to Notch signalling must be linked to a cDNA encoding a 
reporter protein that allows visualization of the promoter’s transcriptional activation. A good 
candidate promoter is that from the Hes5 gene, which has been shown to be a target and an 
effector of Notch activation in neural progenitors of frog, chick and mouse embryos 
(Wettstein et al., 1997; Deblandre et al., 1999; Ohtsuka et al., 1999; Fior and Henrique, 2005; 
Lamar and Kintner, 2005). Moreover, the promoter of mouse Hes5 has CSL-binding boxes 
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and can be directly activated by Notch signalling (Nishimura et al., 1998). The chicken 
genome contains three Hes5 genes clustered in a 20Kbp region in chromosome 21, all of 
which respond to Notch signalling (Fior and Henrique, 2005). This gene cluster is close to the 
Pank4 gene, which also flanks the single Hes5 gene in the mouse and human genomes. In the 
chick, Hes5-1 is the gene located nearest to Pank4 and has the highest homology to mHes5 
(Fior, 2006), being expressed in all neural progenitors within the neural tube ventricular zone 
(Fior and Henrique, 2005). Moreover, its promoter is highly similar to the mHes5 promoter 
(63.2% over the most proximal 600 nucleotides), containing 5 conserved CSL-binding sites, 4 
of which with an optimal consensus high affinity sequence for CSL. Furthermore, it also 
contains 3 N-boxes (Fior, 2006) that can potentially be used as binding boxes for HES proteins 
to repress cHes5-1 transcription, generating negative feedback loops on its expression. A 2Kbp 
DNA fragment was then chosen from the region immediately upstream of the predicted 
transcription initiation site of Hes5-1 to be used as the promoter in the Notch reporter system. 
To visualize the transcriptional activation of the Hes5-1 promoter, it was linked to a cDNA 
encoding VNP (Nagoshi et al., 2004), a fusion protein containing the fluorescent protein 
Venus (a derivative of EYFP with fast maturation and increased brightness (Nagai et al., 
2002)), a nuclear localization signal (NLS) to facilitate single-cell resolution analysis and, 
finally, a PEST sequence from the mouse ornithine decarboxylase protein that confers fast 
degradation time to the fusion protein (Li et al., 1998). 
The 3’ untranslated region (3’UTR) of the Hes5-1 mRNA was also included in the reporter 
construct, as the presence of this element contributes to post-transcriptional regulation of the 
VNP mRNA and further decreases the time during which the reporter is active (see below). In 
addition, to ensure that a poly(A) tail is present in the mRNA, a SV40 poly(A) signal was 
included downstream of the PHes5-1-VNP-3’UTRHes5-1 cassette. The final reporter construct 
(PHes5-1-VNP-3’UTRHes5-1PolyA) was assembled using pBlueScript II KS as a plasmid backbone 
and will be referred in this thesis as pHes5-VNP (Fig. IV.1A). 
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Figure IV.1: Schematic representation of the various reporters generated. 
(A) pHes5-VNP, Notch reporter. (B) pHes5-UbVNP, Notch reporter with two Ubiquitin moieties. (C) pCAG-
VNP, reporter control. (D) pCAG-VNPΔ3UTR, reporter control without the 3’UTR of Hes5-1. (E) pCAG-
VNPΔ20, reporter control with 20bp missing from the 3’UTR of Hes5-1. (F) pCAG-CherryNLS electroporation 
control. (G) pCAG-CherryGPI electroporation control. (H) pCAG-CherryTub electroporation control. 
 
 
IV.3.2. Generation of electroporation controls 
 
Electroporation of a faithful Notch reporter in the chick embryo should result in its activation 
only in cells with endogenous Notch activity. To identify electroporated cells, a different 
reporter that is constitutively expressed needs to be co-transfected with the Notch reporter 
plasmid. With this purpose, a nuclear monomeric red fluorescent protein expressed under a 
constitutive promoter was engineered. To do this, a DNA fragment encoding the same 
nuclear localization signal (NLS) present in VNP was linked to a cDNA encoding mCherry, a 
red fluorescent protein that has fast folding and high photostability (Shaner et al., 2004). To 
generate a constitutive reporter, this recombinant cDNA fragment was inserted in a plasmid 
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carrying the CAG promoter (Niwa et al., 1991), known to constitutively drive high levels of 
expression in all neuroepithelial cells of the chick embryo (Momose et al., 1999), generating 
pCAG-CherryNLS (Fig. IV.1F). Other electroporation controls that allow visualization of the 
whole perimeter of the cells or their cytoskeleton were also generated. To follow the whole 
perimeter of the cells, a cDNA encoding mCherry was linked to a DNA fragment encoding 
signals for the glycosylphosphatidylinositol (GPI) membrane anchor (Keller et al., 2001), and 
the recombinant DNA was inserted in a plasmid carrying the CAG promoter, generating 
pCAG-CherryGPI, which expresses a constitutively transcribed membrane bound version of 
mCherry (Fig. IV.1G). To visualize the cytoskeleton of the cells and the mitotic apparatus, a 
cDNA encoding mCherry was linked to a cDNA encoding α-tubulin, a critical component of 
microtubules. The recombinant DNA was also placed downstream of the CAG promoter, 
generating pCAG-CherryTub, which expresses a constitutively transcribed microtubule-
bound version of mCherry (Fig. IV.1H). To validate these electroporation controls, each of 
them was co-electroporated with plasmids encoding other nuclear fluorescent proteins in the 
developing spinal cord of chick embryos and their expression was compared (Fig. IV.2). 
After co-electroporation of pCAG-CherryNLS and pCIG (which encodes a nuclear enhanced 
green fluorescent protein (EGFP) driven by the constitutive CAG promoter), CherryNLS and 
EGFP show co-localization in the nucleus, confirming that CherryNLS is also a nuclear 
protein (Fig. IV.2A-C’). In contrast, CherryGPI expressed from pCAG-CherryGPI is absent 
from the nucleus, as shown by the absence of co-localization with EGFP, and delineates the 
contour of the cells (Fig. IV.2D-F’), indicating that CherryGPI labels the cell membrane. 
pCAG-CherryTub expression was next analysed by comparison to the nuclear VNP 
expression. CherryTub expression is detected throughout the cell, except in the nucleus, as no 
co-localization is observed with VNP. Furthermore, CherryTub can be detected in mitotic 
fuses (Fig. IV.2G-I’’), indicating that it is present in microtubules. 
Next, a control for the transcriptional activity of pHes5-VNP was generated. To do this, a 
construct similar to the reporter was generated, in which the Hes5-1 promoter is replaced by 
the CAG promoter. The Hes5-1 Kozak sequence is used by both pCAG-VNP and pHes5-VNP 
to promote translation of VNP. Therefore, the only difference in VNP expression from both 
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reporters is due to transcriptional regulation: the pCAG-VNP being constitutively transcribed 
and the pHes5-VNP being regulated by Notch signalling. This construct (pCAG-VNP-
3’UTRHes5-1-PolyA) will be referred as pCAG-VNP (Fig. IV.1C). 
 
 
 
 
 
Figure IV.2: Validation of the Cherry constructs. 
(A-C’) CherryNLS expressed from pCAG-CherryNLS is present only in the nucleus, as shown by co-expression 
of nuclear GFP expressed from pCIG. (D-F’) CherryGPI expressed from pCAG-CherryGPI is present only in the 
cell membrane, as shown by its specific expression identifying the contour of the cells and its absence from the 
nucleus, labelled with nuclear GFP expressed from pCIG. (G-I’’) CherryTub expressed from pCAG-CherryTub 
is present only in microtubules, as shown by its specific expression throughout the cell, being absent from the 
nucleus (labelled with nuclear VNP expressed from pHes5-VNP) (I’), but being present in mitotic fuses (I’’). 
(C’), (F’) and (I’,I’’) are magnifications of the selected areas in the (C), (F) and (I), respectively. 
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IV.3.3. Expression of VNP mRNA from pHes5-VNP resembles the endogenous cHes5-1 
expression pattern 
 
Previous work in the laboratory demonstrated that the pHes5-VNP reporter responds to 
Notch activity (Fior, 2006). To determine if the 2Kbp fragment of the Hes5-1 promoter drives 
faithful reporter activity, the expression of VNP mRNA driven by the pHes5-VNP or pCAG-
VNP constructs was compared with endogenous Hes5-1 mRNA expression. Two groups of 
embryos were electroporated, one with the pHes5-VNP reporter and another with the pCAG-
VNP control vector, and were harvested 48h later. The presence of VNP mRNA was then 
analysed by in situ hybridization in sections and compared to the pattern of Hes5-1 
transcription, which is confined to progenitors in the ventricular zone of the neural tube (Fior 
and Henrique, 2005). Analysis of electroporated embryos shows that VNP mRNA 
transcription driven by the Hes5-1 promoter is restricted to the ventricular zone (Fig. IV.3A). 
In contrast, VNP mRNA in control embryos electroporated with pCAG-VNP is present not 
only in the ventricular zone but also in the mantle layer (Fig. IV.3D). These experiments show 
that the specific activity of pHes5-VNP in the ventricular zone is due to the activity of the 
Hes5-1 promoter and not due, for instance, to an artefact of the electroporation procedure or 
to post-transcriptional regulation mediated by the Hes5-1 3’UTR. 
These results indicate that VNP mRNA expression driven by the 2Kbp promoter of Hes5-1 
faithfully recapitulates the expression of the endogenous Hes5-1 gene in neural progenitors 
and so may report Notch activity in this context. 
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Figure IV.3: Expression of the pHes5-VNP reporter mimics Hes5-1 endogenous expression. 
(A-I’) Expression of VNP mRNA from pHes5-VNP mimics expression of Hes5-1 mRNA, as VNP mRNA can be 
detected only in the ventricular zone of the spinal cord of E4 embryos (48h after electroporation) (A). In 
contrast, VNP mRNA expressed from pCAG-VNP is present not only in the ventricular zone but also in the 
mantle layer (D), showing that the specific activity of pHes5-VNP in neural progenitors is not an artefact of the 
experiment and indicates that it is a good read-out of Notch activity. Expression of VNP in cells not expressing 
VNP mRNA in embryos electroporated with both constructs shows that VNP protein is retained even if the cell 
is not expressing it anymore, reflecting a perdurance of this protein (A-F’). However, VNP expressed from 
pHes5-VNP in conditions of low levels of transfection is restricted to neural progenitors, as no co-expression 
with the HuC/D neuronal marker can be detected 24h later (E3 embryo) (G-I’). The lumen is identified between 
the two dashed lines. (C’), (F’), (I’) are magnifications of the selected areas in the (C), (F), (I), respectively. 
Arrows in (C’) and (F’) indicate VNP expression in cells expressing VNP mRNA. 
 
 
IV.3.4. Expression of VNP protein from pHes5-VNP is not confined to the ventricular 
zone 
 
Next, the distribution of the VNP reporter protein in electroporated embryos was analysed, to 
determine if it reflects VNP mRNA distribution. Cells expressing the VNP protein driven by 
the CAG promoter (from pCAG-VNP) are found in the ventricular zone and in the mantle 
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layer (Fig. IV.3E), as expected, since the CAG promoter is constitutively active in all cells (Fig. 
IV.3D). By contrast, although the Hes5-1 promoter (from pHes5-VNP) drives expression of 
VNP mRNA only in the ventricular zone (Fig. IV.3A), VNP protein can also be found in the 
mantle layer (Fig. IV.3B). The VNP protein detected in the mantle layer is found in cells that 
probably activated Notch (and Hes5-1 expression), but subsequently underwent neuronal 
differentiation and migrated out of the ventricular zone, degrading VNP mRNA, but not 
being able to degrade VNP protein, suggesting that the VNP protein perdures in the cell. 
To try to circumvent this problem, and decrease the stability of VNP, I generated a cDNA 
encoding a new fluorescent protein in which two ubiquitin moieties that resist cleavage by 
ubiquitin hydrolases (UbG76V; Dantuma et al., 2000) are fused N-terminal to VNP. The cDNA 
encoding this novel fusion protein was used to generate a plasmid similar to pHes5-VNP, 
which also contains the promoter and 3’UTR of Hes5-1, generating pHes5-UbVNP (Fig. 
IV.1B). This predictably more unstable reporter was electroporated into the developing spinal 
cord of chick embryos, which were either harvested 24 or 48 hours later, fixed and sectioned, 
or processed for live-imaging experiments 4h or 12h after electroporation (see below). 
Analysis of fixed tissue reveals almost undetectable levels of expression when this reporter is 
transfected into the chick neural tube (data not shown). This could be due to proteasomal 
degradation of UbVNP before this protein fully maturates, and is in agreement with 
experiments showing that a transgenic mouse constitutively expressing UbGFP in all cells 
only presents fluorescence when the proteasome is inhibited (Lindsten et al., 2003). Live-
imaging experiments (see below) also reveal that neuroepithelial cells electroporated with the 
pHes5-UbVNP reporter show increased cell death upon UbVNP expression, especially during 
mitosis (Fig. IV.4). These are probably cells that receive high amounts of plasmid upon 
electroporation and produce an excess of UbVNP proteins that saturate the proteasome and 
induce cell death. Since UbVNP is so unstable that it is degraded before it fully matures, it is 
of no use for the experiments here described. 
It was then decided to use the original pHes5VNP reporter, but the electroporation procedure 
was modified in order to decrease the amount of VNP present in electroporated cells, so that 
the levels of protein that perdures in neural progenitors become negligible, as discussed below. 
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Figure IV.4: Increased cell death in cells electroporated with pHes5-UbVNP. 
(A-H) Live imaging of cells electroporated with pHes5-UbVNP indicates that these cells are able to activate the 
expression of the reporter, as shown by the activation of expression of VNP (A-C), but undergo apoptosis (G,H), 
especially after entering mitosis (D-F). 
 
 
IV.3.5. Modification of the electroporation conditions to increase the fidelity of the 
pHes5-VNP reporter 
 
A possible reason for the perdurance of VNP in differentiating cells is the saturation of cells 
with the electroporated plasmid, which would drive high levels of VNP in neural progenitors. 
It was therefore hypothesized that by transfecting as fewer reporter plasmids as possible, while 
still allowing observation of VNP expression, the fidelity of the reporter would increase, as 
cells would not be saturated with the electroporated plasmid. This was done by altering the 
transfection conditions, lowering the amount of plasmid, voltage and number of pulses 
applied (see Materials and Methods). 
Under these new electroporation conditions, VNP expressing cells can be detected in sections 
of embryos harvested 24h after electroporation (in E2.5 chick embryos), but not later. 
Immunohistochemistry was performed to label neurons using an antibody against the HuC/D 
early neuronal marker (Marusich et al., 1994). In these embryos, only 0.75% of VNP 
expressing cells are positive for this neuronal marker (n=4086 cells, 143 sections, 4 embryos) 
(Fig. IV.3G-I’). Since VNP mRNA is only observed in neural progenitors, even at more 
efficient transfection conditions (see Materials and Methods, Fig. IV.3A), these results suggest 
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that the 0.75% of VNP expressing cells in the mantle layer probably originate from neural 
progenitors that are electroporated with higher amounts of reporter plasmid, therefore 
expressing more VNP after Notch activation and not being able to completely degrade the 
VNP protein upon neuronal differentiation. Altogether, these results show that, under these 
electroporation conditions, the majority of cells expressing VNP from the Notch reporter 
plasmid are neural progenitors, where Notch signalling is active. 
 
IV.3.6. The presence of the 3’UTR of cHes5-1 diminishes the expression of the reporter 
protein 
 
Several mechanisms might control the duration of Notch activity, including post-
transcriptional regulation of mRNA turnover by elements in the 3’UTR, as shown for instance 
for xHairy2 expression during frog somitogenesis (Davis et al., 2001). To evaluate if the 
3’UTR of the Hes5-1 mRNA could contribute to the post-transcriptional regulation of VNP 
expression, a derivative of the pCAG-VNP vector without the 3’UTR of Hes5-1 was generated 
and named pCAG-VNPΔ3UTR (Fig. IV.1D). In both plasmids, the same constitutive 
promoter drives VNP expression in all electroporated cells. The levels of VNP expression 
elicited by the two vectors in the chick neural tube were then compared. Each vector was co-
electroporated with pCAG-CherryNLS as a control for electroporation efficiency. Embryos 
were collected 24 hours later and both red and yellow fluorescence intensities were analysed, 
in whole embryos and after sectioning. 
The results obtained show a strong decrease of VNP expression in embryos electroporated 
with pCAG-VNP (Fig. IV.5G-L), when compared to embryos electroporated with pCAG-
VNPΔ3UTR (Fig. IV.5A-F). Quantification of fluorescence intensities in neural tube sections 
reveals that embryos electroporated with pCAG-VNPΔ3UTR possess 99.1% more 
fluorescence than pCAG-VNP electroporated embryos (p-value=0.0001, t-test, 32 sections, 
total of 4 embryos in 2 independent experiments) (Fig. IV.5S). These results show that the 
presence of the Hes5-1 3’UTR in the pCAG-VNP vector strongly reduces the levels of reporter 
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activity, most likely by decreasing the half-life of the VNP mRNA or by preventing translation 
of the reporter protein. 
Sequence alignment of the 3’UTRs of mouse Hes5, human Hes5 and chick Hes5-1 shows only 
very few conserved regions (Fig. IV.6), the longest spanning 20bp. This region contains a 
sequence (cTATGATa) that resembles a K-box sequence (consensus sequence cTGTGATa) 
present in Drosophila Enhancer of Split gene transcripts and which has been reported to be a 
binding site for specific microRNAs (Lai et al., 1998; Lai et al., 2005). 
Similar sequences can also be found in the 3’UTR of chick Hes5-2 (cTGTAATa) and Hes5-3 
(cTTTGATa) although the nucleotide environment is different from the one present in chick 
Hes5-1 and mammalian Hes5 (Fig. IV.7). 
To test if the 20bp conserved region is responsible for the post-transcriptional regulatory 
activity of the Hes5-1 3’UTR, it was deleted from pCAG-VNP and the levels of VNP 
expression elicited by this construct (pCAG-VNPΔ20 (Fig. IV.1E)) were compared to those of 
pCAG-VNP and pCAG-VNPΔ3UTR in electroporated embryos. The pCAG-CherryNLS 
vector was again used as a control for electroporation efficiency and embryos were harvested 
24h after electroporation (Fig. IV.5M-R). Fluorescence intensities were quantified in cryostat 
sections and comparison between the groups of embryos electroporated with either pCAG-
VNPΔ20 or pCAG-VNP reveals that removal of the 20bp sequence from the Hes5-1 3’UTR 
leads to an 8x increase in fluorescence levels (p-value=0.0016, t-test, 32 sections, total of 4 
embryos in 2 independent experiments) (Fig. IV.5S). This implies that the 20bp conserved 
sequence has a significant contribution to the activity of the Hes5-1 3’UTR in the post-
transcriptional regulation of linked mRNAs, although other regulatory elements must be 
present in the Hes5-1 3’UTR and contribute to the same end. Two AUUUA pentamers (Class 
I AU-rich element - ARE) can be found in the 3'UTR of chick Hes5-1, which might account 
for a decreased expression of proteins encoded in linked mRNAs (Fig. IV.6). However, no 
Class I AREs can be found in the 3'UTR of mouse Hes5, indicating that this possible 
mechanism of Hes5 mRNA post-transcriptional regulation is not conserved in Hes5 genes. 
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Finally, these results reveal also that inclusion of the Hes5-1 3’UTR in the Notch reporter 
plasmid is crucial to provide a more faithful read-out of the dynamic nature of Notch 
signalling. 
 
 
 
Figure IV.5: Effect of Hes5-1 3’UTR on the expression of the VNP reporter protein. 
(A-R) VNP and CherryNLS expression in embryos co-electroporated with either pCAG-VNPΔ3UTR and 
pCAG-CherryNLS (A-F), pCAG-VNP and pCAG-CherryNLS (G-L), or pCAG-VNPΔ3UTR20 and pCAG-
CherryNLS (M-R), showing that the presence of the 3’UTR of Hes5-1 diminishes the expression of VNP and that 
the conserved 20bp region in the 3’UTRs of Hes5 genes largely contributes to this effect. (B,C), (H,I), (N,O) are 
magnifications of the selected areas in the whole-mount brightfield images (A), (G) and (M), respectively. (D-F), 
(J-L), (P-R) show the corresponding VNP and CherryNLS expression in sections. DAPI (blue) was used for 
nuclear counterstaining in (D), (J) and (P). (S) Chart showing the percentage of VNP expression from the 
different reporter constructs relative to pCAG-VNPΔ3UTR. Statistical analysis was done using t-test; *p-
value<0.002; **p-value<0.0002. 
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mHes53UTR      1 ~~~~~~~~~~~~~~~~CC..CAGCGG..CCGACCGGTGC........CTGGAG.CG..GA 
hHes53UTR      1 ~~~~~~~~~~~~~~~~CC..CGGCGGGACCTGCGGGCGC........GCGGCC.CGACGA 
cHes5-13UTR    1 GCCAAGAGCACGCTCACCATCACCTGGAC..ACTGGTGCACATTCCAGAGGAGACTACGA 
 
mHes53UTR     30 C......CAGAGGATGAGCTCGTTCCTCT.GGATGT.GGGAAG.ACATTCCCCAGCCGCA 
hHes53UTR     34 C......CAGAGGGCGAGCCTGCTCCTCTCGCCTGTAGGGAAGCGCCTTCCC..GCCGTC 
cHes5-13UTR   59 CTTGCTACAGAAG.TCCCCCTACTCCTCTCACCAGTAGGAAAAAATGTTTTCCTTCTGCA 
 
mHes53UTR     81 GTTCAGCCCCAGG.TTGGCCGC.....TACCTTCTTCC.GAAG.........GCTCCCTC 
hHes53UTR     86 G.TCCGCCCCGGGCTTGGACGC.....GCCCTTCTCCG.GAAG.........GCTCTGGC 
cHes5-13UTR  118 GAGCATTACTGCGTGTGGATGCCTGCTTCCCTTCTTCCAGAAGGACCGAAATGTTCCCAC 
 
mHes53UTR    125 C..............TCCGGCTG.......GCTGG..........CCAGC.AGGAGG... 
hHes53UTR    130 C..............CCAAGCTG.......GCCGG..........CCCGC.AGGAGC... 
cHes5-13UTR  178 CATGTGGAGAGAAAGTTATTCTGAAGGAATGCAGGACGTAACCCTCCTGCTAGGAGGACC 
 
mHes53UTR    150 ..GTCATTCTTAGA........GAATGT...........GTG....TGCA.GAGT...T. 
hHes53UTR    155 ..CCCATTCTCAGA........GAATGT...........GTG....TGCA.GAGTCCCT. 
cHes5-13UTR  238 GAGTCGTTCAGAGAGGAACGCCGACTGTTCTTAACCTTAGTGAGGTTGCACGGGTACATC 
 
mHes53UTR    180 ..........GTCATTT....GGGGATAATCAGGGCCCACCCTCTGCCGCCCGTCCG... 
hHes53UTR    188 ..........GCCGTTT....TAGGACAATCAGGGCCCATCTTCTGCCAAGTGTCTG... 
cHes5-13UTR  298 TGTTAAGAAAGCTATATCCGCTGAGATGTTCAGG..TCAGCGT.TTTCAGGTGTCCGCTC 
 
mHes53UTR    223 .........ACCCCGTG......GGGTTGTTTTG...........TGTTTGCATTTCAGC 
hHes53UTR    231 .........ACCCCATG......GGGTTGTTCTG...........TGTTTGCATTTAAGC 
cHes5-13UTR  355 AGCAGCAGCCCCCCCTGCCTCCTGCCCTGCTCGGGGCCCCCACACCGCCTGCACCTGAGC 
 
mHes53UTR    257 AAGTGACT.........TCTGCG..AAGTTC...CTGGTCACCACCGGG.........GG 
hHes53UTR    265 AAGTGACT.........TCTGGG..AAGTCC...CCGG...CCGCCCGG.........GG 
cHes5-13UTR  415 CACAGGCTGCAGCTGGGGCTGGGCTAAGCGCACACACGTGAAAACCTGGCTGCCAGCAGG 
 
mHes53UTR    294 TTCTATGATATTTGTAGA..GT.CGGGGGTTG...........GC.......TCACCCCA 
hHes53UTR    299 TTCTATGATATTTGTAG..TGC.CGGGGCTCGC.....ACACTGC.......TGCCCCCA 
cHes5-13UTR  475 TTCTATGATATTTGTAGACTGTACTGAGCATGCTCCAGAAATGGCTAAACCATAACTCAA 
 
mHes53UTR    333 GC.CCGTAGAGGACTTTCTTCAGGGCCCGTTGCTGCTGGGCAAGCACCCTGCAG...GCG 
hHes53UTR    344 GC.CTGTAGAGGACTTTCTTCAGGGCCCGTAGCTGCTGGGCGTACCCCTGGCAG...GCG 
cHes5-13UTR  535 GCTGTGTAGAGGAAATTCCTCGGGATGTCTTGCT....CGCAAA.....GTCAGAGTGCT 
 
mHes53UTR    389 GGCTGTGCCCT...GGGCACATTTGCCTTTTGTGAAGGC.GGAACTGCAGGT.GTTTCCT 
hHes53UTR    400 GGCTGTGCCGC...GGGCACATTTGCCTTTTGTGAAGGC.CGAACTCGAGCT.GTATCCT 
cHes5-13UTR  586 GTTTGTGAGGTTCAGGATATGTATGCCTTTTATAAAGGCAAGAGCTCCTTCTAATATCCT 
 
mHes53UTR    444 CATAGGAA..AGCACTCAGCCTGCGTGGGCG....T..AGGGCCCAT...GGGGCC.TCA 
hHes53UTR    455 CATAGGAAACAGTGATCACCCCGGACGGGCG....TCCAGGACCCTG...AGGGCCATGG 
cHes5-13UTR  646 TATAGGAATGAAAGTTACGGCTGTGTTGTCGATTTTACATGAAATATTTATCAGTCTTTT 
 
mHes53UTR    492 CCTCAAGG......TCCACA.TGGCCTTGGCTGTCTGATGCGCGCTCACAGTGGGCTGTC 
hHes53UTR    508 CCAAAAGGC.....TCCTGAGTGTGCCTGGTGGTCTGGCTGGGGCTCACGGTGGGCTGTC 
cHes5-13UTR  706 ATGAAAGGCAGTTGTACAAATTATATTT.....ACTGATTGGTACCCCCAGAG....... 
 
mHes53UTR    545 T.GGGAGGGTGGG.GTCTCCA..CGATG..ATCCTTAAAGGATTCCTTTGTATGGGTGGG 
hHes53UTR    563 TGGGGAGGGTGGGTGCCTCCA..CTATG..ATCCTTAAAGGATTCCTCTGTGTGGGTGGA 
cHes5-13UTR  754 ..GGGAGAATG......TCAAATCAGTGCTGTCCTTGGAGGAT...GTTATGATGTTACG 
 
mHes53UTR    599 TGCATGTGGGCACGATT.......TTGTACTTAGAAT.....TTGAACTCTTGGTCATGT 
hHes53UTR    619 TGCGTGTGGGCACGACT.......TTGTACTCAGAAA.....TTGAACTCTCAGTCACGT 
cHes5-13UTR  803 TGCGAG.CTGCACCATTGCATAACTTGT.GTGAGAAACCATCCTGAA......TTCAGGG 
 
mHes53UTR    647 GGGAGAACACAGG.CTGTTC..TGAAGGCTTC.TAATA.AAATATCA......AGCCCTC 
hHes53UTR    667 GGAAG.CCACGGGACTGCTC..CGAAGCCGCCATAATA.AAATCTGATTGTTCAGCCCCC 
cHes5-13UTR  855 GGTTG..CACAAAACT.TTCATCAAAG....CAAAAAACAAATAAAATTG...AG~~~~~ 
 
Figure IV.6: Comparison of Hes5 3’UTR sequences. 
Comparison of 3’UTR sequences from chick Hes5-1, mouse Hes5 and human Hes5 genes. Grey and black shaded 
areas indicate regions of homology. The 20bp homology region deleted to generate pCAG-VNPΔ3UTR20 is 
shaded in red. Putative Class I ARE’s are shaded in green. c: chick; m: mouse; h: human. 
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cHes5-13UTR: AACCTGGCTGCCAGCAGGTTCTATGATATTTGTAGACTGTACTGAGCA 
cHes5-23UTR: GCCTTTTGTAAAGGAAATACCTGTAATATATCTTGGGTGAGGGTGGGG 
cHes5-33UTR: ATTTTTCTTCTCTGACAGTCCTTTGATAGTACATGAAGTGTGACGGAT 
 
Figure IV.7: Comparison of the nucleotide environment of sequences similar to K-boxes in the 3’UTR of 
chick Hes5 genes. 
Analysis of the 3’UTR sequences of the three chick Hes5 genes identified regions containing sequences similar to 
K-box in each one of the genes, although the nucleotides surrounding these sequences are not conserved. Only 
part of the 3’UTR of each of the three genes is shown. Sequences similar to K-boxes are depicted in yellow. 
 
 
IV.3.7. cHes5-1 and cDelta1 can be expressed in mitosis and in S-phase 
 
Since one of the aims of this thesis is to monitor Notch activity during the cell cycle of neural 
progenitors, the expression of the Notch target cHes5-1 in the chick neuroepithelium in cells 
undergoing S-phase or mitosis was investigated. For this, in situ hybridization for cHes5-1 was 
performed in sections of E3 embryos which had previously received a 30 minutes pulse of 
BrdU to identify cells in S-phase. Embryonic sections were analysed after performing 
immunohistochemistry for BrdU and labelling all nuclei by DAPI counterstaining, which 
reveals mitotic figures. It was found that cHes5-1 is expressed both in mitotic cells and in cells 
that incorporate BrdU (in S-phase) (Fig. IV.8A-F’), suggesting that Notch activity can occur in 
these different phases of the cell cycle. 
It was also investigated whether signalling cells expressing high levels of the cDelta1 ligand, 
which are cells committed to neuronal differentiation (Henrique et al., 1995), can also be in 
different phases of the cell cycle. It was found that cDelta1 can also be expressed in mitotic 
cells and in cells in S-phase (Fig. IV.8G-L’), suggesting that signalling can occur from cells in 
different phases of the cell cycle. Furthermore, this also suggests that commitment of neural 
progenitors to neuronal differentiation can occur before the final mitosis. 
 
 
 
 
  182
Chapter IV – Real-Time Imaging of Notch Signalling Dynamics 
 
 
Figure IV.8: Cells in mitosis and in S-phase can express cHes5-1 or cDelta1. 
(A-C’) cHes5-1 is expressed during mitosis as shown by the presence of its mRNA (green) in mitotic figures 
identified by DAPI counterstaining (blue) in the spinal cord of E3 embryos. (D-F’) cHes5-1 is expressed in cells 
in S-phase as shown by the presence of its mRNA (green) in cells that incorporate BrdU (red, 30 minutes pulse) 
in the spinal cord of E3 embryos. (G-I’’) cDelta1 is expressed during mitosis as shown by the presence of its 
mRNA (green) in mitotic figures identified by DAPI counterstaining (blue) in the spinal cord of E3 embryos. (J-
L’) cDelta1 is expressed in cells in S-phase as shown by the presence of its mRNA (red) in cells that incorporate 
BrdU (green, 30 minutes pulse) in the spinal cord of E3 embryos. (C’), (F’), (I’), (L’) are magnifications of the 
selected areas in (C), (F), (I), (L), respectively. Arrows in (C’) and (I’) indicate mitotic events where cHes5-1 or 
cDelta1 are expressed, respectively. (i’) and (i’’) correspond to the mitotic figures indicated by arrows in (I’). 
Arrows in (F’) and (L’) indicate cells in S-phase that express cHes5-1 or cDelta1, respectively. 
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IV.3.8. Live imaging of PHes5VNP3UTR reveals distinct behaviours in Notch activity in 
sibling cells 
 
The experiments described above establish the Hes5-1 promoter as a good read-out of Notch 
signalling activity and the fluorescent VNP protein as a suitable reporter of promoter 
activation. This reporter system was then used to monitor Notch activity in live embryonic 
neural progenitors in a wide-field microscope, using cultured slices of electroporated embryos 
in conditions where progenitors continue to proliferate for up to 48 hours, show clear 
interkinetic nuclear movement, and are also able to give rise to differentiated progeny 
(Wilcock et al., 2007). 
First, it was tested which of the three Cherry constructs (pCAG-CherryNLS, pCAG-
CherryGPI and pCAG-CherryTub) allowed the easiest tracking of electroporated cells. It was 
found that although GPI and α-tubulin fusions to mCherry allowed the delineation of the cell 
borders, and α-tubulin also allowed the identification of mitotic fuses, the nuclear CherryNLS 
provided the easiest tracking of individual cells in the meshwork of electroporated 
neuroepithelial cells. Furthermore, only CherryNLS allows quantification of fluorescence 
intensities in the nucleus, being possible to compare the CherryNLS expression to the 
expression of the pHes5-VNP reporter and the pCAG-VNP control. Embryos were then co-
transfected with the pHes5-VNP and pCAG-CherryNLS plasmids, so that electroporated cells 
could be permanently traced by their red fluorescence, while VNP expression would reflect 
the dynamic alterations in Notch signalling activity. In separate control experiments, another 
group of embryos was co-electroporated with pCAG-VNP and pCAG-CherryNLS plasmids. 
In this case, both VNP and CherryNLS expression are driven by the same constitutive 
promoter. Co-transfections were performed under electroporation conditions that don’t 
saturate the cells with reporter plasmids (see Materials and Methods). 
After electroporation, embryo slices from both groups of embryos were prepared and cultured 
together in the same Petri dish. Fluorescent images were taken at 10 minute intervals, using a 
DeltaVision Spectris microscope workstation (Applied Precision) as described elsewhere 
(Wilcock et al., 2007). This highly sensitive wide-field microscope is able to detect low levels 
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of fluorescence upon low levels of light incidence from a mercury arc lamp. Therefore, cells 
are able to survive for prolonged periods of time during the imaging procedure. Slices were 
incubated for up to 48 hours and imaging started at either 4 or 12 hours after electroporation. 
Raw imaging data was deconvolved and individual cells were manually identified in 
maximum intensity projections. Cells that expressed VNP and that divided during the 
imaging period were selected for further analysis in non-projected deconvolved data. These 
cells were manually tracked by identifying the Z plane with the highest fluorescence intensity 
at each time point. A circle of defined size was then delineated in each nucleus in the chosen Z 
plane, and the levels of red and yellow fluorescence were quantified by measuring the mean 
fluorescent intensities in the outlined nucleus area of the selected frames. This process was 
repeated for each time frame and the levels of CherryNLS and VNP expression were plotted 
against time, covering at least one mitotic event, thereby allowing the definition of cell 
lineages with different VNP expression patterns. 
Analysis of CherryNLS levels in cell lineages reveals that expression of this protein increases in 
all transfected cells in the first hours after electroporation (Fig. IV.9 and Movie IV.1), 
reflecting the fact that CherryNLS is constitutively expressed. However, CherryNLS 
expression levels stabilize over time, probably as a result of plasmid dilution/loss together with 
the perdurance of CherryNLS, a stable protein with high photostability (Shaner et al., 2004). 
Analysis of VNP expression in control cell lineages (driven by the constitutive CAG 
promoter) shows also an initial increase of VNP levels after electroporation but, in all 
analysed cases, expression disappears with time, in contrast with the behaviour of CherryNLS 
(Fig. IV.9 and Movie IV.1). Since both reporters are driven by the same constitutive promoter, 
this decrease in VNP expression must be due to plasmid dilution/loss from electroporated 
cells and subsequent degradation of the remaining unstable VNP mRNA and VNP protein, 
while the more stable CherryNLS perdures despite the absence of expressing plasmid. This 
finding suggests that plasmid loss is a common event after electroporation of chick embryos 
(as also reported by Daudet and Lewis (2005)) and implies that any observed decrease in VNP 
reporter expression using the chick electroporation assay cannot be correlated with regulatory 
events that cease promoter activity. 
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The analysis was thus concentrated on lineages where the onset of VNP reporter activity can 
be clearly detected in electroporated cells. This was never observed in cells where VNP is 
driven by the CAG constitutive promoter, since in these cells VNP is already expressed from 
the beginning of imaging. In contrast, the onset of VNP reporter activity could be detected in 
numerous cells electroporated with the Notch reporter pHes5-VNP, implying that this de 
novo expression of VNP reflects a true event of Notch activation. 
From 12 independent experiments, with a total of 36 electroporated embryos, 704 VNP 
expressing cells could be identified, of which 175 lineages could be extracted. From these, 33 
lineages could be defined, where the onset of VNP expression could be traced. These 33 
lineages were classified in two groups: one group where Notch activation occurs before 
mitosis and another group where this event occurs only after cell division takes place. It 
should be noted that in the case where VNP expression occurred between two identified cell 
divisions, the same lineage was counted twice. 
In the first group, the onset of Notch activity can be observed in a wide range of times before 
mitosis (from 27h to 1h, 25 cells, Fig. IV.10,13 and Movie IV.2). In the majority of these cells 
(22/25), the VNP reporter is still detected in daughter cells after cytokinesis, suggesting that 
the two daughter cells are still under the influence of Notch activity (Fig. IV.10 and Movie 
IV.2). 
In the second group of lineages, where the onset of VNP expression occurs after mitosis, 
Notch activation occurs in only one of the two siblings and this event may happen in a wide 
range of times after cytokinesis (from 4h to 12h, 11 cells, Fig. IV.11,13 and Movie IV.3). 
In only one cell lineage, Notch activation can be detected in the two daughter cells, but with 
different onset times, one cell activating Notch 6h after mitosis and the other 11h later (Fig. 
IV.12,13 and Movie IV.4). These results suggest that progenitors where Notch is inactive prior 
and during mitosis might give rise to daughter cells with different abilities to activate Notch 
signalling. 
Altogether, lineage analysis of cells where the onset of Notch activity could be monitored 
shows that signalling can be triggered at different phases of the cell cycle, as Notch activations 
can be detected before and after mitosis in a wide range of times, indicating a stochastic 
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activation of Notch in the vertebrate neuroepithelium. When Notch activity occurs before cell 
division, the two daughter cells maintain similar levels of Notch activity and will probably 
follow similar fates. In contrast, when Notch activity is absent prior and during mitosis, the 
two daughters may activate Notch differently and this might result in the acquisition of 
different fates. Although not analysed, it is possible that neural progenitors devoid of Notch 
activity prior to mitosis may also generate siblings that do not activate Notch, thus acquiring 
similar fates. 
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Figure IV.9: Differential protein stability is evident on comparison of VNP and CherryNLS expression. 
(A) Neural tube of embryos transfected with pCAG-VNP and pCAG-CherryNLS and imaged in a wide-field 
microscope shows an increase in VNP expression soon after transfection and a subsequent loss of fluorescence 
intensity indicative of plasmid loss. In contrast, CherryNLS expression increases soon after transfection, but 
following plasmid loss this fluorescent protein persists over VNP, due to the absence of destabilisation signals in 
the pCAG-CherryNLS vector. Images presented are from maximum intensity projections. (B) Chart showing the 
fluorescence intensities of a typical cell lineage in embryos electroporated with pCAG-VNP and pCAG-
CherryNLS. 
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Figure IV.10: Behaviour of cells with Notch reporter activity prior to mitosis. 
(A) Neural tube of transfected embryos with pHes5-VNP and pCAG-CherryNLS and imaged in a wide-field 
microscope shows Notch activity starting before mitosis, with the two daughter cells being born in the presence 
of Notch signalling. Images presented are from maximum intensity projections. (B) Chart showing the 
fluorescence intensities of a cell lineage of embryos electroporated with pHes5-VNP and pCAG-CherryNLS, 
where Notch activation occurs before mitosis. 
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Figure IV.11: Notch activation after mitosis in only one daughter cell. 
(A) Neural tube of transfected embryos with pHes5-VNP and pCAG-CherryNLS and imaged in a wide-field 
microscope shows Notch activity starting after mitosis in only one of the two daughter cells. Images presented 
are from maximum intensity projections. (B) Chart showing the fluorescence intensities of a cell lineage of 
embryos electroporated with pHes5-VNP and pCAG-CherryNLS, where Notch activity occurs after mitosis in 
only one daughter cell. 
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Figure IV.12: Notch activation after mitosis at different times in daughter cells. 
(A) Neural tube of transfected embryos with pHes5-VNP and pCAG-CherryNLS and imaged in a wide-field 
microscope shows Notch activity starting after mitosis in both daughter cells. Images presented are from 
maximum intensity projections. (B) Chart showing the fluorescence intensities of a cell lineage of embryos 
electroporated with pHes5-VNP and pCAG-CherryNLS, where Notch activity occurs after mitosis in the two 
daughter cells. 
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Figure IV.13: Different timings of Notch activations between cell lineages of embryos electroporated with 
pHes5-VNP and pCAG-CherryNLS. 
Chart showing the distribution of timings of Notch activations between different cell lineages, revealing a wide-
range of times for Notch activation during the cell cycle: 27h to 1h before mitosis (25 cells), 4h to 12h after 
mitosis in only one daughter cell (11 cells), and 4h and 12h after mitosis in the two daughter cells (2 cells, 1 
lineage). Note that the sum of the number of cells is larger than the number of cell lineages (33) analysed here. 
This is due to counting the same lineage twice when VNP expression was followed in two consecutive cell 
divisions. 
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Movie IV.1: Differential protein stability is evident on comparison of VNP and CherryNLS expression. 
Neural tube of transfected embryos with pCAG-VNP and pCAG-CherryNLS and imaged in a wide-field 
microscope shows an increase in VNP expression soon after transfection and a subsequent loss of fluorescence 
intensity due to plasmid loss. In contrast, CherryNLS expression increases soon after transfection, but following 
plasmid loss this fluorescent protein persists over VNP, due to the absence of destabilisation signals in the 
pCAG-CherryNLS vector. Images presented are from maximum intensity projections. Blue dots identify the 
analysed cell lineage. 
 
 
Movie IV.2: Behaviour of cells with Notch reporter activity prior to mitosis. 
Neural tube of transfected embryos with pHes5-VNP and pCAG-CherryNLS and imaged in a wide-field 
microscope shows Notch activity starting before mitosis, with the two daughter cells being born in the presence 
of Notch signalling. Images presented are from maximum intensity projections. Blue dots identify the analysed 
cell lineage. 
 
 
Movie IV.3: Notch activation after mitosis in only one daughter cell. 
Neural tube of transfected embryos with pHes5-VNP and pCAG-CherryNLS and imaged in a wide-field 
microscope shows Notch activity starting after mitosis in only one of the two daughter cells. Images presented 
are from maximum intensity projections. Blue dots identify the analysed cell lineage. 
 
 
Movie IV.4: Notch activation after mitosis at different times in daughter cells. 
Neural tube of transfected embryos with pHes5-VNP and pCAG-CherryNLS and imaged in a wide-field 
microscope shows Notch activity starting after mitosis in both daughter cells. Images presented are from 
maximum intensity projections. Blue dots identify the analysed cell lineage. 
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IV.4. DISCUSSION 
 
Although several Notch signalling reporters have been described, none fulfils all the 
requirements for a faithful reporter of Notch activity in the developing nervous system: 
specific expression in neural progenitors, fast kinetics of response to Notch signalling and 
single-cell resolution in live-imaging experiments. In this Chapter, I describe the initial 
development and validation of a Notch signalling reporter that fulfils these requirements. This 
reporter responds accurately to ectopic Notch signalling and my work shows that it provides a 
faithful read-out of Notch activity in embryonic neural progenitors, mimicking the expression 
of the Notch target gene Hes5-1. I used this reporter to monitor dynamic alterations in Notch 
activity during the cell cycle of neural progenitors and show that the pathway can be activated 
at different phases of the cycle. My results suggest that activation of Notch before mitosis 
correlates with symmetric divisions, while absence of Notch activity prior and during mitosis 
might produce sibling cells with different behaviours. 
 
IV.4.1. pHes5-VNP reporter as a read-out of Notch activity 
 
The Notch reporter system used in my work employs the fluorescent protein Venus as a 
reporter, containing an additional nuclear localization signal to allow single-cell resolution 
and quantification of fluorescence intensities, and a PEST domain to confer a short half-life to 
the fusion protein. The 3’UTR of Hes5-1 is also present in the final transcript encoding VNP 
and I showed that it contributes to the correct post-transcriptional regulation of the reporter. 
To drive expression of the reporter protein, the promoter of Hes5-1 was used and its 
behaviour in the chick embryo was assessed by in ovo electroporation. Analysis of neural tubes 
electroporated with pHes5-VNP revealed that VNP expression occurs specifically in neural 
progenitors at the ventricular zone. This expression was previously shown in the laboratory to 
be induced by ectopic Notch activation, thereby confirming that the pHes5-VNP reporter 
provides an accurate read-out of Notch signalling. Moreover, only 0.75% of VNP-expressing 
cells show co-expression of the early neuronal marker HuC/D (Marusich et al., 1994), 
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implying that VNP does not perdure in neural progenitors when these cells commit to 
differentiation. Together, these experiments indicate that the pHes5-VNP reporter is adequate 
to monitor Notch signalling activity during embryonic neurogenesis. 
 
IV.4.2. Post-transcriptional regulation by the 3’UTR of cHes5-1 
 
Post-transcriptional regulation of mRNA turnover might be an important component of the 
regulatory mechanisms underlying the oscillatory behaviour of Notch signalling during 
somitogenesis. Indeed, the time-delay model proposed by Julian Lewis for the sustained 
oscillations in Notch activity predicts a short existence for both the HES effector proteins and 
their mRNAs, so that the duration of a Notch response is shorter than the time it takes to 
transcribe Hes genes and translate their mRNAs (Lewis, 2003). Although the importance of 
HES protein half-life has been already confirmed experimentally (Hirata et al., 2004), the role 
of mRNA stability remains to be addressed. The only published data concerned the expression 
of xHairy2 mRNA, whose 3’UTR was shown to modulate the expression of this gene during 
frog somitogenesis (Davis et al., 2001) 
In this thesis, I have also investigated whether the 3’UTR of Hes5-1 regulates the expression of 
this gene during neurogenesis. My results show that the presence of the Hes5-1 3’UTR in the 
final mRNA encoding VNP reduces the levels of this protein that accumulate in the cell, 
indicating that the 3’UTR contains signals that limit the mRNA‘s half-life or that restricts its 
translation. Furthermore, I identified a highly conserved region present in the 3’UTRs of Hes5 
genes that contributes to the observed reduction in VNP expression, although other regions of 
the 3’UTR must also be involved in this process, as the 3’UTR without this highly conserved 
region still confers a short half-life to mRNAs, albeit reduced. I thus propose that the 3’UTR 
of Hes5-1 is implicated in the post-transcriptional regulation of its mRNA, and this sequence 
was therefore included in the pHes5-VNP Notch reporter to allow it to better reflect Notch 
activity. 
I should note that various Notch reporters based on the mouse Hes5 promoter and using 
destabilized versions of GFP have been described, but that do not mimic exactly the pattern of 
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Hes5 expression in neural progenitors (see, for instance, Ohtsuka et al., 2006). One of the 
reasons might be the absence of the Hes5 3’UTR in these reporters, which might be a target for 
tissue-specific miRNAs. 
 
IV.4.3. Live imaging of pHes5-VNP provides new insights into the mechanisms underlying 
cell fate decisions in neural progenitors 
 
The pHes5-VNP reporter was used to monitor Notch signalling during neurogenesis, after 
electroporation of the corresponding DNA vectors into the chick neural tube. However, 
control experiments using a constitutive CAG promoter to drive expression of VNP and 
CherryNLS revealed that VNP is present in electroporated cells for a shorter period of time 
than the more stable CherryNLS, even though pCAG-CherryNLS was electroporated at a 10x 
lower concentration than pCAG-VNP. Since both reporters are driven by the same 
constitutive promoter, the observed decrease in VNP expression must be due to plasmid 
loss/dilution from electroporated cells and subsequent degradation of the remaining VNP 
mRNA and VNP protein, while the more stable CherryNLS lasts longer, despite the absence of 
expressing plasmid. This finding of plasmid loss following electroporation poses a limitation 
to the assay to monitor Notch activity using the pHES5-VNP reporter, as any observation of a 
decreasing VNP expression in electroporated cells does not necessarily correspond to loss of 
Notch activity, but could rather reveal loss of the transfected plasmids. Nonetheless, a de novo 
increase in VNP expression in cells electroporated with the pHes5-VNP reporter should 
correspond to a true de novo activation of Notch signalling, as this was never observed in 
control cells electroporated with pCAG-VNP, making pHes5-VNP a useful tool to detect 
events of Notch activation in neural progenitors. 
 
IV.4.3.1. Visualization of Notch activity fluctuations in neural progenitors 
 
Intermittent fluctuations in mouse Hes1 expression in neural progenitors of the developing 
mouse brain have been recently described, using a reporter consisting of the Hes1 promoter to 
  196
Chapter IV – Real-Time Imaging of Notch Signalling Dynamics 
drive expression of an unstable Luciferase reporter (Shimojo et al., 2008). It was previously 
suggested that chick Hes5-1 expression could experience similar dynamic variations in neural 
progenitors (Fior and Henrique, 2005). However, in my experiments using the pHes5-VNP 
reporter, I could not observe any intermittent behaviour in the activity of the reporter, and 
several hypotheses can be advanced to explain this: 
- The reporter VNP might still be too stable to correctly report Notch activity dynamics. 
This seems unlikely, as a similar Venus-PEST reporter was used successfully to 
visualize Notch oscillations in the mouse PSM, driven by a PSM-specific LFng 
promoter (Aulehla et al., 2008). These oscillations have a period of 2 hours, similar to 
the 2-3 hours reported for Hes1 fluctuations (Shimojo et al., 2008), so it is expectable 
that VNP should be able to report Notch signalling fluctuations in neural progenitors. 
- Electroporation of the reporter plasmid could lead to saturating levels of VNP 
expression, hindering the ability of progenitors to degrade VNP fast enough to allow 
visualization of the decreasing phase of the fluctuations. 
- Loss of the reporter plasmid occurs too fast in electroporated cells, leading to high 
variations in plasmid copy number in each progenitor, concealing any intermittent 
behaviour in the expression of the pHes5-VNP reporter. 
It is likely that the fast maturation and degradation of the ubiquitinated Luciferase reporter 
(Masamizu et al., 2006) makes this protein a more suitable reporter to monitor dynamic 
alterations in transcription, driven by the Hes promoters in electroporation assays. However, 
Luciferase visualization does not allow single-cell resolution and a fluorescent reporter is 
preferable. But for this, the VNP reporter must be stably maintained in neural progenitors and 
in low copy number, requiring the generation of transgenic animals or cell lines with the 
reporter plasmid stably integrated into the genome, in single copy, to avoid loss of the 
reporter and saturation of cells with VNP. Only then it will be possible to determine whether 
Hes5-1 expression shows an intermittent behaviour in neural progenitors. 
Neural progenitors are only maintained in the undifferentiated state if they activate Notch (de 
la Pompa et al., 1997; Henrique et al., 1997a; Lutolf et al., 2002). This implies that a neural 
progenitor devoid of Notch activity in any given moment has necessarily activated Notch in a 
  197
Chapter IV – Real-Time Imaging of Notch Signalling Dynamics 
previous phase of its life. The observation of de novo VNP expression in cells devoid of Notch 
activity thus suggests that these cells can activate Notch signalling more than once during 
their lives. 
 
IV.4.3.2. Stochastic Notch activity during the cell cycle of neural progenitors 
 
Although the pHes5-VNP reporter does not provide a reliable monitoring of the termination 
phase of Notch activity, I was able to observe the onset of Notch activity in cells using the live-
imaging assay. More importantly, I could accurately determine the precise timing of Notch 
activation. 
Since different amounts of plasmids may be carried in each electroporated cell, precluding a 
real comparison between levels of Notch activity in different cells, I did not compare levels of 
VNP expression between them. Instead, I have followed VNP expression in individual cell 
lineages in live-imaging experiments. 
I have focused on the analysis of Notch activation timings in cell lineages, using mitosis as a 
time reference. I have observed Notch activations occurring between 1h to 27h before cell 
division or 4h to 12h after cell division, suggesting that Notch signalling can be activated at 
different phases of the cell cycle and in a wide range of times. These results are in agreement 
with what I also observed for Hes5-1 expression using the in situ hybridization technique (Fig. 
IV.8A-F’), as Notch activity can be detected in cells undergoing mitosis and in cells labelled 
with a short BrdU pulse (in S-phase). Moreover, activated Notch protein has also been 
detected in neural progenitors undergoing S-phase in the mouse brain (Tokunaga et al., 2004). 
The activation of Notch signalling in different phases of the cell cycle suggests that Notch 
activity might not be restricted to the ventricular surface of the neuroepithelium, contrary to 
what was previously suggested (Murciano et al., 2002; Cisneros et al., 2008; Del Bene et al., 
2008). This suggests instead a stochastic mode of activation of Notch in vertebrate 
neuroepithelia, except for the few hours after mitosis where neural progenitors seem to be 
unable to receive signals from neighbouring cells. 
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IV.4.3.3. Correlation between differential Notch activity during the cell cycle and behaviours 
of siblings 
 
Besides revealing that Notch activation can occur throughout the cell cycle, my experiments 
also show that activation before cell division extends until mitosis, with both daughter cells 
keeping similar levels of Notch activity, suggesting that the two siblings acquire a similar cell 
fate. Since Notch signalling has been implicated in progenitor maintenance (reviewed in 
Louvi and Artavanis-Tsakonas, 2006), it is possible that Notch activity in these cells correlates 
with a P-P division. 
When Notch activity occurs after cell division, only one of the two daughter cells becomes 
active. The distinct behaviour of the two siblings, with only one cell showing Notch activity, 
suggests that these cells acquire different cell fates and might therefore be born in a P-N 
division. In one cell lineage, I have observed Notch activity occurring in two siblings. 
However, even in this lineage the time at which Notch is activated is different between the two 
cells, one cell at 6h after mitosis and its sister cell 11h after cell division, showing that even in 
this case the presence of Notch activity after cell division leads to different outcomes in the 
two daughter cells. 
In this model of Notch-mediated cell fate decisions, lineages of embryos electroporated with 
pCAG-CherryNLS and pHes5-VNP where presumably two neurons are generated in an N-N 
division would be lineages that express CherryNLS, but do not activate Notch and therefore 
do not express VNP, neither before nor after mitosis. Since I am unable to distinguish cells 
that are transfected only with the pCAG-CherryNLS plasmid from cells that are transfected 
with both pCAG-CherryNLS and pHes5-VNP, but do not present Notch activity, I did not 
count the number of potential N-N divisions. 
Although I did not identify the fates of the daughter cells in VNP expressing lineages, my 
results suggest a correlation between the moment of the cell cycle when Notch is activated and 
the mode of division that follows. Asymmetric cell fate decisions mediated by Notch after cell 
division have also been described for the mouse neocortex (Ochiai et al., 2009). Furthermore, 
the increased number of Notch activations before mitosis, when compared to activation after 
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mitosis in only one sibling, is in agreement with the majority of Notch activations before 
mitosis reported in the zebrafish retina (Del Bene et al., 2008) and might correlate with the 
higher number of P-P divisions in the chick spinal cord when compared to P-N divisions 
(Wilcock et al., 2007). The increased number of Notch activations before mitosis, which is 
reflected in an increased number of cells presenting Notch activity during mitosis, might also 
explain why Notch signalling was reported in several studies to occur preferentially in the 
apical region of the neuroepithelium (Murciano et al., 2002; Cisneros et al., 2008; Del Bene et 
al., 2008). 
My results suggest that the absence of Notch activity before mitosis can result in neuron 
producing divisions (P-N or N-N). But how do these cells, with potential to differentiate, 
divide asymmetrically (P-N division) or symmetrically (N-N division)? Previous studies in the 
chick spinal cord (Wilcock et al., 2007) have shown that P-N divisions are mostly generated in 
parallel cleavage planes (<75º), while N-N divisions are only generated in perpendicular 
cleavage planes (>75º). By contrast, P-P divisions can occur in either parallel or perpendicular 
cleavage planes (0-90º). This means that the regulation of mitotic spindle position is only 
important in cells that have potential to differentiate, while acquisition of the neurogenic 
ability is separable from division orientation. Although I did not measure mitotic cleavage 
plane angles in the current study, I propose that Notch activity prior to cell division promotes 
progenitor maintenance by originating a P-P symmetric division, independent of the cleavage 
plane angle, while the neurogenic ability is characterized by the absence of Notch activity 
during mitosis, where the cleavage plane angle will then be the determining factor to 
distinguish between asymmetric vs. symmetric types of neuron production (Fig. IV.14). 
Whether the cleavage plane angle in P-N divisions promotes the ability of one daughter cell to 
receive Notch signalling, or inhibits Notch activity in the other sibling, is still unclear. 
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Figure IV.14: Model of regulation of division 
types by Notch and cleavage plane orientation. 
(A) Symmetric P-P divisions result from Notch 
activation prior to mitosis, which leads to both 
daughter cells acquiring the progenitor fate. (B) 
Asymmetric P-N divisions correlate with absence 
of Notch activation prior to mitosis and from a 
subsequent parallel cleavage plane (0-75º) in 
mitosis, which results in Notch activity in one 
daughter cell and inactivates the ability of the other 
sibling to respond to new Notch signals. (C) 
Symmetric N-N divisions result from absence of 
Notch activation prior to mitosis and from a 
subsequent perpendicular cleavage plane (75-90º) 
in mitosis. In each panel, the series of images 
corresponds to different time points progressing 
from left to right. Apical is down and basal is up. 
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CHAPTER V – FINAL REMARKS AND FUTURE DIRECTIONS 
 
The ageing of the world population is causing an increase in the number of people affected by 
neurodegenerative diseases. Therefore, the demand for new strategies to prevent or cure these 
diseases is rapidly increasing. To design new strategies, it is necessary to enlarge our 
understanding of the processes underlying the biology of the nervous system during 
development and in the adult. 
Notch signalling is involved in many aspects of animal development, including in the 
regulation of nervous system development, where it has several roles. For instance, during 
vertebrate neurogenesis, Notch signalling is necessary for the maintenance of a pool of 
progenitors that ensures the production of the correct number and types of neurons required 
in the adult (reviewed in Louvi and Artavanis-Tsakonas, 2006). 
In this thesis, I have explored this role of Notch signalling during neurogenesis, using the 
chick embryo as a model organism and focusing on the expression and function of Hes genes. 
 
V.1. MAIN FINDINGS 
 
In the work described in Chapter III, I have identified two subgroups of HES6 proteins in 
vertebrates: HES6-1 and HES6-2. While the genomes of fish, frog, chick and platypus contain 
two Hes6 genes, the mouse and human genomes only have one copy of this gene, encoding a 
protein of the HES6-1 subgroup. This implies that Hes6-2 was extinguished from the genome 
during mammalian evolution. 
In the chick embryo, both HES6-1 and HES6-2 contribute to the termination of Notch activity 
in differentiating neurons, although through different mechanisms: cHES6-2 represses the 
transcription of Hes genes and HES6-1 inactivates the remaining HES proteins. 
In neural progenitors, several mechanisms exist to ensure the short-lived character of Notch 
signalling (reviewed in Fior and Henrique, 2009). In the work described in Chapter IV, I have 
found that the 3’UTR of chick Hes5-1 confers post-transcriptional regulation to its mRNA, 
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which might be reflected in decreased stability and/or in block of translation. Therefore, the 
presence of regulatory elements in the 3’UTR of Hes5-1 might be one of the mechanistic 
features involved in the termination of Notch activity. 
During the course of this work, I have also contributed to the generation of a new Notch 
signalling reporter that can be employed to explore the roles of Notch activity during 
embryonic development. This reporter was electroporated into chick embryos and used to 
monitor Notch signalling in spinal cord neural progenitors. My results suggest that neural 
progenitors might experience successive bursts of Notch signalling. The onset of Notch 
activity can occur throughout the cell cycle, probably with the exception of the first few hours 
following mitosis. My results suggest also that the cell cycle phase at which Notch activity 
starts is likely to determine the division mode of neural progenitors: activation of Notch 
before mitosis might correlate with the generation of two neural progenitors (P-P division), 
whereas absence of Notch activity before mitosis might lead to a neuron-generating division, 
giving rise to a progenitor and a neuron or to two neurons (P-N or N-N divisions, 
respectively). In my analysis, a higher number of progenitors activating Notch before mitosis 
was detected, which correlates well to the higher number of P-P divisions reported to occur in 
the neuroepithelium of chick embryos at similar stages to the ones examined (Wilcock et al., 
2007). Given that neural progenitors that activate Notch before mitosis maintain Notch 
activity until cell division, this observation might explain also why Notch signalling was 
reported in several studies to occur preferentially in the apical region of the neuroepithelium, 
where mitosis takes place (Murciano et al., 2002; Cisneros et al., 2008; Del Bene et al., 2008). 
Together, the work described in Chapters III and IV provides new insights into the 
mechanisms involved in the termination of Notch signalling and the functional role of 
dynamic Notch activity in neural progenitors. My findings suggest the following model for the 
lateral inhibition process and termination of Notch activity in differentiating neurons. 
As the embryo grows posteriorly, ectodermal cells leave the influence of the stem zone, where 
they are maintained in a proliferative state by FGF signalling. During neurulation, ectodermal 
cells in the newly formed neural tube become under the influence of Retinoic Acid, produced 
by the somites that are being formed in the adjacent paraxial mesoderm. RA signalling is 
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crucial for the acquisition of neurogenic competence by neural tube cells, triggered by the 
activity of proneural genes. These encode transcription factors that not only induce neuronal 
differentiation, but also promote the expression of Notch ligands, activating the process of 
lateral inhibition. Initially, it is possible that all neuroepithelial cells have the same levels of 
expression of proneural genes. However, transcriptional noise might create differences in 
levels of expression between cells. Small differences in proneural gene expression will lead to 
similar differences in the expression of Notch ligands. These small differences in proneural 
activity are then amplified by Notch signalling, which acts as a binary switch between cells to 
increase directional signalling. The process will result in the emergence of cells expressing 
high levels of proneural proteins, which will promote their commitment to differentiation. At 
the same time, these cells continue to signal to surrounding cells, causing an increase in the 
expression of Notch targets, like the Hes genes. The encoded HES proteins repress the 
expression of proneural proteins and will thereby maintain neighbours of newborn neurons in 
the undifferentiated state. However, after differentiating neurons migrate out of the 
ventricular zone, they lose contact to neural progenitors and Notch signalling is reduced to 
lower levels in these cells, with down-regulation of HES repressors. After Notch activity is 
reduced, the expression of proneural proteins slightly increases in neural progenitors, 
activating the expression of Notch ligands. These progenitors are therefore ready to start a 
new event of lateral inhibition, with transcriptional differences in Notch components and 
proneural genes between progenitors being amplified again. In the end, one cell wins over the 
others and differentiates, while the remaining cells are maintained as progenitors through 
Notch signalling. Therefore, neurogenesis can be viewed as a reiterative process in which 
neural progenitors decide again and again whether to differentiate or to be maintained as 
progenitors. In this model, fluctuations in low levels of expression of proneural proteins and 
Notch ligands are generated, and Notch activity is stochastically reiterated in neural 
progenitors, depending on the availability of Delta/Serrate signals in their neighbourhood 
(Fig. V.1). If Notch is active during mitosis, the neural progenitor divides into two identical 
neural progenitors. However, if there is no Notch activity at mitosis, the two daughter cells 
might differentiate or might behave differently: the cell that contacts with ligand-expressing 
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neurons activates Notch signalling and is maintained as progenitor, while its sibling might 
escape Notch activation and will able to differentiate. In the differentiating cell, Notch activity 
must be completely terminated to allow the cell to properly differentiate, with several 
mechanisms cooperating to this end, such as the expression of HES6 proteins to counteract 
the action of Notch-dependent HES proteins. 
 
V.2. FUTURE WORK 
 
V.2.1. Hes6-1 and Hes6-2 role in neurogenesis 
 
Although differences in the mechanisms of action of HES6-1 and HES6-2 have been unveiled, 
the molecular mechanisms underlying the different activities of the two HES6 proteins are still 
not completely understood. It will be important, for instance, to determine the binding 
partners for each HES6 protein. These experiments shall provide further insights into the 
physiological in vivo roles of the two proteins, and will also help to unveil the reasons for the 
disappearance of the Hes6-2 gene during mammalian evolution. 
 
V.2.2. pHes5-VNP Notch signalling reporter – the first steps to a better Notch reporter 
 
V.2.2.1. Generation of a new Notch signalling reporter 
 
I have generated a novel Notch signalling reporter with features that allow tracking the 
dynamic changes in Notch activity in neural progenitors, with single-cell resolution, in live 
cell imaging experiments. However, the chick embryo electroporation assay that was used in 
these experiments poses several limitations that precluded a more extensive application of the 
reporter. The main problem arises from the fact that electroporation leads to irregular and 
transient expression of the transfected plasmid. Actually, not only it is impossible to control 
the number of plasmids that reaches each cell, but these plasmids are also lost very fast, 
creating a heterogeneous distribution of reporter plasmid in electroporated cells. This 
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precludes any comparison between the reported levels of Notch activity in different cells and 
the correct identification of cells where Notch activity decreases due to the normal 
mechanisms of signalling termination. Saturation of cells with high levels of VNP, due to 
excess of plasmid, was also a problem. Together, these limitations made it impossible to 
monitor possible fluctuations or oscillations in Notch activity in neural progenitors. 
To circumvent these limitations, the reporter must be stably integrated in the genome of the 
cells and in single or low-copy number. Different levels of VNP expression, or its absence, 
would then necessarily correspond to differences in Notch activity or its absence, respectively. 
Several transgenic animals carrying genome-integrated Notch reporters have already been 
generated (Zhang and Gridley, 1998; Davis et al., 2001; Lamar and Kintner, 2005; Masamizu et 
al., 2006; Ohtsuka et al., 2006; Souilhol et al., 2006; Basak and Taylor, 2007; Yeo et al., 2007; 
Aulehla et al., 2008; Imayoshi et al., 2010). However, some of these promoter-driven reporters 
were found not to reflect Notch activity, since their expression does not coincide with the 
endogenous expression of Notch effectors (Davis et al., 2001; Ohtsuka et al., 2006; Souilhol et 
al., 2006; Yeo et al., 2007; Aulehla et al., 2008). This suggests that not all required regulatory 
elements are present in the promoters and mRNA molecules used, indicating that larger 
promoter regions and 3’UTRs of genes must be used to drive correct spatio-temporal reporter 
expression. 
In the last part of my work, I initiated experiments to generate a Notch reporter driven by the 
mouse Hes5 promoter, stably integrated into the genome and in low copy number. The 
chosen approach employs a bacterial artificial chromosome (BAC) that carries the genomic 
regions around the Hes5 gene and that is likely to contain all the required regulatory regions. 
This BAC was manipulated by homologous recombination (reviewed in Copeland et al., 2001) 
to replace the mouse Hes5 coding region with a cDNA encoding VNP, therefore maintaining 
all the regulatory elements of Hes5, including the promoter region and elements for the post-
transcriptional regulation, such as the 3’UTR. 
This paradigm has been the basis of strategies to generate new reporters in several labs (e.g. 
Xian et al., 2005; Kessaris et al., 2006; Tomishima et al., 2007), including Notch reporters 
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(Tomishima et al., 2007; Placantonakis et al., 2009). However, these reporters have stable 
mRNAs and proteins, which do not allow monitoring of the Notch dynamic activity. 
In my strategy, I decided to start by incorporating the recombined BAC carrying the Notch 
reporter in mouse embryonic stem (ES) cells, generating various ES cell clones that will be 
tested for integration, copy number and correct spatio-temporal expression. These ES cells 
carrying the Notch reporter stably integrated into their genomes can be driven into neuronal 
differentiation, in adherent monolayer cultures, using a highly efficient protocol for neural 
stem cell differentiation (Abranches et al., 2009). During this process, neural progenitors 
organize into rosette-like structures that mimic the vertebrate neural tube in its apical-basal 
polarity and Notch activity (Abranches et al., 2009). These structures can thus be viewed as 
small two-dimensional neural tubes that can be easily imaged in a wide-field microscope in 
live-imaging experiments. 
I will combine this Hes5-promoter-driven VNP reporter with a Dll1-promoter-driven 
reporter (using a different fluorescent protein) to allow the identification of nascent neurons 
and thereby correlate Notch activity with cell fate decisions occurring in progenitors. This 
novel 2-reporter system will be a useful tool to accurately monitor Notch activity dynamics, 
extending my previous observations of Notch activity and the understanding of the Notch-
mediated mechanisms underlying cell fate decisions. 
 
V.2.2.2. Questions to be addressed by the new reporter 
 
There are several questions that can be answered by using this novel reporter and I will 
address these in the following paragraphs. 
 
Visualization of intermittent Notch activity 
Hes1 transcriptional dynamics have been visualized in mouse pre-somitic mesoderm (PSM) 
(Masamizu et al., 2006) and mouse neural progenitors (Shimojo et al., 2008). While Hes1 
oscillations in the PSM are part of the mechanisms regulating mesodermal segmentation, 
fluctuations in neural progenitors were suggested to be necessary for their maintenance. 
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Although Hes1 is a Notch target gene, it is also known that Hes1 is regulated through other 
pathways (reviewed in Sanalkumar et al., 2010). Indeed, Hes1 fluctuations in neural 
progenitors have been described to require the activity of the JAK-STAT signalling pathway 
(Shimojo et al., 2008). In contrast, Hes5 expression responds to Notch activity and is a bona 
fide target of this pathway, but Hes5 intermittent fluctuations have not yet been observed (see 
Chapter IV). I thus expect the new reporter to answer the question of whether Hes5 
expression does indeed reflect Notch activity and show an intermittent behaviour. Moreover, I 
expect also to determine whether Notch activations are fluctuation or oscillation-driven. 
 
Different Notch activities between cells 
Differentiating neurons, expressing Dll1, signal to surrounding neural progenitors to inhibit 
their differentiation through Notch signalling. The existence of intermittent and 
desynchronized Notch activations in neural progenitors implies that different cells in the 
neuroepithelium have different levels of Notch activity at any given moment. However, it is 
not known whether Notch activity duration and intensity can be distinct in different cells, by 
receiving Dll1 signals for longer or shorter periods of time. Furthermore, it is not known if the 
extent of Notch activation can influence the fate of the cells: for instance, is a cell with low 
levels of Notch activity still able to differentiate, while neighbouring cells with stronger Notch 
activation will be maintained as neural progenitors? The new 2-reporter system will allow 
answering this question and indicating whether different thresholds of Notch activity are 
permissive or non-permissive for neuronal differentiation. 
 
Timing of commitment to neuronal differentiation 
As described in Chapters I and IV, sister cells arising from a cell division can both be 
maintained as progenitors (P-P divisions), or one cell maintained as progenitor while its 
sibling differentiates into a neuron (P-N division), or even the two cells can differentiate (N-N 
division). However, it is not known whether the commitment to differentiation, which 
originates post-mitotic neurons (cells that do not divide again), occurs before or after the final 
mitosis. The results described in Chapter IV suggest that absence of Notch activity during 
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mitosis correlates with the capacity of daughter cells to differentiate into neurons. 
Furthermore, in situ hybridization results show that the early-born neuron-specific marker 
Dll1 is also expressed in cells undergoing S-phase (Fig. IV.8J-L'), mitosis (Fig. IV.8G-I') or 
even in recently divided siblings (top cells identified with arrows in Fig. IV.8I'). In agreement, 
Dll1 expression has been observed in all phases of the cell cycle in the developing spinal cord 
of chick embryos (Hammerle and Tejedor, 2007), although acquisition of Dll1 expression 
mainly occurs in the area of the neuroepithelium where cells in G2, mitosis and the initial part 
of G1 are situated (near the apical surface) (Murciano et al., 2002). Although it is possible that 
these observations are caused by fluctuations in Dll1 expression in neural progenitors 
(Shimojo et al., 2008), it is also possible that high levels of Dll1 expression are acquired before 
the last cell division, supporting the hypothesis that cells are committed to differentiation 
before they become post-mitotic. If this is indeed the case, it will be interesting to determine if 
a cell expressing Dll1 before mitosis necessarily originates two neurons or if a progenitor can 
still be born in a P-N asymmetric cell division. By monitoring the expression of the new Dll1 
reporter, I expect to unveil the timing of commitment to neuronal differentiation. 
 
V.3. CONCLUSION 
 
The work described in Chapters III and IV of this thesis contributes to the understanding of 
how Notch signalling and Hes genes regulate the development of the vertebrate nervous 
system. I expect this work, not only to be important for adding knowledge to the scientific 
pool, but also to contribute to society in general, by helping to discover new ways to prevent 
or cure existing nervous system diseases. 
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Avé, Célula Estaminal, cheia de graça, 
o Nanog é convosco. 
Bendita sois vós entre as rosetas, 
e bendito é o fruto da vossa diferenciação, Neurónio. 
Santa Célula, Mãe de Tudo, 
rogai por nós, diferenciados, agora e na hora da nossa tese. 
 
Amém. 
